# ::snt A screen for proteins that interact with PAX6 : C-terminal mutations disrupt interaction with HOMER3 , DNCL1 and TRIM11 .
# ::tok A screen for proteins that interact with PAX6 : C-terminal mutations disrupt interaction with HOMER3 , DNCL1 and TRIM11 .
# ::alignments 17-18|0 12-13|0.0 11-12|0.0.0 10-11|0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.0.0.0.0 1-2|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:14.206
(a / and 
      :ARG1-of (i / interact-01 
            :ARG1-of (d / disrupt-01 
                  :ARG0 (m / mutate-01 
                        :ARG1 (i2 / interact-01 
                              :ARG0 (p / protein) 
                              :ARG1 (s / screen))))))

# ::snt The PAX6 protein is a transcriptional regulator with a key role in ocular and neurological development .
# ::tok The PAX6 protein is a transcriptional regulator with a key role in ocular and neurological development .
# ::alignments 15-16|0.2.0 14-15|0.2 13-14|0 12-13|0.1 10-11|0.2.0.0 9-10|0.2.0.0.0 6-7|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:14.385
(a / and 
      :domain-of (r2 / regulator 
            :domain (p / protein)) 
      :op1 (o / ocular) 
      :op2 (n / neurological 
            :ARG1-of (d / develop-02 
                  :mod-of (r / role 
                        :ARG1-of (k / key-02)))))

# ::snt Individuals with heterozygous loss-of-function mutations in the PAX6 gene have malformations of the eye and brain .
# ::tok Individuals with heterozygous loss-of-function mutations in the PAX6 gene have malformations of the eye and brain .
# ::alignments 15-16|0.3 14-15|0 13-14|0.2 10-11|0.1 8-9|0.0.1 4-5|0.0 2-3|0.0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:14.543
(a / and 
      :ARG1-of (m2 / mutate-01 
            :ARG0 (h / heterozygou) 
            :ARG2 (g / gene) 
            :topic (i / individual)) 
      :op1 (m / malformation) 
      :op2 (e / eye) 
      :op3 (b / brain))

# ::snt Little is known about the interactions of PAX6 with other proteins , so we carried out a systematic screen for proteins that interact with PAX6 .
# ::tok Little is known about the interactions of PAX6 with other proteins , so we carried out a systematic screen for proteins that interact with PAX6 .
# ::alignments 22-23|0.1.1.0 20-21|0.1.1.0.0 18-19|0.1.1 17-18|0.1.1.1 14-15|0.1 13-14|0.1.0 12-13|0 10-11|0.1.2 9-10|0.1.2.0 5-6|0.0.1 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:15.018
(c2 / cause-01 
      :ARG0 (k / know-02 
            :ARG1 (l / little) 
            :ARG2 (i2 / interaction)) 
      :ARG1 (c / carry-01 
            :ARG0 (w / we) 
            :ARG1 (s / screen 
                  :ARG1-of (i / interact-01 
                        :ARG0 (p / protein)) 
                  :mod (s2 / systematic)) 
            :op1-of (p2 / protein 
                  :mod (o / other))))

# ::snt We used bioinformatics techniques to characterise a highly conserved peptide at the C-terminus of the PAX6 protein .
# ::tok We used bioinformatics techniques to characterise a highly conserved peptide at the C-terminus of the PAX6 protein .
# ::alignments 16-17|0.2.1 12-13|0.2.1.0 9-10|0.2 8-9|0.2.0 7-8|0.2.0.0 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:15.168
(u / use-01 
      :ARG0 (w / we) 
      :ARG1 (t / technique 
            :mod (b / bioinformatic)) 
      :ARG2 (p2 / peptide 
            :ARG1-of (c2 / conserve-01 
                  :degree (h / high)) 
            :mod-of (p / protein 
                  :poss-of (c / c-terminu))))

# ::snt Yeast two-hybrid library screens were then carried out to identify brain-expressed proteins that interact with the C-terminal peptide and with the entire PAX6 proline-serine-threonine-rich domain .
# ::tok Yeast two-hybrid library screens were then carried out to identify brain-expressed proteins that interact with the C-terminal peptide and with the entire PAX6 proline-serine-threonine-rich domain .
# ::alignments 24-25|0.1 21-22|0.0.0.0.0 18-19|0 17-18|0.0.1 13-14|0.0 11-12|0.0.0 10-11|0.0.0.1 9-10|0.0.0.0 6-7|0.0.0.0.1 5-6|0.0.0.0.1.1 3-4|0.0.0.0.1.0 2-3|0.0.0.0.1.0.0 0-1|0.0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:15.814
(a / and 
      :location-of (i / interact-01 
            :ARG0 (p2 / protein 
                  :ARG1-of (i2 / identify-01 
                        :ARG0 (e / entire) 
                        :purpose-of (c / carry-out-03 
                              :ARG1 (s / screen-01 
                                    :ARG1 (l / library) 
                                    :mod (y / yeast)) 
                              :time (t / then))) 
                  :mod (b / brain-express)) 
            :ARG1 (p / peptide)) 
      :op1 (d / domain))

# ::snt Three novel PAX6-interacting proteins were identified : the post-synaptic density ( PSD ) protein HOMER3 , the dynein subunit DNCL1 , and the tripartite motif protein TRIM11 .
# ::tok Three novel PAX6-interacting proteins were identified : the post-synaptic density ( PSD ) protein HOMER3 , the dynein subunit DNCL1 , and the tripartite motif protein TRIM11 .
# ::alignments 26-27|0.1 25-26|0 24-25|0.0 23-24|0.1.0 21-22|0.2.1.0 19-20|0.2.1 18-19|0.2 17-18|0.2.0 14-15|0.2.1.0.1 13-14|0.2.1.0.1.0 11-12|0.1.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0 9-10|0.2.1.0.0 5-6|0.1.0.0.0.0 3-4|0.1.0.0.0 2-3|0.1.0.0 1-2|0.1.0.1 0-1|0.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:16.319
(p / protein 
      :mod (m / motif) 
      :mod-of (t / TRIM11 
            :mod (t2 / tripartite 
                  :mod (p4 / pax6-interact 
                        :mod-of (p3 / protein 
                              :ARG1-of (i / identify-01 
                                    :ARG0 (o / organization 
                                          :name (n / name 
                                                :op1 "PSD"))) 
                              :quant 3)) 
                  :mod (n2 / novel))) 
      :quant-of (s / subunit 
            :mod (d2 / dynein) 
            :mod-of (d / DNCL1 
                  :op3-of (a / and 
                        :op1 (d3 / density) 
                        :op2 (h / HOMER3 
                              :mod (p2 / protein))))))

# ::snt Three C-terminal PAX6 mutations , previously identified in patients with eye malformations , all reduced or abolished the interactions .
# ::tok Three C-terminal PAX6 mutations , previously identified in patients with eye malformations , all reduced or abolished the interactions .
# ::alignments 18-19|0.1.0 16-17|0.2 15-16|0 14-15|0.1 13-14|0.0 11-12|0.2.0.0.0.0.0 10-11|0.2.0.0.0.0.0.0 8-9|0.2.0.0.0.0.1+0.2.0.0.0.0+0.2.0.0.0 6-7|0.2.0.0 5-6|0.2.0.0.1 3-4|0.2.0 0-1|0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:16.506
(o / or 
      :mod (a2 / all) 
      :op1 (r / reduce-01 
            :ARG1 (i / interaction)) 
      :op2 (a / abolish-01 
            :ARG0 (m2 / mutate-01 
                  :ARG1-of (i2 / identify-01 
                        :ARG0 (p / person 
                              :ARG0-of (h / have-rel-role-91 
                                    :ARG1 (m / malformation 
                                          :mod (e / eye)) 
                                    :ARG2 (p2 / patient))) 
                        :time (p3 / previous)) 
                  :quant 3)))

# ::snt Our preliminary data suggest that PAX6 interacts with HOMER3 , DNCL1 and TRIM11 .
# ::tok Our preliminary data suggest that PAX6 interacts with HOMER3 , DNCL1 and TRIM11 .
# ::alignments 12-13|0.1.1.0.1 11-12|0.1.1.0 10-11|0.1.1.0.0 8-9|0.1.1 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:17.100
(s / suggest-01 
      :ARG0 (d2 / data 
            :mod (p2 / preliminary) 
            :poss (w / we)) 
      :ARG1 (i / interact-01 
            :ARG0 (p / PAX6) 
            :ARG1 (h / HOMER3 
                  :op1-of (a / and 
                        :op2 (d / DNCL1) 
                        :op3 (t / TRIM11)))))

# ::snt We propose that the interaction of PAX6 with HOMER3 and DNCL1 is a mechanism by which synaptic activation could lead to changes in neuronal transcriptional activity , and that some of the neural anomalies in patients with PAX6 mutations could be explained by impaired protein-protein interactions .
# ::tok We propose that the interaction of PAX6 with HOMER3 and DNCL1 is a mechanism by which synaptic activation could lead to changes in neuronal transcriptional activity , and that some of the neural anomalies in patients with PAX6 mutations could be explained by impaired protein-protein interactions .
# ::alignments 45-46|0.1.0.0.0.1.1.0.0 43-44|0.1.0.0.0.1.1.0.0.0 41-42|0.1.0.0.0.1.1.0 39-40|0.1.0.0.0.1.1 38-39|0.1.0.0.0.1.0.1 35-36|0.1.0.0.0.1.0.0.0+0.1.0.0.0.1.0.0+0.1.0.0.0.1.0 33-34|0.1.0.0.0.1.1.0.1 32-33|0.1.0.0.0.1.1.0.1.0 29-30|0.1.0.0.0.1.0.1.0 27-28|0.1.0.0.0.1 25-26|0.3.0 23-24|0.3.0.0 21-22|0.3 19-20|0 18-19|0.2 17-18|0.0 16-17|0.0.0 13-14|0.1 9-10|0.1.0.0 4-5|0.1.0 1-2|0.1.0.0.0 0-1|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:18.019
(l / lead-03 
      :ARG0 (a4 / activation 
            :mod (s2 / synaptic)) 
      :ARG1 (m2 / mechanism 
            :ARG2-of (i3 / interact-01 
                  :ARG1 (a5 / and 
                        :op1 (p5 / propose-01 
                              :ARG0 (w / we) 
                              :ARG1 (a2 / and 
                                    :op1 (p2 / person 
                                          :ARG0-of (h / have-rel-role-91 
                                                :ARG2 (p3 / patient)) 
                                          :ARG1-of (m / mutate-01 
                                                :op1-of (s / some))) 
                                    :op2 (p / possible-01 
                                          :ARG1 (e / explain-01 
                                                :ARG0 (i / interaction 
                                                      :ARG1-of (i2 / impair-01)) 
                                                :ARG1 (a / anomali 
                                                      :mod (n / neural))))))))) 
      :ARG1-of (p4 / possible-01) 
      :ARG2 (c / change-01 
            :ARG1 (a3 / activity-06 
                  :mod (n2 / neuronal))))

# ::snt The PAX6 protein is a member of the PAX ( paired-box ) family of transcriptional regulators and is essential for normal ocular and neural development [ 1 ] .
# ::tok The PAX6 protein is a member of the PAX ( paired-box ) family of transcriptional regulators and is essential for normal ocular and neural development [ 1 ] .
# ::alignments 26-27|0.0.1.0.0.3 24-25|0.1 23-24|0.1.0 22-23|0 21-22|0.0 20-21|0.0.0 18-19|0.0.1 16-17|0.0.1.0 15-16|0.0.1.0.1 12-13|0.0.1.0.0.1 8-9|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 5-6|0.0.1.0.0.2+0.0.1.0.0 2-3|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:19.067
(a / and 
      :op1 (o / ocular 
            :ARG1-of (n2 / normal-02 
                  :ARG0 (o2 / organization 
                        :name (n3 / name 
                              :op1 "PAX"))) 
            :beneficiary-of (e / essential 
                  :op3-of (a2 / and 
                        :op1 (h / have-org-role-91 
                              :ARG0 (p / protein) 
                              :ARG1 (f / family) 
                              :ARG2 (m / member) 
                              :mod 1) 
                        :op2 (r / regulator)))) 
      :op2 (d / develop-02 
            :ARG1 (n / neural)))

# ::snt Heterozygous mutations of the human PAX6 gene cause aniridia ( absence of the iris ) and a range of other congenital eye malformations [ 2 ] .
# ::tok Heterozygous mutations of the human PAX6 gene cause aniridia ( absence of the iris ) and a range of other congenital eye malformations [ 2 ] .
# ::alignments 24-25|0.0 22-23|0.2.2.0.0 21-22|0.2.2.0.0.0 20-21|0.2.2.0.0.2 19-20|0.2.2.0.0.1 17-18|0.2.2.0 15-16|0.2.2 13-14|0.1 10-11|0 8-9|0.2.0 7-8|0.2.0.0 6-7|0.2.0.1 4-5|0.2.0.0.0 1-2|0.2 0-1|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:19.354
(a2 / absent-01 
      :ARG0 2 
      :ARG1 (i / iri) 
      :purpose-of (m2 / mutate-01 
            :ARG1 (a3 / aniridia 
                  :ARG1-of (c2 / cause-01 
                        :ARG0 (h / human)) 
                  :mod (g / gene)) 
            :mod (h2 / heterozygou) 
            :op1-of (a / and 
                  :op2 (r / range-01 
                        :ARG1 (m / malformation 
                              :mod (e / eye) 
                              :mod (o / other) 
                              :mod (c / congenital))))))

# ::snt Neural defects such as foveal hypoplasia and optic nerve hypoplasia are common in PAX6-associated eye disease [ 3-5 ] .
# ::tok Neural defects such as foveal hypoplasia and optic nerve hypoplasia are common in PAX6-associated eye disease [ 3-5 ] .
# ::alignments 15-16|0.0.0 14-15|0.0.0.0 13-14|0.2 11-12|0.0.1.0.0.1 9-10|0.0 8-9|0.1 7-8|0 6-7|0.0.1 5-6|0.0.1.0 2-3|0.0.1.0.0.0 1-2|0.0.1.0.0 0-1|0.0.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:19.479
(o / optic 
      :mod-of (h / hypoplasia 
            :mod (d / disease 
                  :mod (e / eye)) 
            :op2-of (a / and 
                  :op1 (h2 / hypoplasia 
                        :example-of (d2 / defect-01 
                              :ARG1 (s / such) 
                              :domain-of (c / common) 
                              :mod (n2 / neural))))) 
      :mod-of (n / nerve) 
      :poss (p / pax6-associat))

# ::snt Homozygous mutations in man and mouse are lethal and result in severe developmental abnormalities including anophthalmia , severe reduction of the olfactory structures and gross brain malformations [ 2,6 ] .
# ::tok Homozygous mutations in man and mouse are lethal and result in severe developmental abnormalities including anophthalmia , severe reduction of the olfactory structures and gross brain malformations [ 2,6 ] .
# ::alignments 26-27|0.0.0.0.1.1.1 25-26|0.0.0.0.1.1.0.1.0.0 24-25|0.0.0.0.1.1.0.1.0 23-24|0.0.0.0.1.1 22-23|0.0.0.0.1.1.0.0 21-22|0.0.0.0.1.1.0.0.0 18-19|0.0.0.0.1.1.0 17-18|0.0.0.0.1.1.0.1 15-16|0.0.1.0 13-14|0.0.0.0.0 12-13|0.0.0.0.0.1 11-12|0.0.0.0.0.0 9-10|0.0.0.0 8-9|0.0.0.0.1 7-8|0.0.0.0.1.0 5-6|0 4-5|0.0 3-4|0.0.1 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:20.714
(m2 / mouse 
      :op2-of (a5 / and 
            :ARG1-of (m4 / mutate-01 
                  :ARG1-of (r2 / result-01 
                        :ARG2 (a3 / abnormaliti 
                              :mod (s3 / severe) 
                              :mod (d / developmental)) 
                        :op2-of (a4 / and 
                              :op1 (l / lethal) 
                              :op1-of (a / and 
                                    :op2 (r / reduce-01 
                                          :ARG1 (s / structure 
                                                :mod (o / olfactory)) 
                                          :mod (s2 / severe 
                                                :op1 (g / gross-03 
                                                      :ARG1 (b / brain)))) 
                                    :op3 (m / malformation)))) 
                  :mod (h / homozygou)) 
            :op1 (m3 / man 
                  :poss (a2 / anophthalmia))))

# ::snt The roles of PAX6 in brain development have mainly been studied in homozygous mutant mice or rats and include arealisation of the cerebral cortex [ 7 ] , formation of the prosencephalon-mesencephalon boundary [ 8 ] , axon guidance [ 8 ] , differentiation of neurons from glia [ 9 ] and neuronal migration in the cerebellum [ 10 ] .
# ::tok The roles of PAX6 in brain development have mainly been studied in homozygous mutant mice or rats and include arealisation of the cerebral cortex [ 7 ] , formation of the prosencephalon-mesencephalon boundary [ 8 ] , axon guidance [ 8 ] , differentiation of neurons from glia [ 9 ] and neuronal migration in the cerebellum [ 10 ] .
# ::alignments 58-59|0.0.0.1 56-57|0.1.2 53-54|0.3 52-53|0.3.0 51-52|0 49-50|0.1.1 47-48|0.0.1.2.0.1.2.0.0 45-46|0.2.0 43-44|0.2 40-41|0.0.0.0 38-39|0.0.0 37-38|0.0.1.2.0.1.2.0.1 34-35|0.0.1.2.0.0 32-33|0.1.0 28-29|0.1 25-26|0.0.1.2.0.2.0 23-24|0.0 22-23|0.0.2 19-20|0.0.1.1 18-19|0.0.1 17-18|0.0.1.2 16-17|0.0.1.2.0.1.2.0 15-16|0.0.1.2.0.1.2 14-15|0.0.1.2.0.1 13-14|0.0.1.2.0.1.0 12-13|0.0.1.2.0.1.1 10-11|0.0.1.2.0 8-9|0.0.1.2.0.3 6-7|0.0.1.2.0.2 5-6|0.0.1.2.0.2.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:22.550
(a / and 
      :op1 (c2 / cortex 
            :ARG0-of (g2 / guide-01 
                  :ARG1 8 
                  :op1-of 10) 
            :ARG2-of (i / include-01 
                  :ARG0 (r2 / role) 
                  :ARG1 (a3 / arealisation) 
                  :op2-of (a4 / and 
                        :op1 (s / study-01 
                              :ARG0 8 
                              :ARG1 (m2 / mouse 
                                    :mod (m3 / mutant) 
                                    :mod (h / homozygou) 
                                    :op1-of (o / or 
                                          :op2 (r / rat-01 
                                                :ARG0 (g / glia) 
                                                :ARG1 (a2 / axon)))) 
                              :ARG2 (d2 / develop-02 
                                    :ARG0 7 
                                    :ARG1 (b2 / brain)) 
                              :mod (m4 / main)))) 
            :mod (c3 / cerebral)) 
      :op2 (f / form-01 
            :ARG1 (b / boundary) 
            :ARG2 9 
            :op1-of (c / cerebellum)) 
      :op3 (d / differentiation 
            :mod (n2 / neuron)) 
      :op4 (m / migration 
            :mod (n / neuronal)))

# ::snt The discovery of multiple and diverse roles for PAX6 in brain development prompted MRI analyses of aniridia patients , and a range of distinctive brain anomalies were uncovered .
# ::tok The discovery of multiple and diverse roles for PAX6 in brain development prompted MRI analyses of aniridia patients , and a range of distinctive brain anomalies were uncovered .
# ::alignments 27-28|0.1.0.0 25-26|0.1.0.0.0.0 24-25|0.0.0 23-24|0.1.1 21-22|0.1.0.0.0 19-20|0.1 17-18|0.1.0.2.3.0.0+0.1.0.2.3.0+0.1.0.2.3 16-17|0.1.0.2.3.0.0.0 14-15|0.0 13-14|0.1.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0 12-13|0 11-12|0.1.0.1.0 10-11|0.1.0.1.0.0 8-9|0.1.0.1 6-7|0.1.0.2.2 5-6|0.1.0.2.1 4-5|0.1.0.2 3-4|0.1.0.2.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:23.232
(p3 / prompt-01 
      :ARG1 (a4 / analysis 
            :mod (b / brain)) 
      :op2-of (a2 / and 
            :op1 (d4 / discover-01 
                  :ARG0-of (u / uncover-01 
                        :ARG1 (r / range-01 
                              :ARG1 (a / anomali 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "MRI"))))) 
                  :ARG1 (p4 / PAX6 
                        :topic (d2 / develop-02 
                              :ARG1 (b2 / brain))) 
                  :op1-of (a5 / and 
                        :op2 (m / multiple) 
                        :op3 (d3 / diverse) 
                        :op4 (r2 / role) 
                        :op5 (p / person 
                              :ARG0-of (h / have-rel-role-91 
                                    :ARG2 (p2 / patient 
                                          :mod (a3 / aniridia)))))) 
            :op3 (d / distinctive)))

# ::snt The most common and striking of these was absence or hypoplasia of the anterior commissure [ 11 ] .
# ::tok The most common and striking of these was absence or hypoplasia of the anterior commissure [ 11 ] .
# ::alignments 16-17|0.0 14-15|0.2.1.0 13-14|0.1 10-11|0.2.1.1.0 9-10|0.2.1.1 8-9|0.2.1 6-7|0.2.0.1 4-5|0 3-4|0.2 2-3|0.2.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:23.379
(s / strike-05 
      :ARG0 11 
      :ARG1 (a / anterior) 
      :op2-of (a3 / and 
            :op1 (c2 / common 
                  :degree (m / most) 
                  :domain (t / this)) 
            :op3 (a2 / absent-01 
                  :ARG1 (c / commissure) 
                  :op1-of (o / or 
                        :op2 (h / hypoplasia)))))

# ::snt Other defects included absence or hypoplasia of the pineal gland , cortical polymicrogyria , white matter changes in the corpus callosum and grey matter changes in the cerebellum [ 11-13 ] .
# ::tok Other defects included absence or hypoplasia of the pineal gland , cortical polymicrogyria , white matter changes in the corpus callosum and grey matter changes in the cerebellum [ 11-13 ] .
# ::alignments 27-28|0.1.0 24-25|0.0.0.1.2 23-24|0.0.0.1.2.0 22-23|0.0.0.1.2.1 21-22|0.0.0.1 20-21|0.0.0.1.1.1 19-20|0.0.0.1.1.1.0 16-17|0.0.0.1.1 15-16|0.0.0.1.1.0 14-15|0.0.0.1.1.2 12-13|0.0.0.1.0 11-12|0.0.0.1.0.0 9-10|0.0.0.0 8-9|0.0.0.0.0 5-6|0.0.1 4-5|0.0 3-4|0.0.0 2-3|0 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:25.469
(i / include-01 
      :ARG1 (o / or 
            :op1 (a2 / absent-01 
                  :ARG1 (g2 / gland 
                        :mod (p2 / pineal)) 
                  :op1-of (a / and 
                        :op2 (p / polymicrogyria 
                              :mod (c6 / cortical)) 
                        :op3 (c5 / change-01 
                              :ARG1 (m2 / matter) 
                              :location (c3 / callosum 
                                    :mod (c4 / corpu)) 
                              :mod (w / white)) 
                        :op4 (c2 / change-01 
                              :ARG1 (m / matter) 
                              :mod (g / grey)))) 
            :op2 (h / hypoplasia)) 
      :ARG2 (d / defect-01 
            :ARG1 (c / cerebellum) 
            :mod (o2 / other)))

# ::snt Functional changes included hyposmia and abnormal inter-hemispheric auditory transfer [ 11,14 ] .
# ::tok Functional changes included hyposmia and abnormal inter-hemispheric auditory transfer [ 11,14 ] .
# ::alignments 8-9|0.0.2 7-8|0.0.2.0 5-6|0.0.1 4-5|0.0 3-4|0.0.0 2-3|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:25.788
(i / include-01 
      :ARG1 (a3 / and 
            :op1 (h / hyposmia) 
            :op2 (a2 / abnormal) 
            :op3 (t / transfer-01 
                  :ARG1 (a / auditory))) 
      :ARG2 (c / change-01 
            :mod (f / functional)))

# ::snt The defining feature of all PAX proteins is the presence of a 128 amino acid DNA-binding paired domain that has been highly conserved over evolution [ 1 ] .
# ::tok The defining feature of all PAX proteins is the presence of a 128 amino acid DNA-binding paired domain that has been highly conserved over evolution [ 1 ] .
# ::alignments 26-27|0.1.0.0 24-25|0.1 22-23|0 21-22|0.2 17-18|0.0 16-17|0.0.0 15-16|0.0.0.0 14-15|0.0.0.0.1 13-14|0.0.0.0.2 9-10|0.0.0.0.0 6-7|0.1.0.1.0 5-6|0.1.0.1.0.0.0.0+0.1.0.1.0.0.0+0.1.0.1.0.0 4-5|0.0.0.0.0.0 2-3|0.1.0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:26.313
(c / conserve-01 
      :ARG1 (d / domain 
            :ARG1-of (p / pair-01 
                  :ARG0 (d2 / dna-bind 
                        :consist (p2 / presence 
                              :mod (a3 / all)) 
                        :mod (a / acid) 
                        :mod (a2 / amino)))) 
      :ARG2 (e / evolve-02 
            :ARG1 (d3 / define-01 
                  :ARG0 1 
                  :ARG1 (f / feature 
                        :poss (p3 / protein 
                              :mod (o / organization 
                                    :name (n / name 
                                          :op1 "PAX")))))) 
      :degree (h / high))

# ::snt In addition to the paired domain , PAX6 also contains a DNA-binding homeodomain and a proline , serine and threonine-rich ( PST ) domain at the C-terminus [ 1,6 ] .
# ::tok In addition to the paired domain , PAX6 also contains a DNA-binding homeodomain and a proline , serine and threonine-rich ( PST ) domain at the C-terminus [ 1,6 ] .
# ::alignments 26-27|0.2.0 23-24|0.4.0.3 21-22|0.4.0.2 18-19|0.4.0 17-18|0.4.0.1 15-16|0.4.0.0 13-14|0.4 12-13|0.1 11-12|0.1.0 9-10|0 8-9|0.3 5-6|0.2.1 4-5|0.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:27.437
(c2 / contain-01 
      :ARG0 (a4 / addition) 
      :ARG1 (h / homeodomain 
            :mod (d2 / dna-bind)) 
      :manner (p2 / pair-01 
            :ARG0 (c / c-terminu) 
            :ARG1 (d3 / domain)) 
      :mod (a3 / also) 
      :op1-of (a2 / and 
            :op2 (a / and 
                  :op1 (p / proline) 
                  :op2 (s / serine) 
                  :op3 "PST" 
                  :op4 (d / domain))))

# ::snt The PST domain , which encompasses the C-terminal 145 amino acids of PAX6 , has been shown to act as a transcriptional activator [ 6 ] .
# ::tok The PST domain , which encompasses the C-terminal 145 amino acids of PAX6 , has been shown to act as a transcriptional activator [ 6 ] .
# ::alignments 24-25|0.0.0.0.1 22-23|0.0.2 18-19|0.0 16-17|0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0 8-9|0.0.1 5-6|0.0.0.0 2-3|0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:27.586
(s / show-01 
      :ARG1 (a2 / act-02 
            :ARG0 (d / domain 
                  :ARG0-of (e / encompass-01 
                        :ARG1 (a3 / acid 
                              :mod (a4 / amino)) 
                        :ARG2 6) 
                  :mod "PST") 
            :ARG1 145 
            :ARG2 (a / activator)))

# ::snt The PAX6 protein directly regulates a wide range of target genes [ 1,2 ] including Pax2 [ 15 ] , Ngn2 [ 16 ] and glucagon [ 17 ] .
# ::tok The PAX6 protein directly regulates a wide range of target genes [ 1,2 ] including Pax2 [ 15 ] , Ngn2 [ 16 ] and glucagon [ 17 ] .
# ::alignments 27-28|0.0.1.2.0 25-26|0.0.1.1.2 24-25|0 22-23|0.0.1.0 17-18|0.0.1.1.1.0 10-11|0.0 9-10|0.0.0 7-8|0.0.1 6-7|0.0.1.2 4-5|0.0.1.1 3-4|0.0.1.1.1 2-3|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:27.886
(a / and 
      :op1 (g2 / gene 
            :ARG1-of (t / target-01) 
            :ARG1-of (r / range-01 
                  :ARG0 16 
                  :ARG1-of (r2 / regulate-01 
                        :ARG0 (p / protein) 
                        :ARG1-of (d / direct-02 
                              :ARG0 15) 
                        :ARG2 (g / glucagon)) 
                  :ARG2 (w / wide-02 
                        :ARG0 17))))

# ::snt The Pax6 gene has a spatially and temporally complex expression pattern in the eye , brain , nasal structures , spinal cord and pancreas [ 1 ] .
# ::tok The Pax6 gene has a spatially and temporally complex expression pattern in the eye , brain , nasal structures , spinal cord and pancreas [ 1 ] .
# ::alignments 25-26|0.5.0.0.0.0.1 23-24|0.5.0.2 22-23|0 21-22|0.5 20-21|0.4 18-19|0.3 17-18|0.2 15-16|0.1 13-14|0.0 10-11|0.5.0.0.0 9-10|0.5.0.0.0.0 8-9|0.5.0.0.0.1 7-8|0.5.0.1 6-7|0.5.0 5-6|0.5.0.0 2-3|0.5.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:28.467
(a / and 
      :op1 (e / eye) 
      :op2 (b / brain) 
      :op3 (n / nasal) 
      :op4 (s2 / structure) 
      :op5 (s / spinal) 
      :op6 (c / cord 
            :mod-of (a2 / and 
                  :op1 (s3 / spatially 
                        :mod-of (p2 / pattern 
                              :ARG1-of (e2 / express-01 
                                    :ARG0 (g / gene) 
                                    :ARG2 1) 
                              :mod (c2 / complex))) 
                  :op2 (t / temporally) 
                  :op3 (p / pancrea))))

# ::snt Although PAX6 is clearly involved in multiple developmental processes , common themes are now emerging concerning the role of PAX6 in neural tissues .
# ::tok Although PAX6 is clearly involved in multiple developmental processes , common themes are now emerging concerning the role of PAX6 in neural tissues .
# ::alignments 22-23|0.0.0 21-22|0.0.0.0 17-18|0.0 15-16|0 14-15|0.1 13-14|0.2 11-12|0.1.0 10-11|0.1.0.0 8-9|0.1.1.1 7-8|0.1.1.1.0 6-7|0.1.1.1.1 4-5|0.1.1 3-4|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:28.580
(c / concern-02 
      :ARG1 (r / role 
            :mod (t / tissue 
                  :mod (n / neural))) 
      :ARG1-of (e / emerge-01 
            :ARG0 (t2 / theme 
                  :mod (c2 / common)) 
            :condition (i / involve-01 
                  :ARG1-of (c3 / clear-06) 
                  :ARG2 (p / process-02 
                        :mod (d / developmental) 
                        :quant (m / multiple)))) 
      :time (n2 / now))

# ::snt Gradients of Pax6 expression are important for determining positional characteristics in the retina [ 18 ] and the neocortex [ 7 ] .
# ::tok Gradients of Pax6 expression are important for determining positional characteristics in the retina [ 18 ] and the neocortex [ 7 ] .
# ::alignments 20-21|0.0.0 18-19|0.0.1.0.0.0 16-17|0 14-15|0.0.1.0.0.2 12-13|0.0.1.0.0.1.0.0 9-10|0.0.1.0.0.1.0+0.0.1.0.0.1 8-9|0.0.1.0.0.1.1 7-8|0.0.1.0.0 5-6|0.0.1.0 3-4|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:28.725
(a / and 
      :ARG1-of (e / express-01 
            :ARG0 7 
            :mod-of (g / gradient 
                  :domain-of (i / important 
                        :purpose (d / determine-01 
                              :ARG0 (n / neocortex) 
                              :ARG1 (t / thing 
                                    :ARG2-of (c / characteristic-02 
                                          :ARG1 (r / retina)) 
                                    :mod (p / positional)) 
                              :ARG2 18)))))

# ::snt PAX6 plays a role in development of specific axonal connections between the retina and the brain [ 18 ] and within the forebrain [ 8,19 ] .
# ::tok PAX6 plays a role in development of specific axonal connections between the retina and the brain [ 18 ] and within the forebrain [ 8,19 ] .
# ::alignments 22-23|0 19-20|0.0.0.1.2 17-18|0.0.0.1.0 15-16|0.0.0.1.1.0 13-14|0.0.0.0.0 12-13|0.0.0.0 9-10|0.0.0 8-9|0.0.0.2 7-8|0.0 5-6|0.0.0.1 3-4|0.0.0.1.1.1 1-2|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:28.870
(f / forebrain 
      :ARG0-of (s / specific-02 
            :ARG1 (c / connect-01 
                  :ARG1 (r / retina 
                        :op1-of (a2 / and)) 
                  :ARG1-of (d / develop-02 
                        :ARG0 18 
                        :ARG2-of (p / play-02 
                              :ARG0 (b / brain) 
                              :ARG1 (r2 / role)) 
                        :op1-of (a / and)) 
                  :mod (a3 / axonal))))

# ::snt It is also involved in the differentiation of neural cell types from multipotent precursors in the retina [ 16 ] and the cerebral cortex [ 9 ] through activation of bHLH genes such as Ngn2 and Mash1 .
# ::tok It is also involved in the differentiation of neural cell types from multipotent precursors in the retina [ 16 ] and the cerebral cortex [ 9 ] through activation of bHLH genes such as Ngn2 and Mash1 .
# ::alignments 36-37|0.3 35-36|0 34-35|0.2 32-33|0.1 31-32|0.0 28-29|0.0.0 25-26|0.4.0.0 23-24|0.4.1 22-23|0.4.1.0 20-21|0.4 18-19|0.4.0.4 16-17|0.4.0.5.0 13-14|0.4.0.5 12-13|0.4.0.5.1 10-11|0.4.0.5.2 9-10|0.4.0.5.2.0 8-9|0.4.0.5.2.1 6-7|0.4.0.2 3-4|0.4.0 2-3|0.4.0.3 0-1|0.4.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:29.495
(a / and 
      :example-of (g / gene 
            :mod-of (a2 / activation)) 
      :op1 (s / such) 
      :op2 (n / Ngn2) 
      :op3 (m / Mash1) 
      :op3-of (a3 / and 
            :op1 (i / involve-01 
                  :ARG0 9 
                  :ARG1 (i2 / it) 
                  :ARG2 (d / differentiation) 
                  :mod (a4 / also) 
                  :op1-of 16 
                  :source (p / precursor 
                        :location (r / retina) 
                        :mod (m2 / multipotent) 
                        :source-of (t / type 
                              :mod (c3 / cell) 
                              :mod (n2 / neural)))) 
            :op2 (c / cortex 
                  :mod (c2 / cerebral))))

# ::snt These studies provide a clear link between PAX6 function in the retina and the brain , and are of particular relevance to the neurological phenotypes of individuals with PAX6 mutations .
# ::tok These studies provide a clear link between PAX6 function in the retina and the brain , and are of particular relevance to the neurological phenotypes of individuals with PAX6 mutations .
# ::alignments 29-30|0.0.1.0.1.1 26-27|0.0.1.0.1.1.0 24-25|0.0.0.0.0 23-24|0.0.0.0 20-21|0.0.1.0.0 19-20|0.0.1.0.0.0 16-17|0 14-15|0.0.1.2 12-13|0.0.1 11-12|0.0.1.1 8-9|0.0.1.0.1 7-8|0.0.1.0.1.0 5-6|0.0.1.0 4-5|0.0.1.0.2 2-3|0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:30.242
(a / and 
      :op1 (p4 / provide-01 
            :ARG0 (s / study-01 
                  :ARG1 (n / neurological 
                        :mod-of (p / phenotyp)) 
                  :mod (t / this)) 
            :ARG1 (a2 / and 
                  :op1 (l / link-01 
                        :ARG0 (r / relevance 
                              :mod (p2 / particular)) 
                        :ARG1 (f / function-01 
                              :ARG1 (p3 / PAX6) 
                              :ARG1-of (m / mutate-01 
                                    :ARG0 (i / individual))) 
                        :ARG1-of (c / clear-06)) 
                  :op2 (r2 / retina) 
                  :op3 (b / brain))))

# ::snt It is becoming apparent that transcription factors do not act in isolation but are dependent on interactions with other proteins to carry out their function [ 20,21 ] .
# ::tok It is becoming apparent that transcription factors do not act in isolation but are dependent on interactions with other proteins to carry out their function [ 20,21 ] .
# ::alignments 24-25|0.0.0.0.0 21-22|0.0.0.0 19-20|0.0.0.0.0.0 18-19|0.0.0.0.0.0.0 16-17|0.1.0 14-15|0.1 12-13|0 11-12|0.0.2 9-10|0.0 8-9|0.0.3 6-7|0.0.0 5-6|0.0.0.1 3-4|0.0.1 2-3|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:31.582
(c2 / contrast-01 
      :ARG1 (a / act-02 
            :ARG0 (f2 / factor 
                  :ARG0-of (c / carry-out-03 
                        :ARG1 (f / function-01 
                              :ARG1 (p / protein 
                                    :mod (o / other)))) 
                  :mod (t / transcription)) 
            :ARG1 (a2 / apparent 
                  :ARG2-of (b / become-01 
                        :ARG1 (i3 / it))) 
            :manner (i2 / isolate-01) 
            :polarity -) 
      :ARG2 (d / depend-01 
            :ARG1 (i / interaction)))

# ::snt These interactions introduce more specificity into the regulatory function of a given transcription factor .
# ::tok These interactions introduce more specificity into the regulatory function of a given transcription factor .
# ::alignments 13-14|0.2.1 12-13|0.2.1.1 11-12|0.2.1.0 8-9|0.2 7-8|0.2.0 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:31.782
(i / introduce-02 
      :ARG0 (i2 / interaction 
            :mod (t2 / this)) 
      :ARG1 (s / specificity 
            :quant (m / more)) 
      :ARG2 (f2 / function-01 
            :ARG0-of (r / regulate-01) 
            :ARG1 (f / factor 
                  :ARG1-of (g / give-01) 
                  :mod (t / transcription))))

# ::snt To date only three PAX6 protein-protein interactions have been described : with SOX2 on the lens-specific enhancer element of the -crystallin gene [ 22 ] ; with MDIA , which modulates PAX6 activity in early neuronal development [ 23 ] , and with MAF proteins on the glucagon promoter , which causes increased expression of this pancreatic hormone gene [ 17 ] .
# ::tok To date only three PAX6 protein-protein interactions have been described : with SOX2 on the lens-specific enhancer element of the -crystallin gene [ 22 ] ; with MDIA , which modulates PAX6 activity in early neuronal development [ 23 ] , and with MAF proteins on the glucagon promoter , which causes increased expression of this pancreatic hormone gene [ 17 ] .
# ::alignments 60-61|0.0.0.0.0.1.1.0.0.1.0 58-59|0.0.0 57-58|0.0.0.0 56-57|0.0.0.1 55-56|0.0.0.2 53-54|0.0 52-53|0.0.1 51-52|0 48-49|0.1 47-48|0.1.1 44-45|0.0.0.0.0 43-44|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 41-42|0.0.0.0.0.1 38-39|0.0.0.0.0.1.0.0.0 36-37|0.0.0.0.0.1.1.0.0.1 35-36|0.0.1.0 34-35|0.0.0.0.0.1.1.0.1 32-33|0.0.0.0.0.1.1.0.0 30-31|0.0.0.0.0.1.1.0 27-28|0.0.0.0.0.1.1.1.0+0.0.0.0.0.1.1.1+0.0.0.0.0.1.1 25-26|0.0.1.1 23-24|0.1.0 21-22|0.0.0.0.0.1.0.1 17-18|0.0.0.0.0.1.0 16-17|0.0.0.0.0.1.0.0 9-10|0.0.0.0.0.1.1.0.0.0 6-7|0.0.0.0.0.1.1.0.0.0.0 3-4|0.0.0.0.0.1.0.0.1 2-3|0.0.0.0.0.1.1.0.0.0.0.0 1-2|0.0.0.0.0.1.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:35.296
(c / cause-01 
      :ARG1 (e / express-01 
            :ARG1 (g / gene 
                  :mod (h / hormone 
                        :topic-of (p3 / protein 
                              :mod (o / organization 
                                    :name (n / name 
                                          :op1 "MAF")) 
                              :op2-of (a / and 
                                    :example-of (e3 / element 
                                          :mod (e4 / enhance-01 
                                                :ARG0 23 
                                                :ARG1 3) 
                                          :part-of (g3 / gene)) 
                                    :op1 (o2 / organization 
                                          :ARG0-of (m / modulate-01 
                                                :ARG1 (a2 / activity-06 
                                                      :ARG1 (d2 / describe-01 
                                                            :ARG1 (i2 / interaction 
                                                                  :quant (o3 / only)) 
                                                            :ARG3 (d3 / date)) 
                                                      :ARG2 (d / develop-02 
                                                            :ARG1 17)) 
                                                :time (e2 / early)) 
                                          :name (n3 / name 
                                                :op1 "MDIA"))))) 
                  :mod (p / pancreatic) 
                  :mod (t / this)) 
            :ARG1-of (i / increase-01 
                  :ARG0 (n2 / neuronal) 
                  :op1-of (a3 / and))) 
      :ARG2 (p2 / promote-01 
            :ARG0 22 
            :ARG1 (g2 / glucagon)))

# ::snt Here we report the preliminary results of the first systematic screen for proteins that interact with PAX6 .
# ::tok Here we report the preliminary results of the first systematic screen for proteins that interact with PAX6 .
# ::alignments 16-17|0.2.1 14-15|0.2 12-13|0.2.0 10-11|0.1.0.0 9-10|0.1.0.0.0 5-6|0.1.0+0.1 4-5|0.1.1 2-3|0 1-2|0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:35.589
(r2 / report-01 
      :ARG0 (w / we) 
      :ARG1 (t / thing 
            :ARG2-of (r / result-01 
                  :ARG1 (s / screen 
                        :mod (s2 / systematic))) 
            :mod (p3 / preliminary)) 
      :ARG2 (i / interact-01 
            :ARG0 (p2 / protein) 
            :ARG1 (p / PAX6)) 
      :location (h / here))

# ::snt We used sequence alignment algorithms and secondary structure prediction programs to define a new domain of 32 amino acids at the C-terminal end of the PAX6 protein .
# ::tok We used sequence alignment algorithms and secondary structure prediction programs to define a new domain of 32 amino acids at the C-terminal end of the PAX6 protein .
# ::alignments 26-27|0 25-26|0.1 22-23|0.0 18-19|0.0.0.1.1 17-18|0.0.0.1.1.0 16-17|0.0.0.2.1.0.0.0 14-15|0.0.0.1 13-14|0.0.0.1.0 11-12|0.0.0 9-10|0.0.0.2.1.0 8-9|0.0.0.2.1.0.0 7-8|0.0.0.2.1.0.0.1.0 6-7|0.0.0.2.1.0.0.1 5-6|0.0.0.2.1 4-5|0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0.0.0.0 1-2|0.0.0.2 0-1|0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:36.575
(p / protein 
      :ARG1-of (e / end-01 
            :ARG2-of (d2 / define-01 
                  :ARG0 (a4 / algorithm 
                        :ARG0-of (a5 / align-01 
                              :ARG1 (s3 / sequence))) 
                  :ARG1 (d / domain 
                        :mod (n / new) 
                        :poss (a / acid 
                              :mod (a2 / amino))) 
                  :ARG2-of (u / use-01 
                        :ARG0 (w / we) 
                        :ARG1 (a3 / and 
                              :op1 (p3 / program 
                                    :topic (p4 / predict-01 
                                          :ARG0 32 
                                          :mod (s2 / secondary 
                                                :mod-of (s / structure)))))))) 
      :mod (p2 / PAX6))

# ::snt We then screened a brain library with this peptide using the yeast two-hybrid technique and identified three novel interacting proteins , HOMER3 , DNCL1 and TRIM11 .
# ::tok We then screened a brain library with this peptide using the yeast two-hybrid technique and identified three novel interacting proteins , HOMER3 , DNCL1 and TRIM11 .
# ::alignments 24-25|0.0.0.0 19-20|0.0.0.0.1 18-19|0.0.0.0.0 17-18|0.0.0.0.0.0 16-17|0.2.2 15-16|0.0.0 14-15|0.0.0.1 13-14|0.2.1 11-12|0.2.1.0 9-10|0.2 8-9|0.2.0 7-8|0.2.0.0 5-6|0.1 4-5|0.0.0.0.0.1 2-3|0 1-2|0.3 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:37.072
(s / screen-01 
      :ARG0 (w / we 
            :ARG0-of (i2 / identify-01 
                  :ARG1 (a / and 
                        :ARG1-of (i / interact-01 
                              :ARG0 (n / novel) 
                              :op1-of (b / brain)) 
                        :op1 (p / protein)) 
                  :op1-of (a2 / and))) 
      :ARG1 (l / library) 
      :manner (u / use-01 
            :ARG0 (p2 / peptide 
                  :mod (t2 / this)) 
            :ARG1 (t / technique 
                  :mod (y / yeast)) 
            :ARG2 3) 
      :time (t3 / then))

# ::snt The interaction between PAX6 and these proteins was disrupted by naturally occurring C-terminal PAX6 mutations .
# ::tok The interaction between PAX6 and these proteins was disrupted by naturally occurring C-terminal PAX6 mutations .
# ::alignments 14-15|0.0.0 11-12|0.0 10-11|0.0.1 8-9|0.0.0.0 6-7|0 5-6|0.1 4-5|0.2 3-4|0.2.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:37.171
(p / protein 
      :ARG0-of (o / occur-01 
            :ARG1 (m / mutate-01 
                  :ARG0-of (d / disrupt-01 
                        :ARG1 (i / interact-01))) 
            :ARG1-of (n / natural-03)) 
      :mod (t / this) 
      :op2-of (a / and 
            :op1 (p2 / PAX6)))

# ::snt A highly conserved C-terminal PAX6 peptide .
# ::tok A highly conserved C-terminal PAX6 peptide .
# ::alignments 5-6|0 4-5|0.1 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:37.193
(p / peptide 
      :ARG1-of (c / conserve-01 
            :degree (h / high)) 
      :mod (p2 / PAX6))

# ::snt We and others [ 31-33 ] noted that there is significant sequence conservation at the C-terminal end of the PAX6 protein .
# ::tok We and others [ 31-33 ] noted that there is significant sequence conservation at the C-terminal end of the PAX6 protein .
# ::alignments 20-21|0 16-17|0.0 12-13|0.0.0 11-12|0.0.0.0 10-11|0.0.0.1 6-7|0.0.1.0.0 2-3|0.0.1.1 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:37.302
(p / protein 
      :ARG1-of (e / end-01 
            :ARG2-of (c / conserve-01 
                  :ARG1 (s / sequence) 
                  :ARG1-of (s2 / significant-02)) 
            :op3-of (a / and 
                  :op1 (w / we 
                        :ARG0-of (n / note-01)) 
                  :op2 (o / other))))

# ::snt BLAST analysis of the amino acid sequence of the PAX6 PST domain ( aa 278 -- 422 ) revealed a highly conserved motif within the last 28 amino acids ( beginning at the ` GLISP ' motif , Figure 1a ) .
# ::tok BLAST analysis of the amino acid sequence of the PAX6 PST domain ( aa 278 -- 422 ) revealed a highly conserved motif within the last 28 amino acids ( beginning at the ` GLISP ' motif , Figure 1a ) .
# ::alignments 39-40|0.1.0.0.0 38-39|0.1.0.0 36-37|0.0.0 30-31|0.2.0 28-29|0.2 27-28|0.2.2 26-27|0.0.2.0 25-26|0.2.1 22-23|0.1 21-22|0.1.0 20-21|0.1.0.1 18-19|0 16-17|0.2.0.0 13-14|0.0.2.1 11-12|0.0.1.2 10-11|0.0.1.2.0 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0.1.1 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:38.502
(r / reveal-01 
      :ARG0 (a6 / analyze-01 
            :ARG0 (m / motif) 
            :ARG1 (s / sequence 
                  :mod (a4 / acid) 
                  :mod (a5 / amino) 
                  :poss-of (d / domain 
                        :mod "PST")) 
            :ARG2 (b2 / blast-01 
                  :ARG0 28 
                  :ARG1 (a3 / aa))) 
      :ARG1 (m2 / motif 
            :ARG1-of (c / conserve-01 
                  :ARG0 (f / figure 
                        :mod 1a) 
                  :degree (h / high))) 
      :ARG2 (a / acid 
            :ARG1-of (b / begin-01 
                  :ARG0 422) 
            :mod (l / last) 
            :mod (a2 / amino)))

# ::snt Strong conservation was seen in distantly related species such as axolotl ( Ambystoma mexicanum ) and sea urchin ( Paracentrotus lividus ) ( Figure 1a ) .
# ::tok Strong conservation was seen in distantly related species such as axolotl ( Ambystoma mexicanum ) and sea urchin ( Paracentrotus lividus ) ( Figure 1a ) .
# ::alignments 23-24|0.1.1.0.0.3 20-21|0.1.0.0 19-20|0.1.0 17-18|0.1.1.0.0.2 16-17|0.1.1.0.0.1 15-16|0.1.1.0.0 13-14|0.0.0 12-13|0.0.1.0+0.0.1+0.0 10-11|0.1.1.0.0.0 8-9|0.1.2 7-8|0.1.1.0 6-7|0.1.1 5-6|0.1.1.1 3-4|0 1-2|0.1 0-1|0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:38.735
(s4 / see-01 
      :ARG0 (p2 / person 
            :mod-of (m / mexicanum) 
            :name (n / name 
                  :op1 "Ambystoma")) 
      :ARG1 (c / conserve-01 
            :ARG0 (p / paracentrotu 
                  :mod-of (l / lividu)) 
            :ARG0-of (r / relate-01 
                  :ARG1 (s3 / species 
                        :example (a / and 
                              :op1 (a2 / axolotl) 
                              :op2 (s / sea) 
                              :op3 (u / urchin) 
                              :op4 (f / figure))) 
                  :mod (d / distantly)) 
            :ARG1 (s2 / such) 
            :mod (s5 / strong)))

# ::snt Characterisation of the PAX6 C-terminal peptide .
# ::tok Characterisation of the PAX6 C-terminal peptide .
# ::alignments 5-6|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:38.744
(c / characterisation 
      :poss (p / peptide))

# ::snt ( a ) CLUSTAL alignment of the terminal 42 amino acids of PAX6 from diverse species .
# ::tok ( a ) CLUSTAL alignment of the terminal 42 amino acids of PAX6 from diverse species .
# ::alignments 15-16|0.0 14-15|0.0.0 10-11|0.1 9-10|0 8-9|0.1.1 7-8|0.1.0.0 4-5|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:38.819
(a2 / amino 
      :mod-of (s / species 
            :mod (d / diverse)) 
      :mod-of (a / acid 
            :ARG1-of (a3 / align-01 
                  :ARG2 (t / terminal)) 
            :quant 42))

# ::snt ( * ) indicates invariant residues , ( :) indicates highly similar substitutions and ( . )
# ::tok ( * ) indicates invariant residues , ( :) indicates highly similar substitutions and ( . )
# ::alignments 13-14|0.0 12-13|0.0.0 11-12|0.0.0.0 10-11|0.0.0.0.0 9-10|0 5-6|0.1.0 4-5|0.1.0.0 3-4|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:38.986
(i / indicate-01 
      :ARG1 (a / and 
            :op1 (s / substitution 
                  :ARG1-of (r / resemble-01 
                        :degree (h / high)))) 
      :condition (i3 / indicate-01 
            :ARG1 (r2 / residu 
                  :mod (i2 / invariant))))

# ::snt indicates moderately similar substitutions .
# ::tok indicates moderately similar substitutions .
# ::alignments 3-4|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:39.000
(i / indicate-01 
      :ARG1 (s / substitution 
            :ARG1-of (r / resemble-01 
                  :degree (m / moderate))))

# ::snt ( b ) Secondary structure analysis of the highly conserved terminal 28 amino acids predicts a single beta sheet ( arrow ) in the SVPVQ peptide .
# ::tok ( b ) Secondary structure analysis of the highly conserved terminal 28 amino acids predicts a single beta sheet ( arrow ) in the SVPVQ peptide .
# ::alignments 25-26|0.0.1.0 24-25|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 18-19|0.1 17-18|0.1.1 16-17|0.1.0 14-15|0 13-14|0.0 12-13|0.0.1 11-12|0.1.0.0 10-11|0.1.0.1.1 9-10|0.1.0.1 8-9|0.1.0.1.2 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0.0.1 1-2|0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:39.816
(p2 / predict-01 
      :ARG0 (a / acid 
            :ARG1-of (a3 / analyze-01 
                  :ARG0 (s3 / structure) 
                  :manner (s4 / secondary)) 
            :mod (a2 / amino 
                  :poss-of (p / peptide 
                        :mod (c / country 
                              :name (n / name 
                                    :op1 "SVPVQ"))))) 
      :ARG1 (s / sheet 
            :ARG1-of (s2 / single-02 
                  :ARG0 28 
                  :ARG2-of (c2 / conserve-01 
                        :ARG0 (b2 / b) 
                        :ARG1 (t / terminal) 
                        :degree (h / high))) 
            :mod (b / beta)))

# ::snt ( c ) When 4 residues are added in the N-terminal direction , 2 beta sheets are now predicted .
# ::tok ( c ) When 4 residues are added in the N-terminal direction , 2 beta sheets are now predicted .
# ::alignments 18-19|0 17-18|0.2 15-16|0.0 14-15|0.0.0 13-14|0.0.1 11-12|0.1.2 7-8|0.1 5-6|0.1.1 4-5|0.1.1.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:39.961
(p / predict-01 
      :ARG1 (s / sheet 
            :mod (b / beta) 
            :quant 2) 
      :purpose (a / add-01 
            :ARG0 (c / c) 
            :ARG1 (r / residu 
                  :quant 4) 
            :ARG2 (d / direction)) 
      :time (n / now))

# ::snt We subjected the whole PAX6 PST domain to secondary structure analysis using JPRED , a program that uses a number of different protein structure prediction algorithms to generate a consensus secondary structure ( Figure 1 ) [ 25,26 ] .
# ::tok We subjected the whole PAX6 PST domain to secondary structure analysis using JPRED , a program that uses a number of different protein structure prediction algorithms to generate a consensus secondary structure ( Figure 1 ) [ 25,26 ] .
# ::alignments 34-35|0.0.3.0.0.0.1.2 33-34|0.0.0.1.0.0 31-32|0.0.2 30-31|0.0.3.0.0.0.1.3 29-30|0.0.1 27-28|0.0 25-26|0.0.0 24-25|0.0.0.0 23-24|0.0.0.0.1 22-23|0 21-22|0.0.0.1.0 19-20|0.0.0.1 17-18|0.0.3 15-16|0.0.3.0 12-13|0.0.3.0.0.0.1.0.0.0.0+0.0.3.0.0.0.1.0.0.0+0.0.3.0.0.0.1.0.0 11-12|0.0.3.0.0.0.1.0 10-11|0.0.3.0.0.0.1 9-10|0.0.3.0.0.0.1.1 8-9|0.0.3.0.0.0.1.1.0 6-7|0.0.3.0.0.0.0 5-6|0.0.3.0.0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.3.0.0.0 0-1|0.0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:41.870
(p2 / protein 
      :mod-of (g / generate-01 
            :ARG0 (a / algorithm 
                  :mod (p / predict-01 
                        :ARG0 (w / whole) 
                        :ARG1 (s3 / structure)) 
                  :quant (n / number 
                        :ARG1-of (d / differ-02 
                              :ARG0 (f / figure)))) 
            :ARG1 (c / consensus) 
            :ARG2 (s / structure) 
            :purpose-of (u / use-01 
                  :ARG1 (p3 / program 
                        :poss (w2 / we 
                              :ARG0-of (s6 / subject-01 
                                    :ARG1 (d2 / domain 
                                          :mod "PST") 
                                    :ARG2 (a2 / analyze-01 
                                          :ARG0-of (u2 / use-01 
                                                :ARG1 (o / organization 
                                                      :name (n2 / name 
                                                            :op1 "JPRED"))) 
                                          :ARG1 (s4 / structure 
                                                :mod (s5 / secondary)) 
                                          :ARG2 1 
                                          :op1-of (s2 / secondary))))))))

# ::snt The PST domain was largely devoid of predicted secondary structure except for the C-terminal region , which contained two predicted beta sheets within the highly conserved domain , one in the ` GLISP ' motif and one in the ` SPVPQ ' motif ( identical to the pattern shown in Figure 1c ) .
# ::tok The PST domain was largely devoid of predicted secondary structure except for the C-terminal region , which contained two predicted beta sheets within the highly conserved domain , one in the ` GLISP ' motif and one in the ` SPVPQ ' motif ( identical to the pattern shown in Figure 1c ) .
# ::alignments 51-52|0.1.0.0.3.1.0.0 50-51|0.1.0.0.3.1.0.0.0 48-49|0.1.0.0.3.1.0 47-48|0.1.0.0.3.1 44-45|0.1.0.0.3 42-43|0.0 35-36|0.1.0.0.4.1 34-35|0.1.0.0.2.0 26-27|0.1.0.0.4 25-26|0.1.0.0.4.0 24-25|0.1.0.0.4.0.1 21-22|0.1.0.0.1 20-21|0.1.0.0.1.0 19-20|0.1.0.0 18-19|0.1.0.0.3.0 17-18|0 14-15|0.1 10-11|0.1.0 9-10|0.1.0.0.0 8-9|0.1.0.0.4.0.0 7-8|0.1.0.0.2 5-6|0.1.0.0.2.1 4-5|0.1.0.0.2.1.0 2-3|0.1.0.0.2.1.1 1-2|0.1.0.0.2.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:42.846
(c2 / contain-01 
      :ARG0 (m / motif) 
      :ARG1 (r / region 
            :ARG0-of (e / except-01 
                  :ARG1 (p2 / predict-01 
                        :ARG0 (s3 / structure) 
                        :ARG1 (s2 / sheet 
                              :mod (b / beta)) 
                        :ARG1-of (p3 / predict-01 
                              :ARG0 (m2 / motif) 
                              :purpose-of (d2 / devoid 
                                    :degree (l / large) 
                                    :domain (d3 / domain 
                                          :mod "PST"))) 
                        :ARG2 (i / identical-01 
                              :ARG0 2 
                              :ARG2 (p / pattern 
                                    :ARG1-of (s / show-01 
                                          :ARG0 (1 / 1c 
                                                :mod-of (f / figure))))) 
                        :location (d / domain 
                              :ARG1-of (c / conserve-01 
                                    :ARG0 (s4 / secondary) 
                                    :degree (h / high)) 
                              :op1-of (a / and))))))

# ::snt Initially we defined the C-terminal domain as running from the ` GLISP ' motif up to the stop codon , since this region was most highly conserved and contained strongly predicted secondary structure elements .
# ::tok Initially we defined the C-terminal domain as running from the ` GLISP ' motif up to the stop codon , since this region was most highly conserved and contained strongly predicted secondary structure elements .
# ::alignments 33-34|0.0.0.1.1.0.0 32-33|0.0.0.1.1.0.0.0 31-32|0.0.0.1.1.0.0.0.0 30-31|0.0.0.1.1.0 29-30|0.0.0.1.1.0.1 28-29|0.0.0.1 27-28|0.0.0.1.1 26-27|0.0.0.1.0.0 25-26|0.0.0.1.0.0.0 24-25|0.0.0.1.0.0.0.0 22-23|0.0.0.1.0 21-22|0.0.0.1.0.1 20-21|0.1.0 18-19|0 17-18|0.1 13-14|0.0.1 7-8|0.0 5-6|0.0.0.0.0 2-3|0.0.0.0 1-2|0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:43.338
(c3 / codon 
      :ARG1-of (r2 / run-01 
            :ARG0 (w / we 
                  :ARG0-of (d2 / define-01 
                        :ARG1 (d / domain) 
                        :time (i / initial)) 
                  :ARG1-of (c / contain-01 
                        :ARG0 (r / region 
                              :ARG1-of (c2 / conserve-01 
                                    :degree (h / high 
                                          :degree (m / most))) 
                              :mod (t / this)) 
                        :op1-of (a / and 
                              :op2 (p / predict-01 
                                    :ARG1 (e / element 
                                          :mod (s / structure 
                                                :mod (s2 / secondary))) 
                                    :ARG1-of (s3 / strong-02))))) 
            :ARG2 (m2 / motif)) 
      :ARG1-of (s5 / stop-01 
            :op1-of (s4 / since)))

# ::snt However when we performed secondary structure prediction analysis on this 28 amino acid peptide , the first beta sheet was lost ( Figure 1b ) .
# ::tok However when we performed secondary structure prediction analysis on this 28 amino acid peptide , the first beta sheet was lost ( Figure 1b ) .
# ::alignments 23-24|0.1 22-23|0.1.0 20-21|0 18-19|0.2 17-18|0.2.0 13-14|0.0.0.0.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.1 10-11|0.2.1 9-10|0.1.0.0 7-8|0.0.0.0 6-7|0.0.0.0.1 5-6|0.0.0.0.1.0 4-5|0.0.0.0.1.0.0 3-4|0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:44.197
(l / lose-02 
      :ARG0 (w / we 
            :ARG0-of (p3 / perform-02 
                  :ARG1 (a3 / analyze-01 
                        :ARG0 (p / peptide 
                              :mod (a / acid) 
                              :mod (a2 / amino)) 
                        :ARG1 (p2 / predict-01 
                              :ARG1 (s2 / structure 
                                    :mod (s3 / secondary)))))) 
      :ARG1 (1 / 1b 
            :mod-of (f / figure 
                  :mod (t / this))) 
      :ARG2 (s / sheet 
            :mod (b / beta) 
            :name 28))

# ::snt Addition of another 4 amino acids ( TTST ) immediately before ` GLISP ' caused recovery of the first beta sheet ( Figure 1c ) .
# ::tok Addition of another 4 amino acids ( TTST ) immediately before ` GLISP ' caused recovery of the first beta sheet ( Figure 1c ) .
# ::alignments 23-24|0.1.0 22-23|0.1.0.0 20-21|0.1.1 19-20|0.1.1.0 15-16|0.1 14-15|0 10-11|0.2 9-10|0.3 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0.0.1.0 2-3|0.0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:44.466
(c / cause-01 
      :ARG0 (a4 / addition 
            :poss (a / acid 
                  :mod (a2 / amino) 
                  :quant (a3 / another 
                        :quant 4))) 
      :ARG1 (r / recover-01 
            :ARG0 (1 / 1c 
                  :mod-of (f / figure)) 
            :ARG1 (s / sheet 
                  :mod (b / beta))) 
      :ARG2 (b2 / before) 
      :time (i / immediate))

# ::snt Although these 4 residues are not highly conserved ( Figure 1a ) , they appear to be important for seeding the first beta sheet and therefore for secondary structure .
# ::tok Although these 4 residues are not highly conserved ( Figure 1a ) , they appear to be important for seeding the first beta sheet and therefore for secondary structure .
# ::alignments 28-29|0.1.1.0.0 27-28|0.0 24-25|0.1.1.1 23-24|0.1.1.0 22-23|0.1.1.0.1 19-20|0.1.1 17-18|0.1 14-15|0 13-14|0.1.0 9-10|0.2.0 7-8|0.2 6-7|0.2.2 5-6|0.2.3 3-4|0.2.1 2-3|0.2.1.1 1-2|0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:44.859
(a2 / appear-02 
      :ARG0 (s2 / secondary) 
      :ARG1 (i / important 
            :domain (t / they) 
            :purpose (s4 / seed-01 
                  :ARG1 (s3 / sheet 
                        :location-of (s / structure) 
                        :mod (b / beta)) 
                  :op1-of (a / and))) 
      :condition (c / conserve-01 
            :ARG0 (f / figure) 
            :ARG1 (r / residu 
                  :mod (t2 / this) 
                  :quant 4) 
            :degree (h / high) 
            :polarity -))

# ::snt Thus we define the C-terminal peptide as being the final 32 amino acids of PAX6 , running from threonine 391 to the stop codon ( top line of Figure 1c ) .
# ::tok Thus we define the C-terminal peptide as being the final 32 amino acids of PAX6 , running from threonine 391 to the stop codon ( top line of Figure 1c ) .
# ::alignments 29-30|0.0.0.0.0.1.0.0.0 28-29|0.0.0.0.0.1.0.0 26-27|0.0.0.0.0.1.0 25-26|0.0.0.0.0.1.0.1 23-24|0.0.0.0.2 22-23|0.0.0.0 19-20|0.0.0.0.0.1.1 18-19|0.0.0.0.0.1.1.0 16-17|0.0.0.0.0.1 12-13|0.0 11-12|0 10-11|0.0.0.0.1 9-10|0.0.0 5-6|0.0.0.0.0.0.0 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:45.182
(a2 / amino 
      :mod-of (a / acid 
            :mod (f2 / final 
                  :op1 (s / stop-01 
                        :ARG0 (w / we 
                              :ARG0-of (d / define-01 
                                    :ARG1 (p / peptide) 
                                    :location (t3 / thu)) 
                              :ARG0-of (r / run-01 
                                    :ARG1 (l / line 
                                          :consist-of (f / figure 
                                                :mod 1c) 
                                          :mod (t / top)) 
                                    :ARG2 (3 / 391 
                                          :mod (t2 / threonine)))) 
                        :ARG2 32 
                        :mod-of (c / codon)))))

# ::snt We hypothesised that the C-terminal peptide might be involved in protein-protein interactions , and we tested this by screening a cDNA library using the yeast two-hybrid system with a construct ( PAX6CTP ) in which the 32 amino acid C-terminal peptide was fused to the yeast GAL4 DNA binding domain .
# ::tok We hypothesised that the C-terminal peptide might be involved in protein-protein interactions , and we tested this by screening a cDNA library using the yeast two-hybrid system with a construct ( PAX6CTP ) in which the 32 amino acid C-terminal peptide was fused to the yeast GAL4 DNA binding domain .
# ::alignments 49-50|0.1.0.0.0.0.2.0.1.0.0.0 48-49|0.1.0.0.0.0.2.0.1.0.0 47-48|0.1.0.0.0.0.2.0.1.0 46-47|0.1.0.0.0.0.2.0.1.1.0+0.1.0.0.0.0.2.0.1.1+0.1.0.0.0.0.2.0.1 45-46|0.1.0.0.0.0.1 42-43|0.1.0.0.0.0.2.0 40-41|0.1.0.0.0.0.2.0.0 38-39|0.1.0.0.0.0.2.0.0.0 37-38|0.1.3 36-37|0.1.2 29-30|0.1.0.0.0.0.2 26-27|0.1.0.0.0.0.0 24-25|0.1.0.0.0.0.0.0 22-23|0.1.0.0.0.0 21-22|0.1.0.0.0 20-21|0.1.0.0.0.1 18-19|0.1.0.0 16-17|0.1.1 15-16|0.1 14-15|0.1.0 13-14|0 11-12|0.0.1.0.1 8-9|0.0.1.0 6-7|0.0.1 5-6|0.0.1.0.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:46.422
(a3 / and 
      :op1 (h / hypothesize-01 
            :ARG0 (w2 / we) 
            :ARG1 (p2 / possible-01 
                  :ARG1 (i2 / involve-01 
                        :ARG1 (p3 / peptide) 
                        :ARG2 (i / interaction)))) 
      :op2 (t3 / test-01 
            :ARG0 (w / we 
                  :ARG0-of (s2 / screen-01 
                        :ARG1 (l / library 
                              :ARG0-of (u / use-01 
                                    :ARG1 (s / system 
                                          :mod (y2 / yeast)) 
                                    :ARG2 (y / yeast) 
                                    :prep-with (c / construct-01 
                                          :ARG0-of (f / fuse-01 
                                                :ARG1 (p / peptide 
                                                      :mod (a / acid)) 
                                                :ARG2 (t / thing 
                                                      :mod-of (d2 / DNA 
                                                            :ARG0-of (b / binding-07 
                                                                  :ARG1 (d / domain))) 
                                                      :name (n / name 
                                                            :op1 "GAL4"))))) 
                              :mod (c2 / cdna)))) 
            :ARG1 (t2 / this) 
            :ARG2 32 
            :op1-of (a2 / amino)))

# ::snt We chose to screen a mouse brain cDNA library as no human libraries were available .
# ::tok We chose to screen a mouse brain cDNA library as no human libraries were available .
# ::alignments 14-15|0.2 12-13|0.2.1 11-12|0.2.1.0 10-11|0.2.2 8-9|0.2.0 7-8|0.2.0.0 6-7|0.2.0.0.0 5-6|0.2.0.0.0.0 3-4|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:46.498
(c2 / choose-01 
      :ARG0 (w / we) 
      :ARG1 (s / screen) 
      :purpose (a / available-02 
            :ARG1 (l2 / library 
                  :mod (c / cdna 
                        :mod (b / brain 
                              :mod (m / mouse)))) 
            :ARG2 (l / library 
                  :mod (h / human)) 
            :polarity -))

# ::snt Given the fact that the amino acid sequence of the PAX6 protein is identical in man and mouse , we reasoned that a mouse brain library would yield relevant interactors .
# ::tok Given the fact that the amino acid sequence of the PAX6 protein is identical in man and mouse , we reasoned that a mouse brain library would yield relevant interactors .
# ::alignments 29-30|0.0.0.0.0.0.1 28-29|0.0.0.0.0.0.1.0 27-28|0.0.0.0.0.0 25-26|0.0.0.0.0.0.0 24-25|0.0.1.0 23-24|0.0.1.0.0 20-21|0.0.0.0.0 19-20|0.0.0.0 17-18|0.0.3 16-17|0.0 15-16|0.0.2 13-14|0.0.1 11-12|0 7-8|0.0.1.1 6-7|0.0.1.1.0 5-6|0.0.1.1.1 2-3|0.0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:46.804
(p / protein 
      :op1-of (a / and 
            :ARG2-of (g / give-01 
                  :ARG0 (w / we 
                        :ARG0-of (r2 / reason-01 
                              :ARG1 (y / yield-01 
                                    :ARG0 (l / library) 
                                    :ARG1 (i / interactor 
                                          :ARG1-of (r / relevant-01))))) 
                  :ARG1 (f / fact)) 
            :op2 (i2 / identical-01 
                  :ARG0 (b / brain 
                        :mod (m / mouse)) 
                  :ARG1 (s / sequence 
                        :mod (a2 / acid) 
                        :mod (a3 / amino))) 
            :op3 (m3 / man) 
            :op4 (m2 / mouse)))

# ::snt For comparison we also carried out the screen using a construct containing the whole PST domain ( PAX6PST ) .
# ::tok For comparison we also carried out the screen using a construct containing the whole PST domain ( PAX6PST ) .
# ::alignments 15-16|0.0.1.1.0 14-15|0.1.0 13-14|0.0.1.1.0.0 11-12|0.0.1.1 10-11|0.0.1.0 8-9|0.0.1 7-8|0.1 4-5|0 3-4|0.2 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:47.083
(c3 / carry-01 
      :ARG0 (w2 / we 
            :ARG0-of (c4 / compare-01) 
            :ARG0-of (u / use-01 
                  :ARG1 (c2 / construct-01) 
                  :ARG2 (c / contain-01 
                        :ARG1 (d / domain 
                              :mod (w / whole))))) 
      :ARG1 (s / screen 
            :domain-of "PST") 
      :mod (a / also))

# ::snt The C-terminal peptide screen gave 15 colonies that were positive with all three reporters and the PST domain screen gave 62 colonies .
# ::tok The C-terminal peptide screen gave 15 colonies that were positive with all three reporters and the PST domain screen gave 62 colonies .
# ::alignments 21-22|0.2.1 20-21|0.2.1.0 19-20|0.2 18-19|0.2.0 17-18|0.2.0.0 16-17|0.2.0.0.0 14-15|0 13-14|0.1.0+0.1 12-13|0.1.1 11-12|0.1.2 9-10|0.0.1.0 6-7|0.0.1 5-6|0.0.1.1 4-5|0.0 3-4|0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:47.414
(a / and 
      :op1 (g2 / give-01 
            :ARG0 (s2 / screen 
                  :consist-of (p3 / peptide)) 
            :ARG1 (c2 / colony 
                  :domain-of (p2 / positive) 
                  :quant 15)) 
      :op2 (p / person 
            :ARG0-of (r / report-01) 
            :quant 3 
            :quant (a2 / all)) 
      :op3 (g / give-01 
            :ARG0 (s / screen 
                  :consist-of (d / domain 
                        :mod "PST")) 
            :ARG1 (c / colony 
                  :quant 62)))

# ::snt The interacting plasmids were isolated and the cDNA inserts sequenced .
# ::tok The interacting plasmids were isolated and the cDNA inserts sequenced .
# ::alignments 8-9|0.0.0 7-8|0.0.0.0 5-6|0 4-5|0.0 2-3|0.0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:47.461
(a / and 
      :op1 (i2 / isolate-01 
            :ARG0-of (i / insert-01 
                  :ARG1 (c / cdna)) 
            :ARG1 (p / plasmid 
                  :ARG1-of (i3 / interact-01))))

# ::snt Three cDNAs were identified 3 or more times , Homer3 ( NM_011984 ) , Dncl1 ( Dynein cytoplasmic light chain 1 , NM_019682 , also known as Pin or Dlc8 ) and Trim11 ( Tripartite motif protein family member 11 , NM_053168 ) .
# ::tok Three cDNAs were identified 3 or more times , Homer3 ( NM_011984 ) , Dncl1 ( Dynein cytoplasmic light chain 1 , NM_019682 , also known as Pin or Dlc8 ) and Trim11 ( Tripartite motif protein family member 11 , NM_053168 ) .
# ::alignments 41-42|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 39-40|0.1.0.0.0.0.0 38-39|0.1.0.1+0.1.0 37-38|0.1 36-37|0 35-36|0.0 34-35|0.0.0 32-33|0.1.0.2.1.1.4.0.0+0.1.0.2.1.1.4.0+0.1.0.2.1.1.4 31-32|0.1.0.2.1.1 29-30|0.1.0.2.2.1.0.0+0.1.0.2.2.1.0+0.1.0.2.2.1 28-29|0.1.0.2.2 27-28|0.1.0.2.2.0.0.0+0.1.0.2.2.0.0+0.1.0.2.2.0 25-26|0.1.0.2 24-25|0.1.0.2.3 22-23|0.1.0.2.1.0.0+0.1.0.2.1.0+0.1.0.2.1 20-21|0.1.0.2.1.1.0.0 19-20|0.1.0.0.0 18-19|0.1.0.0.0.0 17-18|0.1.0.0.0.1 16-17|0.1.0.0.2.0+0.1.0.0.2+0.1.0.0 14-15|0.1.0.2.1.1.3.0.0+0.1.0.2.1.1.3.0+0.1.0.2.1.1.3 11-12|0.1.0.2.1.1.2 9-10|0.1.0.2.1.1.1.0.0+0.1.0.2.1.1.1.0+0.1.0.2.1.1.1 6-7|0.1.0.2.4.0 5-6|0.1.0.2.4 4-5|0.1.0.2.0 3-4|0.1.0.2.1.1.0 1-2|0.1.0.2.1.1.0.1 0-1|0.1.0.2.1.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:51.158
(p / protein 
      :mod (m2 / motif 
            :mod (t / tripartite)) 
      :mod-of (f / family 
            :ARG1-of (h / have-org-role-91 
                  :ARG0 (p4 / person 
                        :consist (c2 / chain 
                              :ARG1-of (l / light-06 
                                    :ARG0 11) 
                              :mod (c3 / cytoplasmic)) 
                        :mod (c / country 
                              :name (n / name 
                                    :op1 "NM_053168")) 
                        :name (n6 / name 
                              :op1 "Dynein")) 
                  :ARG2 (m / member) 
                  :manner-of (k / know-02 
                        :ARG0 3 
                        :ARG1 (p3 / person 
                              :name (n5 / name 
                                    :op1 "NM_019682") 
                              :op4-of (a / and 
                                    :ARG1-of (i / identify-01 
                                          :ARG0 1 
                                          :ARG2 (c4 / cdna 
                                                :quant 3)) 
                                    :op1 (p6 / person 
                                          :name (n9 / name 
                                                :op1 "Homer3")) 
                                    :op2 (n8 / nm_011984) 
                                    :op3 (p5 / person 
                                          :name (n7 / name 
                                                :op1 "Dncl1")) 
                                    :op5 (p2 / person 
                                          :name (n2 / name 
                                                :op1 "Trim11")))) 
                        :ARG2 (o2 / or 
                              :op1 (o3 / organization 
                                    :name (n4 / name 
                                          :op1 "Pin")) 
                              :op2 (o / organization 
                                    :name (n3 / name 
                                          :op1 "Dlc8"))) 
                        :mod (a2 / also) 
                        :op2-of (o4 / or 
                              :op1 (m3 / more))))))

# ::snt Homer3 ( 6 clones ) and Dncl1 ( 2 clones ) were identified in the C-terminal peptide screen .
# ::tok Homer3 ( 6 clones ) and Dncl1 ( 2 clones ) were identified in the C-terminal peptide screen .
# ::alignments 17-18|0.0.1.0.0 16-17|0.0.1.0.0.0 12-13|0.0.1.0 9-10|0.0.1.1.0 8-9|0.0.1.1.0.1 6-7|0.0.1.1.1.0+0.0.1.1.1+0.0.1.1 5-6|0.0.1 3-4|0 2-3|0.0.1.1.0.0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:51.417
(c2 / clone-01 
      :ARG0 (p3 / person 
            :name (n2 / name 
                  :op1 "Homer3") 
            :op1-of (a / and 
                  :ARG1-of (i / identify-01 
                        :time (s / screen 
                              :consist-of (p / peptide))) 
                  :op2 (p2 / person 
                        :ARG0-of (c / clone-01 
                              :ARG1 6 
                              :quant 2) 
                        :name (n / name 
                              :op1 "Dncl1")))))

# ::snt Homer3 ( 7 clones ) , Dncl1 ( 2 clones ) and Trim11 ( 6 clones ) were identified in the PST domain screen .
# ::tok Homer3 ( 7 clones ) , Dncl1 ( 2 clones ) and Trim11 ( 6 clones ) were identified in the PST domain screen .
# ::alignments 23-24|0.0.3.0.0 22-23|0.0.3.0.0.0 21-22|0.0.3.0.0.0.0 18-19|0.0.3.0 15-16|0.0.1 14-15|0.1 12-13|0.0.2.0+0.0.2+0.0 11-12|0.0.3 9-10|0.0.0 8-9|0.0.0.0 6-7|0.0.3.0.0.0.1.0.0+0.0.3.0.0.0.1.0+0.0.3.0.0.0.1 3-4|0 2-3|0.0.1.0 0-1|0.0.3.1.0.0+0.0.3.1.0+0.0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:51.661
(c3 / clone-01 
      :ARG0 (p / person 
            :ARG0-of (c2 / clone-01 
                  :quant 2) 
            :ARG0-of (c / clone-01 
                  :ARG1 7) 
            :name (n / name 
                  :op1 "Trim11") 
            :op2-of (a / and 
                  :ARG1-of (i / identify-01 
                        :time (s / screen 
                              :consist-of (d / domain 
                                    :mod "PST" 
                                    :mod-of (p2 / person 
                                          :name (n2 / name 
                                                :op1 "Dncl1"))))) 
                  :op1 (p3 / person 
                        :name (n3 / name 
                              :op1 "Homer3")))) 
      :ARG1 6)

# ::snt All cDNA inserts were in-frame with the coding region of the pPC86 GAL4 activation domain .
# ::tok All cDNA inserts were in-frame with the coding region of the pPC86 GAL4 activation domain .
# ::alignments 14-15|0.2 13-14|0.2.0 12-13|0.2.1.0.0+0.2.1.0+0.2.1 8-9|0.0 7-8|0.0.0 2-3|0 1-2|0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:51.735
(i / insert-01 
      :ARG0 (r / region 
            :ARG1-of (c / code-01 
                  :ARG0 (a2 / all))) 
      :ARG1 (c2 / cdna) 
      :mod (d / domain 
            :mod (a / activation) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "GAL4"))))

# ::snt None of the cDNAs was present in a list of known false positives [ 34 ] .
# ::tok None of the cDNAs was present in a list of known false positives [ 34 ] .
# ::alignments 14-15|0.0 12-13|0.1 11-12|0.1.1 10-11|0 8-9|0.1.0 5-6|0.1.0.0.0 3-4|0.1.0.0.1 0-1|0.1.0.0.2+0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:51.818
(k / know-02 
      :ARG0 34 
      :ARG1 (p / positive 
            :ARG2-of (l / list-01 
                  :ARG0 (p3 / person 
                        :domain-of (p2 / present) 
                        :mod (c / cdna) 
                        :quant (n / none))) 
            :mod (f / false)))

# ::snt HOMER3 is a member of the HOMER family of neuronal post-synaptic density ( PSD ) proteins [ 35 ] .
# ::tok HOMER3 is a member of the HOMER family of neuronal post-synaptic density ( PSD ) proteins [ 35 ] .
# ::alignments 17-18|0.0.0.4 15-16|0.0.0.2.0 13-14|0.0.0.3.0.0+0.0.0.3.0+0.0.0.3 11-12|0.0.0.2 9-10|0 7-8|0.0.0.0 6-7|0.0.1.0+0.0.1+0.0 3-4|0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:52.199
(n2 / neuronal 
      :mod-of (p2 / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f / family) 
                  :ARG2 (m / member) 
                  :location (d / density 
                        :mod-of (p / protein)) 
                  :manner (o / organization 
                        :name (n / name 
                              :op1 "PSD")) 
                  :op1-of 35) 
            :name (n3 / name 
                  :op1 "HOMER")))

# ::snt DNCL1 is a subunit of two motor protein complexes , dynein and myosin-Va , both of which are involved in intracellular trafficking of proteins and organelles in neurons [ 36,37 ] .
# ::tok DNCL1 is a subunit of two motor protein complexes , dynein and myosin-Va , both of which are involved in intracellular trafficking of proteins and organelles in neurons [ 36,37 ] .
# ::alignments 27-28|0.0.0.0 25-26|0.0.2 24-25|0.0 23-24|0 21-22|0.0.0 20-21|0.0.0.2 18-19|0.0.0.1 14-15|0.0.1 11-12|0.0.0.1.0.1 10-11|0.0.0.1.0.1.1 8-9|0.0.0.1.0 7-8|0.0.0.1.0.0.0 6-7|0.0.0.1.0.0 5-6|0.0.0.1.0.2 3-4|0.0.0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:52.524
(p / protein 
      :op1-of (a / and 
            :ARG0-of (t / traffic-01 
                  :ARG1 (n / neuron) 
                  :ARG2-of (i2 / involve-01 
                        :ARG1 (c / complex 
                              :mod (m / motorcycle 
                                    :mod-of (p2 / protein)) 
                              :op1-of (a2 / and 
                                    :mod (s / subunit) 
                                    :op2 (d / dynein)) 
                              :quant 2)) 
                  :mod (i / intracellular)) 
            :mod (b / both) 
            :op2 (o / organell)))

# ::snt TRIM11 is a member of the tripartite motif protein family and contains a RING finger , a B-box zinc finger , a coiled coil domain and a B30 .2 domain [ 38 ] .
# ::tok TRIM11 is a member of the tripartite motif protein family and contains a RING finger , a B-box zinc finger , a coiled coil domain and a B30 .2 domain [ 38 ] .
# ::alignments 31-32|0.0.0.0.0 29-30|0.0.1.0.0 27-28|0.3.0.0+0.3.0+0.3 25-26|0 24-25|0.2 23-24|0.2.0 22-23|0.2.1 19-20|0.1 18-19|0.1.0 17-18|0.1.1.0.0+0.1.1.0+0.1.1 14-15|0.0.0 13-14|0.0.0.0 11-12|0.0 10-11|0.0.1 9-10|0.0.1.0.1 8-9|0.0.1.0.1.1 7-8|0.0.1.0.1.1.0 6-7|0.0.1.0.1.0 3-4|0.0.1.0.2+0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:54.647
(a / and 
      :ARG0-of (c3 / contain-01 
            :ARG1 (f2 / finger 
                  :ARG1-of (r / ring-01 
                        :ARG0 38)) 
            :op2-of (a2 / and 
                  :op1 (h / have-org-role-91 
                        :ARG0 (d / domain) 
                        :ARG1 (f3 / family 
                              :mod (t2 / tripartite) 
                              :mod (p / protein 
                                    :mod (m / motif))) 
                        :ARG2 (m2 / member)))) 
      :op1 (f / finger 
            :mod (z / zinc) 
            :mod (o / organization 
                  :name (n2 / name 
                        :op1 "B-box"))) 
      :op2 (d2 / domain 
            :ARG1-of (c / coil-01) 
            :ARG1-of (c2 / coil-01)) 
      :op3 (t / thing 
            :name (n / name 
                  :op1 "B30")))

# ::snt The possible significance of the interactions between these proteins and PAX6 is discussed below .
# ::tok The possible significance of the interactions between these proteins and PAX6 is discussed below .
# ::alignments 13-14|0.0.3 12-13|0 10-11|0.0.2 9-10|0.0 8-9|0.0.1 7-8|0.0.0 5-6|0.1.0 2-3|0.1 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:54.705
(d / discuss-01 
      :ARG0 (a / and 
            :mod (t / this) 
            :op1 (p2 / protein) 
            :op2 (p / PAX6) 
            :op3 (b / below)) 
      :ARG1 (s / significant-02 
            :ARG1 (i / interaction) 
            :ARG1-of (p3 / possible-01)))

# ::snt To check that the Homer3 , Dncl1 and Trim11 clones were not identified multiple times solely because they are highly abundant in the library , we performed a semi-quantitative PCR assay .
# ::tok To check that the Homer3 , Dncl1 and Trim11 clones were not identified multiple times solely because they are highly abundant in the library , we performed a semi-quantitative PCR assay .
# ::alignments 30-31|0.1.0.0.1.1.0.0.1 26-27|0.1.0.0.1.1.0.0 25-26|0.1.0.0.1.1.0.0.0 23-24|0.0.2 20-21|0.0 19-20|0.0.0 17-18|0.0.1 16-17|0 15-16|0.1.1 13-14|0.1.0.0.1.2 12-13|0.1 11-12|0.2 9-10|0.1.0 8-9|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 7-8|0.1.0.0.1 6-7|0.1.0.0.1.1.1.0+0.1.0.0.1.1.1+0.1.0.0.1.1 4-5|0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 1-2|0.1.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:55.211
(c / cause-01 
      :ARG0 (a2 / abundance 
            :degree (h / high) 
            :domain (t / they) 
            :location (l / library)) 
      :ARG1 (i / identify-01 
            :ARG1 (c2 / clone-01 
                  :mod (p2 / person 
                        :name (n / name 
                              :op1 "Trim11") 
                        :op3-of (a3 / and 
                              :op1 (p4 / person 
                                    :name (n3 / name 
                                          :op1 "Homer3")) 
                              :op2 (p3 / person 
                                    :ARG1-of (c3 / check-01 
                                          :purpose-of (p / perform-02 
                                                :ARG0 (w / we) 
                                                :ARG1 (a / assay))) 
                                    :name (n2 / name 
                                          :op1 "Dncl1")) 
                              :op4 (m / multiple)))) 
            :manner (s / sole)) 
      :polarity -)

# ::snt We compared the relative abundance of Homer3 , Dncl1 , Trim11 and Pax6 with Gapdh and Atp5a1 .
# ::tok We compared the relative abundance of Homer3 , Dncl1 , Trim11 and Pax6 with Gapdh and Atp5a1 .
# ::alignments 16-17|0.4.1.1.0.0+0.4.1.1.0+0.4.1.1 15-16|0.4.1 14-15|0.4.1.0.0.0+0.4.1.0.0+0.4.1.0 12-13|0.4.0.0+0.4.0+0.4 11-12|0 10-11|0.3.0.0+0.3.0+0.3 8-9|0.2.0.0+0.2.0+0.2 6-7|0.1.0.0+0.1.0+0.1 4-5|0.0.1 3-4|0.0.1.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:56.167
(a2 / and 
      :ARG2-of (c / compare-01 
            :ARG0 (w / we) 
            :ARG1 (a3 / abundance 
                  :mod (r / relative))) 
      :op1 (p6 / person 
            :name (n6 / name 
                  :op1 "Homer3")) 
      :op2 (p5 / person 
            :name (n5 / name 
                  :op1 "Dncl1")) 
      :op3 (p4 / person 
            :name (n4 / name 
                  :op1 "Trim11")) 
      :op4 (p3 / person 
            :name (n3 / name 
                  :op1 "Pax6") 
            :op1-of (a / and 
                  :op2 (p2 / person 
                        :name (n2 / name 
                              :op1 "Gapdh")) 
                  :op3 (p / person 
                        :name (n / name 
                              :op1 "Atp5a1")))))

# ::snt Gapdh and Atp5a1 both show strong constitutive expression in a variety of tissues including the brain [ 29,30 ] .
# ::tok Gapdh and Atp5a1 both show strong constitutive expression in a variety of tissues including the brain [ 29,30 ] .
# ::alignments 15-16|0.2 12-13|0.1.0.0 10-11|0.1.0 7-8|0.1 6-7|0.1.2 5-6|0.1.1 4-5|0 3-4|0.0.0 2-3|0.0.2.0.0+0.0.2.0+0.0.2 1-2|0.0 0-1|0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:56.485
(s2 / show-01 
      :ARG0 (a / and 
            :mod (b2 / both) 
            :op1 (p2 / person 
                  :name (n2 / name 
                        :op1 "Gapdh")) 
            :op2 (p / person 
                  :name (n / name 
                        :op1 "Atp5a1"))) 
      :ARG1 (e / express-01 
            :ARG1 (v / variety 
                  :mod-of (t / tissue)) 
            :ARG1-of (s / strong-02) 
            :mod (c / constitutive)) 
      :ARG3 (b / brain))

# ::snt Homer3 , Dncl1 , Trim11 and Pax6 were only amplified strongly after 35 cycles of PCR ( Figure 2 ) and were therefore present at relatively low levels compared to Gapdh ( amplified strongly after 25 cycles ) and Atp5a1 ( amplified strongly after 30 cycles ; Figure 2 ) .
# ::tok Homer3 , Dncl1 , Trim11 and Pax6 were only amplified strongly after 35 cycles of PCR ( Figure 2 ) and were therefore present at relatively low levels compared to Gapdh ( amplified strongly after 25 cycles ) and Atp5a1 ( amplified strongly after 30 cycles ; Figure 2 ) .
# ::alignments 48-49|0.2.0.0.3.1.0.0.0 47-48|0.1 46-47|0 45-46|0.0 44-45|0.0.1 43-44|0.0.0 42-43|0.0.0.0.1 41-42|0.0.0.0 39-40|0.2.0.0.3.1.1.0.0+0.2.0.0.3.1.1.0+0.2.0.0.3.1.1 38-39|0.2.0.0.3.1 36-37|0.2.0.0.3.1.0.0.2.0 35-36|0.2.0.0.3.1.0.0.2.0.1 34-35|0.2.0.0.3.1.0.0.2 33-34|0.2.0.0.3.1.0.0.1 32-33|0.2.0.0.3.1.0.0 30-31|0.2.0.0.3.0.0+0.2.0.0.3.0+0.2.0.0.3 28-29|0.2.0.0.3.1.0 27-28|0.2.0.0.3.1.0.1 26-27|0.2.0.0.3.1.0.1.0 25-26|0.2.0.0.3.1.0.1.0.0 23-24|0.2.1 20-21|0.2 18-19|0.0.0.0.0 17-18|0.2.0.3.1 13-14|0.2.0.3.0 12-13|0.2.0.0.3.1.0.0.2.0.0 11-12|0.2.0.3 10-11|0.2.0.1 9-10|0.2.0 8-9|0.2.0.2 6-7|0.2.0.0.2.0.0+0.2.0.0.2.0+0.2.0.0.2 5-6|0.2.0.0 4-5|0.2.0.0.1.0.0+0.2.0.0.1.0+0.2.0.0.1 2-3|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:58.215
(a / and 
      :op1 (c / cycle-02 
            :op1-of (a2 / after 
                  :time-of (a3 / amplify-01 
                        :ARG1 2 
                        :ARG1-of (s / strong-02))) 
            :quant 30) 
      :op2 (f / figure) 
      :op3-of (a7 / and 
            :op1 (a9 / amplify-01 
                  :ARG1 (a10 / and 
                        :op1 (p6 / person 
                              :name (n5 / name 
                                    :op1 "Dncl1")) 
                        :op2 (p5 / person 
                              :name (n4 / name 
                                    :op1 "Trim11")) 
                        :op3 (p4 / person 
                              :name (n3 / name 
                                    :op1 "Pax6")) 
                        :op4 (p2 / person 
                              :name (n2 / name 
                                    :op1 "Gapdh") 
                              :op1-of (a4 / and 
                                    :ARG2-of (c3 / compare-01 
                                          :ARG1 (a6 / amplify-01 
                                                :ARG1 2 
                                                :ARG1-of (s2 / strong-02) 
                                                :time (a5 / after 
                                                      :op1 (c2 / cycle-02 
                                                            :ARG1 35 
                                                            :quant 25))) 
                                          :mod-of (l / level 
                                                :ARG1-of (l2 / low-04 
                                                      :mod (r / relative)))) 
                                    :op2 (p / person 
                                          :name (n / name 
                                                :op1 "Atp5a1"))))) 
                  :ARG1-of (s3 / strong-02) 
                  :mod (o / only) 
                  :time (a8 / after 
                        :op1 (c4 / cycle-02) 
                        :op2 (f2 / figure))) 
            :op2 (p3 / present)))

# ::snt Semi-quantitative PCR analysis of Homer3 , Dncl1 , Trim11 and Pax6 in the mouse brain cDNA library .
# ::tok Semi-quantitative PCR analysis of Homer3 , Dncl1 , Trim11 and Pax6 in the mouse brain cDNA library .
# ::alignments 16-17|0.0.1.2.0 15-16|0.0.1.2.0.0 14-15|0.0.1.2.0.0.0 13-14|0.0.1.2.0.0.0.0 10-11|0.0.1.2.1.0+0.0.1.2.1+0.0.1.2 9-10|0.0.1 8-9|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 6-7|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 4-5|0.0.0.0+0.0.0+0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:58.305
(a2 / analyze-01 
      :ARG1 (p4 / person 
            :name (n4 / name 
                  :op1 "Homer3") 
            :op1-of (a / and 
                  :op2 (p3 / person 
                        :name (n3 / name 
                              :op1 "Dncl1")) 
                  :op3 (p2 / person 
                        :name (n2 / name 
                              :op1 "Trim11")) 
                  :op4 (p / person 
                        :location (l / library 
                              :mod (c / cdna 
                                    :mod (b / brain 
                                          :mod (m / mouse)))) 
                        :name (n / name 
                              :op1 "Pax6")))))

# ::snt Library cDNA was amplified with primers specific for Pax6 ( 600 bp ) , Homer3 ( 485 bp band ) , Dncl1 ( 485 bp ) and Trim11 ( 609 bp ) for 20 , 25 , 30 or 35 cycles .
# ::tok Library cDNA was amplified with primers specific for Pax6 ( 600 bp ) , Homer3 ( 485 bp band ) , Dncl1 ( 485 bp ) and Trim11 ( 609 bp ) for 20 , 25 , 30 or 35 cycles .
# ::alignments 40-41|0.6.0 39-40|0.6.2 38-39|0.6.2.0 37-38|0.1.3 35-36|0.1.4 33-34|0.1.0 27-28|0.6.1.0+0.6.1+0.6 26-27|0 23-24|0.0.0 21-22|0.5.0.0+0.5.0+0.5 18-19|0.4 16-17|0.6.0.0 14-15|0.3.0.0+0.3.0+0.3 10-11|0.1.2 8-9|0.2.0.0+0.2.0+0.2 6-7|0.0 5-6|0.0.1 3-4|0.1 0-2|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:58.848
(a / and 
      :ARG1-of (s / specific-02 
            :ARG0 485 
            :op1-of (p5 / primer)) 
      :op1 (a2 / amplify-01 
            :ARG0 20 
            :ARG1 (t / thing 
                  :name (n5 / name 
                        :op1 (l / Library) 
                        :op2 (c2 / cDNA))) 
            :ARG2 600 
            :op1-of 30 
            :op1-of 25) 
      :op2 (p4 / person 
            :name (n4 / name 
                  :op1 "Pax6")) 
      :op3 (p3 / person 
            :name (n3 / name 
                  :op1 "Homer3")) 
      :op4 (b / band) 
      :op5 (p2 / person 
            :name (n2 / name 
                  :op1 "Dncl1")) 
      :op6 (p / person 
            :ARG0-of (c / cycle-02 
                  :ARG2 485) 
            :name (n / name 
                  :op1 "Trim11") 
            :quant (3 / 35 
                  :op1-of (o / or))))

# ::snt Atp5a1 ( 415 bp ) and Gapdh ( 450 bp ) , which are highly expressed in the brain , are included for comparison .
# ::tok Atp5a1 ( 415 bp ) and Gapdh ( 450 bp ) , which are highly expressed in the brain , are included for comparison .
# ::alignments 23-24|0.1 21-22|0 18-19|0.1.1.0.0 15-16|0.1.1.0 14-15|0.1.1.0.1 8-9|0.1.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 5-6|0.0 0-1|0.1.1.1.0+0.1.1.1+0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:58.950
(i / include-01 
      :ARG1 (a / and 
            :op1 (p / person 
                  :name (n / name 
                        :op1 "Gapdh"))) 
      :ARG2 (c / compare-01 
            :ARG0 450 
            :ARG1 (p2 / person 
                  :ARG0-of (e / express-01 
                        :ARG1 (b / brain) 
                        :degree (h / high)) 
                  :name (n2 / name 
                        :op1 "Atp5a1"))))

# ::snt M indicates the   174 HaeIII DNA size marker ; the positions of the 603 bp and 310 bp marker bands are indicated .
# ::tok M indicates the   174 HaeIII DNA size marker ; the positions of the 603 bp and 310 bp marker bands are indicated .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:58.952
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt We concluded that Homer3 , Dncl1 and Trim11 clones were not highly abundant in the library .
# ::tok We concluded that Homer3 , Dncl1 and Trim11 clones were not highly abundant in the library .
# ::alignments 15-16|0.1.2 12-13|0.1 11-12|0.1.0 10-11|0.1.3 8-9|0.1.1.1.1.0 7-8|0.1.1.1.1.1.0+0.1.1.1.1.1+0.1.1.1.1 6-7|0.1.1.1 5-6|0.1.1.0.0+0.1.1.0+0.1.1 3-4|0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:59.043
(c2 / conclude-01 
      :ARG0 (w / we) 
      :ARG1 (a / abundance 
            :degree (h / high) 
            :domain (p2 / person 
                  :name (n2 / name 
                        :op1 "Dncl1") 
                  :op2-of (a2 / and 
                        :op1 (p3 / person 
                              :name (n3 / name 
                                    :op1 "Homer3")) 
                        :op3 (p / person 
                              :ARG0-of (c / clone-01) 
                              :name (n / name 
                                    :op1 "Trim11")))) 
            :location (l / library) 
            :polarity -))

# ::snt This is consistent with the idea that they were pulled out because the encoded proteins interact specifically with the C-terminal peptide or PST domain of PAX6 .
# ::tok This is consistent with the idea that they were pulled out because the encoded proteins interact specifically with the C-terminal peptide or PST domain of PAX6 .
# ::alignments 23-24|0.0.1 22-23|0.0.1.0 21-22|0.0 20-21|0.0.0 16-17|0.1.1.0.1 15-16|0.1.1.0 14-15|0.1.1.0.0 13-14|0.1.1.0.0.0 11-12|0 9-10|0.1 7-8|0.1.1 5-6|0.1.0.1 2-3|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:59.295
(c / cause-01 
      :ARG0 (o / or 
            :op1 (p / peptide) 
            :op2 (d / domain 
                  :mod "PST")) 
      :ARG1 (p3 / pull-01 
            :ARG0-of (c2 / consistent-01 
                  :ARG1 (t2 / this) 
                  :ARG2 (i2 / idea)) 
            :ARG1 (t / they 
                  :ARG1-of (i / interact-01 
                        :ARG0 (p2 / protein 
                              :ARG1-of (e / encode-01)) 
                        :manner (s / specific-02)))))

# ::snt Yeast two-hybrid pairwise interactions .
# ::tok Yeast two-hybrid pairwise interactions .
# ::alignments 3-4|0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:59.303
(i / interaction 
      :mod (p / pairwise 
            :mod (y / yeast)))

# ::snt By library screening we identified two proteins ( HOMER3 and DNCL1 ) that interact with the C-terminal peptide and three proteins ( HOMER3 , DNCL1 and TRIM11 ) that interact with the whole PST domain .
# ::tok By library screening we identified two proteins ( HOMER3 and DNCL1 ) that interact with the C-terminal peptide and three proteins ( HOMER3 , DNCL1 and TRIM11 ) that interact with the whole PST domain .
# ::alignments 34-35|0.0.1.0.0.1 33-34|0.0.1.0.0.1.0 32-33|0.0.1.0.0.1.1 29-30|0.0.1.0.0 25-26|0 20-21|0.0.1.0.0.0 19-20|0.0.1.0.0.0.0 18-19|0.0.1.0 17-18|0.0.1.0.2 13-14|0.0.1.0.1 9-10|0.0 6-7|0.0.1 5-6|0.0.1.1 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0.0.1 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:59.633
(a / and 
      :op1 (a3 / and 
            :ARG1-of (i3 / identify-01 
                  :ARG0 (w2 / we) 
                  :manner (s / screen-01 
                        :ARG1 (l / library))) 
            :op1 (p3 / protein 
                  :prep-with (a2 / and 
                        :ARG0-of (i / interact-01 
                              :ARG1 (p / protein 
                                    :quant 3) 
                              :ARG2 (d / domain 
                                    :mod "PST" 
                                    :mod (w / whole))) 
                        :ARG1-of (i2 / interact-01) 
                        :op1 (p2 / peptide)) 
                  :quant 2)))

# ::snt This suggests that HOMER3 and DNCL1 interact specifically with the C-terminal peptide while TRIM11 interacts with a more N-terminal part of the PST domain .
# ::tok This suggests that HOMER3 and DNCL1 interact specifically with the C-terminal peptide while TRIM11 interacts with a more N-terminal part of the PST domain .
# ::alignments 23-24|0.1.0.0.0.0 22-23|0.1.0.0.0 17-18|0.1.2.0 14-15|0.1.0.0 11-12|0.1.1 7-8|0.1.2 6-7|0.1 4-5|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:09:59.737
(s2 / suggest-01 
      :ARG0 (t / this) 
      :ARG1 (i2 / interact-01 
            :ARG0 (a / and 
                  :ARG0-of (i / interact-01 
                        :ARG1 (P / "PST" 
                              :mod-of (d / domain)))) 
            :ARG1 (p / peptide) 
            :manner (s / specific-02 
                  :ARG1 (m / more))))

# ::snt We conducted pairwise tests between specific constructs to confirm the interactions identified in the library screen and to further investigate the interaction between PAX6 and HOMER3 , DNCL1 and TRIM11 .
# ::tok We conducted pairwise tests between specific constructs to confirm the interactions identified in the library screen and to further investigate the interaction between PAX6 and HOMER3 , DNCL1 and TRIM11 .
# ::alignments 28-29|0.1 24-25|0 21-22|0.0 19-20|0.0.0 18-19|0.0.0.0 16-17|0.0.0.1 15-16|0.0.0.1.0.1.0.0 14-15|0.0.0.1.0.1.0.0.0 11-12|0.0.0.1.0.1.0 10-11|0.0.0.1.0.1 8-9|0.0.0.1.0 6-7|0.0.0.1.0.0.0.0.0 5-6|0.0.0.1.0.0.0.0.0.0 3-4|0.0.0.1.0.0.0.0 1-2|0.0.0.1.0.0.0 0-1|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:00.096
(a2 / and 
      :ARG1-of (i / interact-01 
            :ARG1-of (i2 / investigate-01 
                  :degree (f / further) 
                  :op2-of (a3 / and 
                        :op1 (c / confirm-01 
                              :ARG0 (w / we 
                                    :ARG0-of (c3 / conduct-01 
                                          :ARG1 (t / test-01 
                                                :ARG1 (c2 / construct 
                                                      :ARG1-of (s2 / specific-02))))) 
                              :ARG1 (i4 / interaction 
                                    :ARG1-of (i3 / identify-01 
                                          :manner (s / screen 
                                                :consist-of (l / library)))))))) 
      :op1 (a / and))

# ::snt The Dncl1 and Trim11 clones that were pulled out of the library were full-length , but the Homer3 cDNAs lacked the N-terminal 70 amino acids .
# ::tok The Dncl1 and Trim11 clones that were pulled out of the library were full-length , but the Homer3 cDNAs lacked the N-terminal 70 amino acids .
# ::alignments 24-25|0.1.1 23-24|0.1.1.0 22-23|0.1.1.1 19-20|0.1 18-19|0.1.0 17-18|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 15-16|0 13-14|0.0 11-12|0.1.2.0.0.0 7-8|0.1.2.0.0 4-5|0.1.2.1 3-4|0.1.2.1.0.0.0+0.1.2.1.0.0+0.1.2.1.0 2-3|0.1.2 1-2|0.1.2.0.1.0+0.1.2.0.1+0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:00.735
(c2 / contrast-01 
      :ARG1 (f / full-length) 
      :ARG2 (l / lack-01 
            :ARG0 (c / cdna 
                  :mod (p / person 
                        :name (n / name 
                              :op1 "Homer3"))) 
            :ARG1 (a / acid 
                  :mod (a2 / amino) 
                  :quant 70) 
            :op3-of (a3 / and 
                  :op1 (p4 / person 
                        :ARG1-of (p2 / pull-01 
                              :ARG2 (l2 / library)) 
                        :name (n3 / name 
                              :op1 "Dncl1")) 
                  :op2 (c3 / clone-01 
                        :ARG0 (p3 / person 
                              :name (n2 / name 
                                    :op1 "Trim11"))))))

# ::snt The missing coding region was inserted into the truncated Homer3 cDNA to give a full-length expression construct ( see Methods ) .
# ::tok The missing coding region was inserted into the truncated Homer3 cDNA to give a full-length expression construct ( see Methods ) .
# ::alignments 19-20|0.1.2.0.0.0.0 18-19|0.1.2.0.0.0 16-17|0.1.0 15-16|0 14-15|0.1.1 12-13|0.1 10-11|0.0 9-10|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 8-9|0.0.0 5-6|0.1.2 3-4|0.1.2.0 2-3|0.1.2.0.0 1-2|0.1.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:01.553
(e / express-01 
      :ARG0 (c2 / cdna 
            :mod (t / truncate-01 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "Homer3")))) 
      :ARG0-of (g / give-01 
            :ARG1 (c / construct-01) 
            :ARG2 (f / full-length) 
            :purpose-of (i / insert-01 
                  :ARG1 (r / region 
                        :mod (c3 / code-01 
                              :ARG1 (s / see-01 
                                    :ARG1 (m / method)) 
                              :ARG1-of (m2 / miss-01))))))

# ::snt Pairwise interactions were carried out with both the full-length and truncated Homer3 clones .
# ::tok Pairwise interactions were carried out with both the full-length and truncated Homer3 clones .
# ::alignments 12-13|0.3 11-12|0.3.0.0.0+0.3.0.0+0.3.0 10-11|0.3.1 9-10|0 8-9|0.2 6-7|0.0 3-4|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:01.607
(a / and 
      :mod (b / both) 
      :op1 (c2 / carry-out-03 
            :ARG1 (i / interaction 
                  :mod (p2 / Pairwise))) 
      :op2 (f / full-length) 
      :op3 (c / clone-01 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "Homer3")) 
            :mod (t / truncate-01)))

# ::snt We confirmed that the whole PAX6 PST domain interacts with HOMER3 ( full-length and truncated constructs ) , TRIM11 and DNCL1 , as all three reporter genes were strongly activated in pairwise tests ( Figure 3 ; Table 1 ) .
# ::tok We confirmed that the whole PAX6 PST domain interacts with HOMER3 ( full-length and truncated constructs ) , TRIM11 and DNCL1 , as all three reporter genes were strongly activated in pairwise tests ( Figure 3 ; Table 1 ) .
# ::alignments 38-39|0.1.0 37-38|0.1 36-37|0 35-36|0.2.1.0.1.0.1.2.0.0 34-35|0.0 32-33|0.2.1.0.1.0.1.2 29-30|0.2.1.0.1.0.1 28-29|0.2.1.0.1.0.1.1 26-27|0.2.1.0.1.0.1.0 25-26|0.2.1.0.1.0.0 24-25|0.2.1.0.1.0.1.2.0.1 23-24|0.2.1.0.1.0.1.0.0 19-20|0.2.1 15-16|0.2.1.0.1.0.1.2.0.2 14-15|0.2.1.0.1.0.1.2.0 13-14|0.2 12-13|0.2.0 8-9|0.2.1.0 7-8|0.2.1.0.0 6-7|0.2.1.0.0.0 4-5|0.2.1.0.1.0.0.0 1-2|0.2.1.0.1 0-1|0.2.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:02.289
(a / and 
      :op1 (f / figure) 
      :op2 (t / table 
            :mod 1) 
      :op2-of (a5 / and 
            :op1 (f2 / full-length) 
            :op1-of (a4 / and 
                  :ARG1-of (i / interact-01 
                        :ARG0 (d / domain 
                              :mod "PST") 
                        :ARG1-of (c2 / confirm-01 
                              :ARG0 (w2 / we 
                                    :ARG0-of (r / report-01 
                                          :ARG1 (w / whole)) 
                                    :ARG0-of (a2 / activate-01 
                                          :ARG1 (g / gene 
                                                :mod (a3 / all)) 
                                          :ARG1-of (s / strong-02) 
                                          :ARG2 (t2 / test-01 
                                                :ARG1 (t3 / truncate-01 
                                                      :ARG0 3 
                                                      :ARG1 3 
                                                      :mod-of (c / construct))))))))))

# ::snt In contrast the interaction between the C-terminal peptide and HOMER3 or DNCL1 could not be confirmed with pairwise tests ( Table 1 ) .
# ::tok In contrast the interaction between the C-terminal peptide and HOMER3 or DNCL1 could not be confirmed with pairwise tests ( Table 1 ) .
# ::alignments 21-22|0.0.0.0.0.0 20-21|0.0.0.0.0.0.0 18-19|0.0.0.0.1 17-18|0.0.0.0.1.0 15-16|0.0.0.0 13-14|0.0.0.1 12-13|0.0.0 10-11|0.0.0.0.0.1 8-9|0.0 7-8|0.0.0.0.0.1.0 3-4|0.0.0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:02.421
(c2 / contrast-01 
      :ARG2 (a / and 
            :op1 (p2 / possible-01 
                  :ARG1 (c / confirm-01 
                        :ARG1 (i / interact-01 
                              :ARG1 (1 / 1 
                                    :mod-of (t / table)) 
                              :ARG2 (o / or 
                                    :op1 (p3 / peptide))) 
                        :ARG2 (t2 / test-01 
                              :ARG1 (p / pairwise))) 
                  :polarity -)))

# ::snt Occasionally , partial suppression of growth on plates containing 5-fluoro-orotic acid was observed , indicating low-level activation of the URA3 reporter ; however HIS3 and LacZ activation were not observed .
# ::tok Occasionally , partial suppression of growth on plates containing 5-fluoro-orotic acid was observed , indicating low-level activation of the URA3 reporter ; however HIS3 and LacZ activation were not observed .
# ::alignments 29-30|0.0.0.0.0.1.1.0.0 28-29|0.0.0.0.0.1.1.0.0.1 26-27|0.0.0.0.0.1.1.0 24-25|0.0.0.0.0.1.1.0.0.0 21-22|0.0.0.0.0.1.1 20-21|0.0.0.0.0.1 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0.0.0 14-15|0.0.0.0.0 12-13|0.0.0.0.1 10-11|0.1 8-9|0 7-8|0.0 5-6|0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.2 0-1|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:02.867
(c / contain-01 
      :ARG0 (p / plate 
            :location-of (g / grow-01 
                  :ARG1-of (s / suppress-01 
                        :ARG0-of (i / indicate-01 
                              :ARG1 (a4 / activation 
                                    :mod (l / low-level)) 
                              :ARG3 (r / report-01 
                                    :ARG0 (o3 / occasional) 
                                    :ARG1 (a3 / and 
                                          :poss-of (a / activation 
                                                :ARG1-of (o / observe-01 
                                                      :op1-of (a2 / and) 
                                                      :polarity -))))) 
                        :ARG1-of (o2 / observe-01) 
                        :mod (p2 / partial)))) 
      :ARG1 (a5 / acid))

# ::snt The reasons for this are not clear , although it may be that the pairwise tests were of sub-optimal sensitivity compared to the library screen .
# ::tok The reasons for this are not clear , although it may be that the pairwise tests were of sub-optimal sensitivity compared to the library screen .
# ::alignments 24-25|0.0 23-24|0 20-21|0.0.0 19-20|0.0.0.2 15-16|0.0.0.0 10-11|0.0.0.1.2 6-7|0.0.0.1 5-6|0.0.0.1.3 3-4|0.0.0.1.0 1-2|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:03.014
(l / library 
      :consist (s / screen 
            :ARG2-of (c / compare-01 
                  :ARG0 (t / test-01) 
                  :ARG1 (c2 / clear-06 
                        :ARG0 (t2 / this) 
                        :ARG1 (r / reason) 
                        :ARG1-of (p / possible-01) 
                        :polarity -) 
                  :mod-of (s2 / sensitivity))))

# ::snt However we were able to confirm that the C-terminal peptide is important for the interaction with HOMER3 and DNCL1 because interaction with the PAX6PST-CT construct , which lacks the final 32 amino acids , was completely abolished ( Figure 3 , Table 1 ) .
# ::tok However we were able to confirm that the C-terminal peptide is important for the interaction with HOMER3 and DNCL1 because interaction with the PAX6PST-CT construct , which lacks the final 32 amino acids , was completely abolished ( Figure 3 , Table 1 ) .
# ::alignments 42-43|0.0.0.1.1 41-42|0.0.0.1.1.0 39-40|0.1.2.0.0 38-39|0.0.2 36-37|0.0 35-36|0.0.1 32-33|0.0.0.1.0.0 31-32|0.0.0.1.0.0.1 30-31|0.0.0.0 29-30|0.0.0.1.0.0.0 27-28|0.0.0.1.0 24-25|0.0.0.1 20-21|0.0.0 19-20|0 17-18|0.1.2 14-15|0.1.2.0 11-12|0.1 9-10|0.1.1 5-6|0.1.0 3-4|0.1.0.1 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:03.875
(c3 / cause-01 
      :ARG0 (a / abolish-01 
            :ARG1 (i / interact-01 
                  :ARG1 32 
                  :ARG2 (c2 / construct-01 
                        :ARG0-of (l / lack-01 
                              :ARG1 (a2 / acid 
                                    :mod (f2 / final) 
                                    :mod (a3 / amino))) 
                        :ARG1 (1 / 1 
                              :mod-of (t / table)))) 
            :ARG1-of (c / complete-02) 
            :ARG2 (f / figure)) 
      :ARG1 (i3 / important 
            :ARG1-of (c4 / confirm-01 
                  :ARG0 (w / we) 
                  :ARG1-of (p2 / possible-01)) 
            :domain (p / peptide) 
            :op1-of (a4 / and 
                  :ARG2-of (i2 / interact-01 
                        :ARG0 3))))

# ::snt TRIM11 interacted equally well with PAX6PST and PAX6PST-CT ( Figure 3 , Table 1 ) .
# ::tok TRIM11 interacted equally well with PAX6PST and PAX6PST-CT ( Figure 3 , Table 1 ) .
# ::alignments 13-14|0.0 12-13|0.0.0 10-11|0.2.0 9-10|0.1 6-7|0.2 2-3|0.0.1 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:03.989
(i / interact-01 
      :ARG0 (1 / 1 
            :mod-of (t / table) 
            :poss (e / equal)) 
      :ARG1 (f / figure) 
      :ARG2 (a / and 
            :op1-of 3))

# ::snt This is consistent with the library screens in which TRIM11 was isolated with the PST domain but not with the C-terminal peptide and supports the idea that the C-terminal peptide is not important for the interaction between PAX6 and TRIM11 .
# ::tok This is consistent with the library screens in which TRIM11 was isolated with the PST domain but not with the C-terminal peptide and supports the idea that the C-terminal peptide is not important for the interaction between PAX6 and TRIM11 .
# ::alignments 38-39|0.0.0.1.1.1.1.0.1 35-36|0.0.0.1.1.1.1.0.1.0 32-33|0.0.0.1.1.1.1.0 31-32|0.0.0.1.1.1.1 29-30|0.0.0.1.1.1.1.0.0 25-26|0.0.0.1.1.1.0 23-24|0.0.0.1.1.1 22-23|0.0.0.1.1 21-22|0.0.0.1.1.0 17-18|0.0.2 16-17|0 15-16|0.0.1 14-15|0.0.1.0 11-12|0.0 6-7|0.0.0 5-6|0.0.0.0 2-3|0.0.0.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:04.329
(c / contrast-01 
      :ARG2 (i4 / isolate-01 
            :ARG1 (s2 / screen-01 
                  :ARG1 (l / library) 
                  :ARG2-of (c2 / consistent-01 
                        :ARG1 (t / this) 
                        :op1-of (a2 / and 
                              :op2 (p2 / peptide) 
                              :op3 (s / support-01 
                                    :ARG1 (i3 / idea) 
                                    :polarity (- / - 
                                          :polarity-of (i2 / important 
                                                :domain (p / peptide) 
                                                :op1-of (a / and 
                                                      :ARG0-of (i / interact-01)))))))) 
            :ARG2 (d / domain 
                  :mod "PST") 
            :mod -))

# ::snt LacZ reporter gene activation in pairwise tests .
# ::tok LacZ reporter gene activation in pairwise tests .
# ::alignments 6-7|0.0.0 3-4|0.0 2-3|0.0.1 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:04.364
(r / report-01 
      :ARG1 (a / activation 
            :ARG1-of (t / test-01) 
            :mod (g / gene)))

# ::snt pPC86 constructs are shown across the top , and pDBLeu constructs are shown down the right hand side .
# ::tok pPC86 constructs are shown across the top , and pDBLeu constructs are shown down the right hand side .
# ::alignments 17-18|0.1.0.0 16-17|0.1.0.0.0 15-16|0.1.0.0.0.0 13-14|0.1.0.2 12-13|0.1.0 10-11|0.1.0.1 8-9|0.1 6-7|0.2.0 4-5|0.2 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:04.782
(s3 / show-01 
      :ARG1 (c2 / construct) 
      :op1-of (a / and 
            :op2 (s2 / show-01 
                  :ARG1 (s / side 
                        :mod (h / hand 
                              :mod (r / right))) 
                  :ARG2 (c / construct) 
                  :direction (d / down))) 
      :path (a2 / across 
            :op1 (t / top)))

# ::snt PAX6PST , PAX6 PST domain ; PAX6PST/Q422R , PAX6 PST domain with the Q422R mutation ; PAX6PST/X423L , PAX6 PST domain with the X423L mutation , PAX6PST/1615del10 , PAX6 PST domain with the 1615 del10 mutation ; PAX6PST-CT , PAX6 PST domain minus the C-terminal peptide .
# ::tok PAX6PST , PAX6 PST domain ; PAX6PST/Q422R , PAX6 PST domain with the Q422R mutation ; PAX6PST/X423L , PAX6 PST domain with the X423L mutation , PAX6PST/1615del10 , PAX6 PST domain with the 1615 del10 mutation ; PAX6PST-CT , PAX6 PST domain minus the C-terminal peptide .
# ::alignments 45-46|0.1.0.1.1.0.0 42-43|0.1.0.1.1.0.0.0.0.0.0.0 41-42|0.1.0.1.1.0.0.0.0.0.0 40-41|0.1.0.1.1.0.0.0.0.0 35-36|0 33-34|0.1.1+0.1 30-31|0.1.0.0.0.0 29-30|0.1.0.0.0 24-25|0.1.0.1.1.0 23-24|0.1.0.1.1.1.0+0.1.0.1.1.1+0.1.0.1.1 20-21|0.1.0.1.1.0.0.0 19-20|0.1.0.1.1.0.0.0.0 14-15|0.0 10-11|0.1.0 9-10|0.1.0.0 5-6|0.1.0.1 4-5|0.1.0.1.0 3-4|0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:05.021
(m2 / mutation 
      :mod (m4 / mutation) 
      :time (d2 / date-entity 
            :mod-of (d5 / domain 
                  :mod (P4 / "PST" 
                        :poss (P2 / "PST" 
                              :mod-of (d3 / domain))) 
                  :op2-of (a / and 
                        :op1 (d6 / domain 
                              :mod "PST") 
                        :op3 (o / organization 
                              :mod-of (m3 / mutation 
                                    :mod (p / peptide 
                                          :mod (d4 / domain 
                                                :mod (P3 / "PST" 
                                                      :mod-of (P / "PST" 
                                                            :mod-of (d / domain 
                                                                  :op1-of (m / minus))))))) 
                              :name (n / name 
                                    :op1 "X423L")))) 
            :year 1615))

# ::snt ` Truncated HOMER3 ' is HOMER3 lacking the N-terminal 70 amino acids .
# ::tok ` Truncated HOMER3 ' is HOMER3 lacking the N-terminal 70 amino acids .
# ::alignments 11-12|0.0.0.0.0 10-11|0.0.0.0.0.0 9-10|0.0.0.0.0.1 6-7|0.0.0.0 1-3|0+0.0.1+0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:05.153
(h / HOMER3 
      :op2-of (n / name 
            :name-of (t / thing 
                  :ARG0-of (l / lack-01 
                        :ARG1 (a / acid 
                              :mod (a2 / amino) 
                              :quant 70))) 
            :op1 (t2 / Truncated)))

# ::snt Five control strains are shown for comparison ( left ) .
# ::tok Five control strains are shown for comparison ( left ) .
# ::alignments 8-9|0.0.0 6-7|0.0 4-5|0 2-3|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:05.212
(s / show-01 
      :ARG0 (c / compare-01 
            :ARG1-of (l / leave-11)) 
      :ARG1 (s2 / strain 
            :ARG0-of (c2 / control-01 
                  :ARG1 5)))

# ::snt These range from non-interactor ( A ) to strong interactor ( E ) .
# ::tok These range from non-interactor ( A ) to strong interactor ( E ) .
# ::alignments 11-12|0.0 9-10|0.1 8-9|0.1.0 1-2|0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:05.276
(r / range-01 
      :ARG0 (e / E) 
      :ARG1 (i / interactor 
            :ARG1-of (s / strong-02)) 
      :mod (t / this))

# ::snt Pairwise interaction tests between normal and mutant PAX6 constructs and HOMER3 , DNCL1 and TRIM11 .
# ::tok Pairwise interaction tests between normal and mutant PAX6 constructs and HOMER3 , DNCL1 and TRIM11 .
# ::alignments 13-14|0.1.0.1 9-10|0.1.0.1.0 8-9|0.1.0 7-8|0.1.0.0 6-7|0.2 5-6|0 4-5|0.1 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:05.329
(a3 / and 
      :op1 (t / test-01 
            :ARG1 (i / interact-01)) 
      :op2 (n / normal-02 
            :ARG1 (c / construct 
                  :mod (p / PAX6) 
                  :op1-of (a / and 
                        :op1-of (a2 / and)))) 
      :op3 (m / mutant))

# ::snt + + + : strong interaction ; + + : moderate interaction ; + : weak interaction ; ( + ) borderline interaction with one or two reporters activated at very low levels ; 0 : no interaction .
# ::tok + + + : strong interaction ; + + : moderate interaction ; + : weak interaction ; ( + ) borderline interaction with one or two reporters activated at very low levels ; 0 : no interaction .
# ::alignments 37-38|0.1 36-37|0.1.1 34-35|0.1.0 32-33|0.0.0.0.1 31-32|0.0.0.0.1.0 30-31|0.0.0.0.1.0.0 28-29|0.0.0.0 27-28|0.0+0.0.0 26-27|0.0.0.2 25-26|0 22-23|0.0.0.1 21-22|0.0.0.1.0 16-17|0.0.0.0.0 15-16|0.0.0.0.0.0 11-12|0.0.0.0.0.1.1 10-11|0.0.0.0.0.1.1.0 6-7|0.0.0.0.0.1 5-6|0.0.0.0.0.1.0 4-5|0.0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:05.691
(o / or 
      :ARG1-of (r / report-01 
            :ARG0 (p / person 
                  :ARG1-of (a / activate-01 
                        :ARG1-of (i3 / interact-01 
                              :ARG1-of (w / weak-02) 
                              :op3-of (a2 / and 
                                    :op1 (i5 / interact-01 
                                          :ARG1-of (s / strong-02)) 
                                    :op2 (i4 / interact-01 
                                          :ARG1-of (m / moderate-03)))) 
                        :location (l / level 
                              :ARG1-of (l2 / low-04 
                                    :degree (v / very)))) 
                  :ARG2-of (i2 / interact-01 
                        :mod (b / borderline)) 
                  :quant 2)) 
      :op1 (i / interact-01 
            :ARG1 0 
            :polarity -))

# ::snt PAX6PST , PAX6 PST domain ; PAX6CTP , PAX6 C-terminal peptide ; PAX6PST-CT , PAX6 PST domain minus the C-terminal peptide ; PAX6PST/Q422R , PAX6 PST domain with the Q422R mutation ; PAX6PST/X423L , PAX6 PST domain with the X423L mutation , PAX6PST/1615del , PAX6 PST domain with the 1615 del10 mutation .
# ::tok PAX6PST , PAX6 PST domain ; PAX6CTP , PAX6 C-terminal peptide ; PAX6PST-CT , PAX6 PST domain minus the C-terminal peptide ; PAX6PST/Q422R , PAX6 PST domain with the Q422R mutation ; PAX6PST/X423L , PAX6 PST domain with the X423L mutation , PAX6PST/1615del , PAX6 PST domain with the 1615 del10 mutation .
# ::alignments 51-52|0.0.0.1.0 49-50|0.0.0.1.0.0.1+0.0.0.1.0.0 46-47|0.0.2.2.1.0.1 45-46|0.0.2.2.1.0 40-41|0 39-40|0.0.1.0+0.0.1+0.0 36-37|0.0.0.0.0 35-36|0.0.0.0 30-31|0.0.0.1 26-27|0.0.0.1.0.0.0 25-26|0.0.0.1.0.0.0.0 20-21|0.0.2.2.1.0.0 17-18|0.0.2.2.1 16-17|0.0.2.2 15-16|0.0.2.2.0 10-11|0.0.2.1 8-10|0.0.0.2.1+0.0.0.2.0+0.0.0.2+0.0.0 5-6|0.0.2 4-5|0.0.2.0 3-4|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:06.053
(m2 / mutation 
      :mod (o / organization 
            :domain-of (t / thing 
                  :mod (P2 / "PST" 
                        :mod-of (d3 / domain)) 
                  :mod-of (m3 / mutation 
                        :mod (m / mutation 
                              :time (d / date-entity 
                                    :mod (d4 / domain 
                                          :mod "PST") 
                                    :year 1615))) 
                  :name (n2 / name 
                        :op1 (p3 / PAX6) 
                        :op2 (c / C-terminal))) 
            :name (n / name 
                  :op1 "X423L") 
            :op4-of (a / and 
                  :op1 (d6 / domain 
                        :mod "PST") 
                  :op2 (p2 / peptide) 
                  :op3 (d5 / domain 
                        :mod "PST" 
                        :op1-of (m4 / minus 
                              :mod-of (P / "PST" 
                                    :mod (p / peptide) 
                                    :mod-of (d2 / domain)))))))

# ::snt HOMER3-FL , HOMER3 full-length clone ; HOMER3-Tr , truncated HOMER3 clone lacking the N-terminal 70 amino acids .
# ::tok HOMER3-FL , HOMER3 full-length clone ; HOMER3-Tr , truncated HOMER3 clone lacking the N-terminal 70 amino acids .
# ::alignments 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0.0.0 14-15|0.0.0.0.0.0.1 11-12|0.0.0.0.0 10-11|0.0.0.1 8-9|0.0.0 5-6|0 4-5|0.0 3-4|0.0.1 0-1|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:06.353
(a3 / and 
      :op1 (c2 / clone 
            :ARG2-of (t / truncate-01 
                  :ARG0 (c3 / country 
                        :ARG0-of (l / lack-01 
                              :ARG1 (a / acid 
                                    :mod (a2 / amino) 
                                    :quant 70)) 
                        :name (n / name 
                              :op1 "HOMER3-FL")) 
                  :ARG1 (c / clone)) 
            :mod (f / full-length)))

# ::snt Having confirmed that HOMER3 , DNCL1 and TRIM11 interact with the PAX6 PST domain , we next investigated how the interactions were affected by three C-terminal PAX6 mutations that have been previously described in patients with ocular anomalies .
# ::tok Having confirmed that HOMER3 , DNCL1 and TRIM11 interact with the PAX6 PST domain , we next investigated how the interactions were affected by three C-terminal PAX6 mutations that have been previously described in patients with ocular anomalies .
# ::alignments 37-38|0.1.0.0.0.0.0 36-37|0.1.0.0.0.0.0.0 34-35|0.1.0.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0 32-33|0.1.0.0 31-32|0.1.0.0.1 27-28|0.1.0 24-25|0.0.0.1.0 22-23|0.1 20-21|0.1.1 17-18|0 16-17|0.2 15-16|0.0 13-14|0.0.0.0.1 12-13|0.0.0.0.1.0 8-9|0.0.0.0 6-7|0.0.0.0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:07.181
(i2 / investigate-01 
      :ARG0 (w / we 
            :ARG0-of (c / confirm-01 
                  :ARG1 (i3 / interact-01 
                        :ARG0 (a3 / and) 
                        :ARG1 (d2 / domain 
                              :mod "PST")) 
                  :ARG1-of (h2 / have-03 
                        :ARG0 3))) 
      :ARG1 (a2 / affect-01 
            :ARG0 (m / mutate-01 
                  :ARG2-of (d / describe-01 
                        :ARG1 (p / person 
                              :ARG0-of (h / have-rel-role-91 
                                    :ARG1 (a / anomali 
                                          :mod (o / ocular)) 
                                    :ARG2 (p2 / patient))) 
                        :time (p3 / previous))) 
            :ARG1 (i / interaction)) 
      :manner (n / next))

# ::snt The first mutation is a single nucleotide substitution 1627A > G that causes a glutamine to arginine amino acid substitution in the last codon of PAX6 .
# ::tok The first mutation is a single nucleotide substitution 1627A > G that causes a glutamine to arginine amino acid substitution in the last codon of PAX6 .
# ::alignments 23-24|0.0.0.1.0 22-23|0.0.0.1.0.0 19-20|0.0.0.1 18-19|0.0.0.1.1 17-18|0.0.0.1.2 14-15|0.1 12-13|0 10-11|0.0.3+0.0.2.0+0.0.2+0.0 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:07.683
(c2 / cause-01 
      :ARG0 (o / organization 
            :ARG0-of (s3 / single-02 
                  :ARG1 (m / mutation) 
                  :purpose (s / substitute-01 
                        :ARG1 (c / codon 
                              :mod (l / last)) 
                        :mod (a / acid) 
                        :mod (a2 / amino))) 
            :ARG0-of (s2 / substitute-01 
                  :ARG1 (n2 / nucleotide)) 
            :name (n / name 
                  :op1 "G-8") 
            :wiki "G8") 
      :ARG1 (g / glutamine))

# ::snt This missense mutation ( Q422R ) has been reported in two patients , one affected by anterior segment dysgenesis with uveal ectropion and one with typical aniridia and foveal hypoplasia [ 27,33 ] .
# ::tok This missense mutation ( Q422R ) has been reported in two patients , one affected by anterior segment dysgenesis with uveal ectropion and one with typical aniridia and foveal hypoplasia [ 27,33 ] .
# ::alignments 29-30|0.0.0.0.0.0.1 27-28|0 26-27|0.0 25-26|0.0.0 22-23|0.0.0.0.0.0.2 21-22|0.0.0.0.0 20-21|0.0.0.0 18-19|0.0.0.0.0.0.0 17-18|0.0.0.0.0.0.0.0 16-17|0.0.0.0.0.0.0.0.0 14-15|0.0.0.0.0.0 11-12|0.0.0.0.0.0.2.1.0.0+0.0.0.0.0.0.2.1.0+0.0.0.0.0.0.2.1 10-11|0.0.0.0.0.0.2.1.1 8-9|0.0.0.0.0.0.2.0 2-3|0.0.0.0.0.0.2.0.0 0-1|0.0.0.0.0.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:08.138
(a / and 
      :op1 (a2 / aniridia 
            :ARG1-of (t / typical-02 
                  :ARG0 (u / uveal 
                        :mod-of (e / ectropion 
                              :manner-of (a5 / affect-01 
                                    :ARG0 (d / dysgenesi 
                                          :mod (s / segment 
                                                :mod (a4 / anterior))) 
                                    :ARG1 (h / hypoplasia) 
                                    :op2-of (a3 / and 
                                          :ARG0-of (r / report-01 
                                                :ARG1 (m / mutation 
                                                      :mod (t2 / this))) 
                                          :op1 (p / person 
                                                :ARG0-of (h2 / have-rel-role-91 
                                                      :ARG2 (p2 / patient)) 
                                                :quant 2))))))))

# ::snt The second mutation ( 1615del10 ) was found in an aniridia family [ 28 ] .
# ::tok The second mutation ( 1615del10 ) was found in an aniridia family [ 28 ] .
# ::alignments 13-14|0.0.0 11-12|0.1.0 10-11|0.1 7-8|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:08.171
(f2 / find-01 
      :ARG1 (m / mutation 
            :poss-of 28) 
      :time (a / aniridia 
            :mod-of (f / family)))

# ::snt This frame-shifting deletion occurs just before the PAX6 stop codon and is predicted to cause translational read-through into the 3 ' untranslated region , generating a protein in which the last 5 amino acids of the C-terminal peptide are replaced by a 103 amino acid-extension .
# ::tok This frame-shifting deletion occurs just before the PAX6 stop codon and is predicted to cause translational read-through into the 3 ' untranslated region , generating a protein in which the last 5 amino acids of the C-terminal peptide are replaced by a 103 amino acid-extension .
# ::alignments 43-44|0.0.1 39-40|0.1.0.0 37-38|0.1.0.0.1.2 33-34|0.1.0.0.1 32-33|0.1.0.0.1.1 31-32|0.0.0.1.1.1.0.0 30-31|0.1.0.0.1.0 26-27|0.1.0 24-25|0.1 22-23|0.0.0.0.0 21-22|0.0.0.0.0.0 19-20|0.0.0.1.0 15-16|0.1.0.0.0 14-15|0.0.0.0 12-13|0.0 10-11|0 9-10|0.0.0.1.1.1 8-9|0.0.0.1.1.1.0 5-6|0.0.0.1.1 4-5|0.0.0.1.1.0 3-4|0.0.0.1 2-3|0.0.0 1-2|0.0.0.3 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:08.729
(a4 / and 
      :op1 (p3 / predict-01 
            :ARG0 (d / deletion 
                  :ARG0-of (c / cause-01 
                        :ARG1 (r2 / region 
                              :mod (u / untranslat))) 
                  :ARG0-of (o / occur-01 
                        :ARG1 3 
                        :time (b / before 
                              :mod (j / just) 
                              :op1 (c2 / codon 
                                    :ARG1-of (s / stop-01 
                                          :ARG0 5)))) 
                  :mod (t2 / this) 
                  :mod (f / frame-shift)) 
            :ARG1 (a / amino)) 
      :op2 (g / generate-01 
            :ARG1 (p2 / protein 
                  :ARG1-of (r / replace-01 
                        :ARG0 (t / translational) 
                        :ARG2 (a2 / acid 
                              :mod (l / last) 
                              :mod (a3 / amino) 
                              :poss (p / peptide))))))

# ::snt Affected individuals in this family showed unusual neurobehavioural traits including impaired social cognition and poor verbal inhibition [ 28 ] .
# ::tok Affected individuals in this family showed unusual neurobehavioural traits including impaired social cognition and poor verbal inhibition [ 28 ] .
# ::alignments 18-19|0.0.0.0.0 16-17|0.0.1.0.0 15-16|0.0.0.0.2 14-15|0.0.0.0.1 13-14|0 12-13|0.1.0 11-12|0.1.0.0 10-11|0.1 8-9|0.0.1 6-7|0.0.1.0.1+0.0.1.0 5-6|0.0 4-5|0.0.0.1 3-4|0.0.0.1.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:08.996
(a / and 
      :op1 (s2 / show-01 
            :ARG0 (i3 / individual 
                  :ARG1-of (a2 / affect-01 
                        :ARG2 28 
                        :op1-of (p / poor) 
                        :op1-of (v / verbal)) 
                  :part-of (f / family 
                        :mod (t2 / this))) 
            :ARG1 (t / trait 
                  :mod (u / usual 
                        :mod (i / inhibition) 
                        :polarity -))) 
      :op2 (i2 / impair-01 
            :ARG1 (c / cognition 
                  :mod (s / society))))

# ::snt MRI analysis revealed grey matter abnormalities in the frontal lobe , temporal lobe and cerebellum , and white matter deficits in the corpus callosum [ 13 ] .
# ::tok MRI analysis revealed grey matter abnormalities in the frontal lobe , temporal lobe and cerebellum , and white matter deficits in the corpus callosum [ 13 ] .
# ::alignments 25-26|0.0.0 23-24|0.2.1.1.1.0 22-23|0.2.1.1.1.0.0 19-20|0.2.1.1.1 18-19|0.2.1.1.1.2 17-18|0.2.1.1.1.1 16-17|0.2 14-15|0.2.1.1.0 13-14|0.2.1.1 12-13|0.2.1 11-12|0.2.1.0 9-10|0.2.0 8-9|0.2.0.0 5-6|0.1 4-5|0.1.0 3-4|0.1.1 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:09.392
(r / reveal-01 
      :ARG0 (a4 / analyze-01 
            :ARG0 13 
            :ARG1 (m3 / mri)) 
      :ARG1 (a3 / abnormaliti 
            :mod (m2 / matter) 
            :mod (g / grey)) 
      :location (a / and 
            :op1 (l2 / lobe 
                  :mod (f / frontal)) 
            :op2 (l / lobe 
                  :mod (t / temporal) 
                  :op1-of (a2 / and 
                        :op2 (c3 / cerebellum) 
                        :op3 (d / deficit 
                              :location (c / callosum 
                                    :mod (c2 / corpu)) 
                              :mod (w / white) 
                              :poss (m / matter))))))

# ::snt The third mutation 1629insT ( X423L ) has been reported in several aniridia patients [ 11,12,27,33 ] .
# ::tok The third mutation 1629insT ( X423L ) has been reported in several aniridia patients [ 11,12,27,33 ] .
# ::alignments 13-14|0.0.0.1+0.0.0+0.0 12-13|0.0.0.1.0 11-12|0.0.1 9-10|0 5-6|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 3-4|0.1 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:09.450
(r / report-01 
      :ARG0 (p / person 
            :ARG0-of (h / have-rel-role-91 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "X423L")) 
                  :ARG2 (p2 / patient 
                        :mod (a / aniridia))) 
            :quant (s / several)) 
      :ARG1 (1 / 1629insT 
            :mod (m / mutation)))

# ::snt Insertion of a single T nucleotide at position 1629 changes the stop codon ( TAA ) to a leucine codon ( TTA ) and generates a full length PAX6 protein with a C-terminal extension that extends for a further 35 amino acids into the 3 ' untranslated region .
# ::tok Insertion of a single T nucleotide at position 1629 changes the stop codon ( TAA ) to a leucine codon ( TTA ) and generates a full length PAX6 protein with a C-terminal extension that extends for a further 35 amino acids into the 3 ' untranslated region .
# ::alignments 47-48|0.2 46-47|0.2.0 44-45|0.1.2 41-42|0.1.1.0.0.0 40-41|0.1.1.0.0.0.1 39-40|0.0.0.0.0 38-39|0.1.1.0.0.0.0 35-36|0.1.1.0.0 33-34|0.1.1.0 29-30|0.1.1 28-29|0.1.1.1 27-28|0.1.1.1.0.0 26-27|0.1.1.1.0 24-25|0.1 23-24|0 21-22|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 19-20|0.0.0.0.1.0 18-19|0.0.0.0.1 14-15|0.1.1.0.0.1.0.0+0.1.1.0.0.1.0+0.1.1.0.0.1 12-13|0.0.0 11-12|0.0.0.0 9-10|0.0 8-9|0.1.1.0.1.0+0.1.1.0.1 7-8|0.0.1 5-6|0.1.0.0 4-5|0.1.0.0.1.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 3-4|0.1.0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:10.747
(a3 / and 
      :ARG0-of (c3 / change-01 
            :ARG1 (c2 / codon 
                  :ARG1-of (s / stop-01 
                        :ARG0 35 
                        :ARG2 (l2 / leucine 
                              :mod-of (c / codon)))) 
            :time (p3 / position)) 
      :op1 (g / generate-01 
            :ARG0 (i / insertion 
                  :mod (n3 / nucleotide 
                        :ARG1-of (s2 / single-02 
                              :ARG2 (o / organization 
                                    :name (n / name 
                                          :op1 "TTA"))) 
                        :mod (a4 / aircraft-type 
                              :name (n4 / name 
                                    :op1 "T50") 
                              :wiki "Sukhoi_PAK_FA"))) 
            :ARG1 (p / protein 
                  :ARG1-of (e2 / extend-01 
                        :ARG1-of (e / extend-01 
                              :ARG2 (a / acid 
                                    :mod (f / further) 
                                    :mod (a2 / amino)) 
                              :op1-of (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "TAA"))) 
                        :ARG3 (d / date-entity 
                              :year 1629)) 
                  :mod (p2 / PAX6 
                        :mod (f2 / full 
                              :mod-of (l / length)))) 
            :op1-of 3) 
      :poss (r / region 
            :mod (u / untranslat)))

# ::snt MRI analysis of six patients with this mutation revealed variable brain defects including absence or hypoplasia of the anterior commissure , pineal gland and olfactory bulbs [ 12 ] .
# ::tok MRI analysis of six patients with this mutation revealed variable brain defects including absence or hypoplasia of the anterior commissure , pineal gland and olfactory bulbs [ 12 ] .
# ::alignments 27-28|0.0.0.0 25-26|0.0.0.2.2 24-25|0.0.0.2.2.0 23-24|0.0.0.2 22-23|0.0.0.2.1 21-22|0.0.0.2.1.0 19-20|0.0 18-19|0 15-16|0.0.0.1.0 14-15|0.0.0.1 13-14|0.0.0 11-12|0.0.0.2.0.1 10-11|0.0.0.2.0.1.0 9-10|0.0.0.2.0.1.1 8-9|0.0.0.2.0 7-8|0.0.0.2.0.0.0.0.0 6-7|0.0.0.2.0.0.0.0.0.0 4-5|0.0.0.2.0.0.0.0.1+0.0.0.2.0.0.0.0+0.0.0.2.0.0.0 3-4|0.0.0.2.0.0.0.1 1-2|0.0.0.2.0.0 0-1|0.0.0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:11.465
(a2 / anterior 
      :mod-of (c / commissure 
            :ARG1-of (a3 / absent-01 
                  :ARG0 12 
                  :op1-of (o2 / or 
                        :op2 (h / hypoplasia)) 
                  :op2-of (a / and 
                        :op1 (r / reveal-01 
                              :ARG0 (a4 / analyze-01 
                                    :ARG1 (p2 / person 
                                          :ARG0-of (h2 / have-rel-role-91 
                                                :ARG1 (m / mutation 
                                                      :mod (t / this)) 
                                                :ARG2 (p3 / patient)) 
                                          :quant 6) 
                                    :manner (m2 / mri)) 
                              :ARG1 (d / defect-01 
                                    :ARG1 (b2 / brain) 
                                    :mod (v / variable))) 
                        :op3 (g / gland 
                              :mod (p / pineal)) 
                        :op4 (b / bulb 
                              :mod (o / olfactory))))))

# ::snt Two patients had temporal polymicrogyria , one in association with epilepsy [ 12 ] .
# ::tok Two patients had temporal polymicrogyria , one in association with epilepsy [ 12 ] .
# ::alignments 12-13|0.0.0.0.0 10-11|0 8-9|0.0 4-5|0.0.0.1 3-4|0.0.0.1.0 1-2|0.0.0.0.1+0.0.0.0+0.0.0 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:11.540
(e / epilepsy 
      :ARG2-of (a / associate-01 
            :ARG1 (p2 / person 
                  :ARG0-of (h / have-rel-role-91 
                        :ARG1 12 
                        :ARG2 (p3 / patient)) 
                  :poss-of (p / polymicrogyria 
                        :mod (t / temporal)) 
                  :quant 2)))

# ::snt The three mutations were introduced into the PAX6PST construct , and pairwise tests were carried out to investigate the interaction of each mutant protein with HOMER3 , DNCL1 and TRIM11 .
# ::tok The three mutations were introduced into the PAX6PST construct , and pairwise tests were carried out to investigate the interaction of each mutant protein with HOMER3 , DNCL1 and TRIM11 .
# ::alignments 28-29|0.1.0.0.0.1 23-24|0.1.0.0.0.1.1 22-23|0.1.0.0.0.1.1.1 21-22|0.1.0.0.0.1.1.0 19-20|0.1.0.0.0.0 17-18|0.1.0.0.0 14-15|0.1.0 12-13|0.1.0.0 10-11|0.1 8-9|0.1.0.0.0.1.0 4-5|0 2-3|0.0 1-2|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:11.656
(i3 / introduce-02 
      :ARG1 (m2 / mutate-01) 
      :op1-of (a2 / and 
            :op2 (c / carry-out-03 
                  :ARG1 (t / test-01 
                        :ARG0-of (i2 / investigate-01 
                              :ARG1 (i / interact-01) 
                              :op1-of (a / and 
                                    :ARG1-of (c2 / construct-01) 
                                    :accompanier-of (p / protein 
                                          :mod (e / each) 
                                          :mod (m / mutant)))) 
                        :ARG1 3))))

# ::snt All three mutations had a clear effect on the interactions .
# ::tok All three mutations had a clear effect on the interactions .
# ::alignments 9-10|0.0.0 6-7|0.0 5-6|0.0.1 2-3|0 1-2|0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:11.712
(m / mutate-01 
      :ARG0-of (e / effect-03 
            :ARG1 (i / interaction) 
            :ARG1-of (c / clear-06 
                  :ARG0 (a / all))) 
      :quant 3)

# ::snt The most subtle mutation ( Q422R ) caused a reduction in the interaction with HOMER3 and DNCL1 ( Figure 3 , Table 1 ) .
# ::tok The most subtle mutation ( Q422R ) caused a reduction in the interaction with HOMER3 and DNCL1 ( Figure 3 , Table 1 ) .
# ::alignments 22-23|0.1.1.0.0 21-22|0.1.1.0.0.0 19-20|0.1.0 18-19|0.2 16-17|0.1.1.2 15-16|0.1.1 14-15|0.1.1.1 12-13|0.1.1.0 9-10|0.1 7-8|0 3-4|0.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:11.937
(c / cause-01 
      :ARG0 (m / mutation 
            :mod (s / subtle 
                  :degree (m2 / most))) 
      :ARG1 (r / reduce-01 
            :ARG2 3 
            :op1-of (a / and 
                  :ARG2-of (i / interact-01 
                        :ARG0 (1 / 1 
                              :mod-of (t / table))) 
                  :op2 (h / HOMER3) 
                  :op3 (d / DNCL1))) 
      :ARG2 (f / figure))

# ::snt The C-terminal extension mutations X423L and1615del10 mutations both dramatically reduced or abolished the interaction with HOMER3 and DNCL1 ( Figure 3 , Table 1 ) .
# ::tok The C-terminal extension mutations X423L and1615del10 mutations both dramatically reduced or abolished the interaction with HOMER3 and DNCL1 ( Figure 3 , Table 1 ) .
# ::alignments 23-24|0.0.0.0.0.1 22-23|0.0.0.0.0.1.0 20-21|0.0.0.0.0.0 19-20|0.0.1.0.1.0 16-17|0 13-14|0.0.1.0.1 11-12|0.0 10-11|0.0.1 9-10|0.0.1.0 8-9|0.0.1.0.2 7-8|0.0.1.0.0 6-7|0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:12.410
(a / and 
      :ARG0-of (a2 / abolish-01 
            :ARG1 (m / mutate-01 
                  :ARG1-of (m2 / mutate-01 
                        :ARG0 (e / extend-01 
                              :ARG0 3 
                              :ARG1 (1 / 1 
                                    :mod-of (t / table))))) 
            :op2-of (o / or 
                  :op1 (r / reduce-01 
                        :ARG0 (b / both) 
                        :ARG1 (i / interact-01 
                              :ARG1 (f / figure)) 
                        :manner (d / dramatic)))))

# ::snt None of the three mutations affected the interaction with TRIM11 which again is consistent with the hypothesis that TRIM11 interacts with a more N-terminal part of the PST domain .
# ::tok None of the three mutations affected the interaction with TRIM11 which again is consistent with the hypothesis that TRIM11 interacts with a more N-terminal part of the PST domain .
# ::alignments 28-29|0.1.0 27-28|0.1.0.0 22-23|0.1.1.0 19-20|0.0.0.0 16-17|0.0.0.1 13-14|0.0.0 11-12|0.0.0.2 7-8|0.1 5-6|0 4-5|0.1.1 3-4|0.0.0.0.0 0-1|0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:12.912
(a2 / affect-01 
      :ARG0 (p / person 
            :ARG0-of (c / consistent-01 
                  :ARG1 (i / interact-01 
                        :ARG1 3) 
                  :ARG2 (h / hypothesi) 
                  :mod (a / again)) 
            :quant (n / none)) 
      :ARG1 (i2 / interact-01 
            :ARG0 (d / domain 
                  :mod "PST") 
            :ARG1 (m2 / mutate-01 
                  :ARG1 (m / more))))

# ::snt On the basis of secondary structure predictions and amino acid sequence conservation , we defined a novel PAX6 protein domain , which we have called the C-terminal peptide .
# ::tok On the basis of secondary structure predictions and amino acid sequence conservation , we defined a novel PAX6 protein domain , which we have called the C-terminal peptide .
# ::alignments 27-28|0 24-25|0.0 22-23|0.0.0 19-20|0.0.1 18-19|0.0.1.1 16-17|0.0.1.0.0.0.3.0.0 14-15|0.0.1.0 13-14|0.0.1.0.0 11-12|0.0.1.0.0.0 10-11|0.0.1.0.0.0.0 9-10|0.0.1.0.0.0.2 8-9|0.0.1.0.0.0.1 7-8|0.0.1.0.0.0.3 6-7|0.0.1.0.0.0.3.0 5-6|0.0.1.0.0.0.3.0.1 4-5|0.0.1.0.0.0.3.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:13.116
(p / peptide 
      :ARG2-of (c / call-01 
            :ARG0 (w / we) 
            :ARG1 (d / domain 
                  :ARG1-of (d2 / define-01 
                        :ARG0 (w2 / we 
                              :ARG0-of (c2 / conserve-01 
                                    :ARG1 (s / sequence) 
                                    :mod (a2 / amino) 
                                    :mod (a / acid) 
                                    :op2-of (a3 / and 
                                          :op1 (p3 / predict-01 
                                                :ARG0 (n / novel) 
                                                :ARG1 (s2 / structure 
                                                      :mod (s3 / secondary))))))) 
                  :mod (p2 / protein))))

# ::snt We performed yeast two-hybrid library screens with the C-terminal peptide and the whole PST domain and we identified three novel interacting proteins , HOMER3 , DNCL1 and TRIM11 .
# ::tok We performed yeast two-hybrid library screens with the C-terminal peptide and the whole PST domain and we identified three novel interacting proteins , HOMER3 , DNCL1 and TRIM11 .
# ::alignments 26-27|0.2.1.1.1 21-22|0.2.1.1.1.0 20-21|0.2.1.1.1.0.0 19-20|0.2.1.1.1.0.0.0 18-19|0.0 17-18|0.2.1.1 16-17|0.2.1.1.0 15-16|0.2.1 14-15|0.2.1.0 13-14|0.2.1.0.0 12-13|0.2.1.0.1 10-11|0.2.1.1.2 9-10|0.2.1.1.2.0 5-6|0 4-5|0.3 2-3|0.1 1-2|0.2 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:13.546
(s / screen-01 
      :ARG0 3 
      :ARG1 (y / yeast) 
      :ARG1-of (p3 / perform-02 
            :ARG0 (w3 / we) 
            :op1-of (a2 / and 
                  :op2 (d / domain 
                        :mod "PST" 
                        :mod (w2 / whole)) 
                  :op3 (i2 / identify-01 
                        :ARG0 (w / we) 
                        :ARG1 (a / and 
                              :op1 (p / protein 
                                    :ARG1-of (i / interact-01 
                                          :ARG0 (n / novel)))) 
                        :op2-of (a3 / and 
                              :op1 (p2 / peptide))))) 
      :mod (l / library))

# ::snt In library screens , HOMER3 and DNCL1 interacted with the C-terminal peptide and the PST domain while TRIM11 interacted only with the PST domain , suggesting that HOMER3 and DNCL1 specifically interact with the C-terminal peptide while TRIM11 interacts with a more N-terminal part of the PST domain .
# ::tok In library screens , HOMER3 and DNCL1 interacted with the C-terminal peptide and the PST domain while TRIM11 interacted only with the PST domain , suggesting that HOMER3 and DNCL1 specifically interact with the C-terminal peptide while TRIM11 interacts with a more N-terminal part of the PST domain .
# ::alignments 47-48|0.1.0.0 46-47|0.1.0 41-42|0.0.1.0 38-39|0.0.2 35-36|0.0.0 31-32|0.0 30-31|0.0.1 28-29|0 25-26|0.1 23-24|0.1.1.0 22-23|0.1.1.0.0 19-20|0.1.1.1 18-19|0.1.1 15-16|0.1.1.2.0.0.2 14-15|0.1.1.2.0.0.2.0 12-13|0.1.1.2.0.0 11-12|0.1.1.2.0.0.1 7-8|0.1.1.2.0 5-6|0.1.1.2 2-3|0.1.1.2.0.0.0 1-2|0.1.1.2.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:13.996
(a / and 
      :ARG0-of (i2 / interact-01 
            :ARG1 (p / peptide) 
            :manner (s / specific-02 
                  :ARG1 (m / more)) 
            :time (i / interact-01)) 
      :op1 (s2 / suggest-01 
            :ARG1 (P / "PST" 
                  :mod-of (d / domain)) 
            :purpose-of (i3 / interact-01 
                  :ARG1 (d2 / domain 
                        :mod "PST") 
                  :mod (o / only) 
                  :op1-of (a3 / and 
                        :ARG0-of (i4 / interact-01 
                              :ARG1 (a2 / and 
                                    :op1 (s3 / screen-01 
                                          :ARG1 (l / library)) 
                                    :op2 (p2 / peptide) 
                                    :op3 (d3 / domain 
                                          :mod "PST")))))))

# ::snt The interactions between the PST domain and HOMER3 , DNCL1 and TRIM11 were confirmed in pairwise tests .
# ::tok The interactions between the PST domain and HOMER3 , DNCL1 and TRIM11 were confirmed in pairwise tests .
# ::alignments 16-17|0.0.1 15-16|0.0.1.0 13-14|0.0 11-12|0.2.2 10-11|0 9-10|0.2.1 7-8|0.1 6-7|0.2 5-6|0.2.0 4-5|0.2.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:14.131
(a / and 
      :ARG0-of (c / confirm-01 
            :ARG1 (i / interaction) 
            :ARG2 (t / test-01 
                  :ARG1 (p / pairwise))) 
      :op1 (h / HOMER3) 
      :op3-of (a2 / and 
            :op1 (d2 / domain 
                  :mod "PST") 
            :op2 (d / DNCL1) 
            :op4 (t2 / TRIM11)))

# ::snt We were not able to confirm the interaction between HOMER3 or DNCL1 with the C-terminal peptide construct in pairwise tests , but we showed that the C-terminal peptide was important for PAX6/HOMER3 or PAX6/DNCL1 interaction because HOMER3 and DNCL1 did not interact with a PST domain construct lacking the C-terminal peptide .
# ::tok We were not able to confirm the interaction between HOMER3 or DNCL1 with the C-terminal peptide construct in pairwise tests , but we showed that the C-terminal peptide was important for PAX6/HOMER3 or PAX6/DNCL1 interaction because HOMER3 and DNCL1 did not interact with a PST domain construct lacking the C-terminal peptide .
# ::alignments 50-51|0.1.1.0.0.1.1 47-48|0.1.1.0.0.1 46-47|0.1.1.0.0 45-46|0.1.1.0.0.0 44-45|0.1.1.0.0.0.0 41-42|0.1.1.0.0.1.0.1 40-41|0.1.1.0.0.1.0.1.0 37-38|0.1.1.0.0.1.0 35-36|0.1.1.0 34-35|0.1.1.0.0.1.0.0 32-33|0.0.0.1.1.0.1 29-30|0.1.1 27-28|0.1.1.1 23-24|0.1 22-23|0.1.0 21-22|0 19-20|0.0.0.1.1 16-17|0.0.0.1 15-16|0.0.0.1.0 10-11|0.0.0.1.1.0.0 7-8|0.0.0.1.1.0 5-6|0.0.0 3-4|0.0 2-3|0.0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:15.051
(c3 / contrast-01 
      :ARG1 (p4 / possible-01 
            :ARG1 (c5 / confirm-01 
                  :ARG0 (w2 / we) 
                  :ARG1 (c4 / construct-01 
                        :ARG0 (p3 / peptide) 
                        :ARG1 (t / test-01 
                              :ARG1 (i4 / interact-01 
                                    :ARG1 (o2 / or) 
                                    :op1-of (o / or))))) 
            :polarity -) 
      :ARG2 (s / show-01 
            :ARG0 (w / we) 
            :ARG1 (i3 / important 
                  :ARG1-of (c2 / cause-01 
                        :ARG0 (c / construct-01 
                              :ARG0 (d / domain 
                                    :mod "PST") 
                              :ARG1 (l / lack-01 
                                    :ARG0 (a / and 
                                          :ARG1-of (i2 / interact-01) 
                                          :ARG1-of (i / interact-01 
                                                :polarity -)) 
                                    :ARG1 (p / peptide)))) 
                  :domain (p2 / peptide))))

# ::snt HOMER3 is found in the PSD of neurons and directly binds to type I metabotropic glutamate receptors , which act via phospholipase C to stimulate IP3-mediated release of Ca2 + from intracellular vesicles [ 35,39 ] .
# ::tok HOMER3 is found in the PSD of neurons and directly binds to type I metabotropic glutamate receptors , which act via phospholipase C to stimulate IP3-mediated release of Ca2 + from intracellular vesicles [ 35,39 ] .
# ::alignments 32-33|0.0.1.0.1.0.0 31-32|0.0.1.0.1.0.0.0 26-27|0.0.1.0.1.0 25-26|0.0.1.0.1.0.1 24-25|0.0.1.0.1 22-23|0.0.1.0.0 19-20|0.0.1.0 16-17|0.0.1 15-16|0.0.1.1 13-14|0.0.0 12-13|0.1.1 10-11|0.1 9-10|0.1.0 8-9|0 7-8|0.0.2.1 5-6|0.0.2.0.0+0.0.2.0+0.0.2 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:15.410
(a2 / and 
      :op1 (f / find-01 
            :ARG0 (i3 / i) 
            :ARG1 (r2 / receptor 
                  :ARG1-of (a / act-02 
                        :ARG0 (c / C) 
                        :purpose (s / stimulate-01 
                              :ARG1 (r / release-01 
                                    :ARG0 (v / vesicl 
                                          :mod (i / intracellular)) 
                                    :ARG1 (i2 / ip3-mediat)))) 
                  :mod (g / glutamate)) 
            :location (o / organization 
                  :name (n2 / name 
                        :op1 "PSD") 
                  :part-of (n / neuron))) 
      :op2 (b / bind-01 
            :ARG1-of (d / direct-02) 
            :ARG2 (t / type)))

# ::snt HOMER3 is a member of the HOMER family of proteins that are constitutively expressed in the brain and play a role in post-synaptic signalling and receptor trafficking by forming multivalent links with various receptors and PSD scaffolding proteins [ 35,39-41 ] .
# ::tok HOMER3 is a member of the HOMER family of proteins that are constitutively expressed in the brain and play a role in post-synaptic signalling and receptor trafficking by forming multivalent links with various receptors and PSD scaffolding proteins [ 35,39-41 ] .
# ::alignments 37-38|0.0.1.0 36-37|0.0.1.0.0 35-36|0.0.1.1.0+0.0.1.1+0.0.1 34-35|0.1.0.0.0.0.0.1 33-34|0.1.0.0.0.0 32-33|0.1.0.0.0.0.1 30-31|0.1.0.0.0.0.0 29-30|0.1.0.0.0.0.0.0 28-29|0.1.0.0.0 26-27|0.1.0.0.1 25-26|0.1.0.0.1.0 24-25|0.1.0.0 23-24|0.1.0.0.2 20-21|0.1.0 18-19|0.1 17-18|0 16-17|0.0.2 13-14|0.0 9-10|0.0.0 7-8|0.1.0.0.0.0.0.1.0.0 6-7|0.1.0.0.0.0.0.1.0.0.0 3-4|0.1.0.0.0.0.0.1.0.1+0.1.0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:16.302
(a3 / and 
      :op1 (e / express-01 
            :ARG1 (p3 / protein) 
            :ARG2 (o / organization 
                  :mod-of (p / protein 
                        :mod (s / scaffold)) 
                  :name (n / name 
                        :op1 "PSD")) 
            :manner (b / brain)) 
      :op2 (p2 / play-01 
            :ARG1 (r3 / role 
                  :op1-of (a2 / and 
                        :ARG1-of (f / form-01 
                              :prep-with (r / receptor 
                                    :ARG2-of (l / link-01 
                                          :ARG1 (m / multivalent) 
                                          :op2-of (a / and 
                                                :op1 (h2 / have-org-role-91 
                                                      :ARG1 (f2 / family 
                                                            :ARG1-of (h / homer-01)) 
                                                      :ARG2 (m2 / member)))) 
                                    :mod (v / various))) 
                        :ARG1-of (t / traffic-01 
                              :ARG0 (r2 / receptor)) 
                        :op2 (s2 / signal-01)))))

# ::snt HOMER proteins have also been implicated in axon guidance during brain development [ 42 ] .
# ::tok HOMER proteins have also been implicated in axon guidance during brain development [ 42 ] .
# ::alignments 13-14|0.0 11-12|0.1.0.0 10-11|0.1.0.0.0 8-9|0.2 7-8|0.2.0 5-6|0 3-4|0.3 1-2|0.1 0-1|0.1.0.1.0+0.1.0.1+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:16.367
(i / implicate-01 
      :ARG0 42 
      :ARG1 (p / protein 
            :mod (p2 / person 
                  :ARG0-of (d / develop-02 
                        :ARG1 (b / brain)) 
                  :name (n / name 
                        :op1 "HOMER"))) 
      :ARG2 (g / guide-01 
            :mod (a / axon)) 
      :mod (a2 / also))

# ::snt DNCL1 is a subunit of two intracellular transport protein complexes , dynein and myosin Va [ 36 ] .
# ::tok DNCL1 is a subunit of two intracellular transport protein complexes , dynein and myosin Va [ 36 ] .
# ::alignments 16-17|0.1.0.0.0 14-15|0.4.0.0+0.4.0+0.4 13-14|0.3 12-13|0 11-12|0.2 9-10|0.1 8-9|0.1.0 7-8|0.1.0.0 6-7|0.1.0.0.1 5-6|0.1.1 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:16.474
(a / and 
      :mod (s / subunit) 
      :op1 (c2 / complex 
            :mod (p / protein 
                  :mod (t / transport-01 
                        :ARG0 36 
                        :ARG1 (i / intracellular))) 
            :quant 2) 
      :op2 (d / dynein) 
      :op3 (m / myosin) 
      :op4 (c / country 
            :name (n / name 
                  :op1 "Va")))

# ::snt Dynein and myosin Va are involved in the microtubule-based and actin-based movement respectively of proteins , organelles and vesicles in neurons [ 36,37 ] .
# ::tok Dynein and myosin Va are involved in the microtubule-based and actin-based movement respectively of proteins , organelles and vesicles in neurons [ 36,37 ] .
# ::alignments 20-21|0.1 18-19|0.4.0.3 17-18|0.4.0 16-17|0.4.0.2 14-15|0.4.0.1 12-13|0.4.0.0 11-12|0.4 10-11|0.3 9-10|0 8-9|0.2 5-6|0.0 2-4|0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 1-2|0.0.0 0-1|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:16.610
(a3 / and 
      :ARG2-of (i / involve-01 
            :ARG1 (a4 / and 
                  :op1 (p2 / person 
                        :name (n3 / name 
                              :op1 "Dynein")) 
                  :op2 (t / thing 
                        :name (n2 / name 
                              :op1 (m3 / myosin) 
                              :op2 (v2 / Va))))) 
      :mod (n / neuron) 
      :op1 (m2 / microtubule-bas) 
      :op2 (a2 / actin-bas) 
      :op3 (m / movement-07 
            :ARG1 (a / and 
                  :mod (r / respective) 
                  :op1 (p / protein) 
                  :op2 (o / organell) 
                  :op3 (v / vesicl))))

# ::snt Myosin Va is enriched in the PSD [ 43 ] , and DNCL1 binds to a variety of PSD proteins including guanylate kinase domain-associated protein [ 44 ] and neuronal nitric oxide synthase [ 45 ] .
# ::tok Myosin Va is enriched in the PSD [ 43 ] , and DNCL1 binds to a variety of PSD proteins including guanylate kinase domain-associated protein [ 44 ] and neuronal nitric oxide synthase [ 45 ] .
# ::alignments 34-35|0.0.3.0.0 31-32|0.0.3.1.1 30-31|0.0.3.1.1.0 29-30|0.0.3.1.1.1 28-29|0.0.3.1 26-27|0.0.4 24-25|0 23-24|0.0.1 22-23|0.0.2 19-20|0.0.3.0.1.0 16-17|0.0.3.0.1 13-14|0.0.3.0 11-12|0.0.3 8-9|0.0.3.1.1.1.0 6-7|0.0.3.1.0.0.0+0.0.3.1.0.0+0.0.3.1.0 3-4|0.0 0-2|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:17.070
(p / protein 
      :op1 (e / enrich-01 
            :ARG1 (t / thing 
                  :name (n4 / name 
                        :op1 (m / Myosin) 
                        :op2 (v2 / Va))) 
            :op1-of (d / domain-associat) 
            :op1-of (k / kinase) 
            :op1-of (a2 / and 
                  :op2 (b / bind-01 
                        :ARG0 45 
                        :ARG2 (v / variety 
                              :mod-of (p2 / protein))) 
                  :op2-of (a / and 
                        :op1 (o2 / organization 
                              :name (n3 / name 
                                    :op1 "PSD")) 
                        :op3 (o / oxide 
                              :mod (n / nitric) 
                              :mod (n2 / neuronal 
                                    :mod 43)))) 
            :op1-of 44))

# ::snt TRIM11 is a member of the mouse tripartite motif protein family ( also known as the RBCC family ) , and contains the three characteristic structural motifs of this protein family , a RING finger , a B-box zinc finger , and a coiled coil domain , as well as a B30 .2 domain that is found in many but not all TRIM proteins [ 38 ] .
# ::tok TRIM11 is a member of the mouse tripartite motif protein family ( also known as the RBCC family ) , and contains the three characteristic structural motifs of this protein family , a RING finger , a B-box zinc finger , and a coiled coil domain , as well as a B30 .2 domain that is found in many but not all TRIM proteins [ 38 ] .
# ::alignments 65-66|0.1.5.0.0 63-64|0.1.5.0.1.0 62-63|0.1.5.0.1 61-62|0.1.1.0.0 60-61|0.1.2.0.0 59-60|0 58-59|0.0 56-57|0.1.6.0 53-54|0.1.6 51-52|0.1.6.1.0.0+0.1.6.1.0+0.1.6.1 45-46|0.1.5 44-45|0.1.5.0 43-44|0.1.5.1 41-42|0.1 39-40|0.1.4 38-39|0.1.4.0 37-38|0.1.3.0.0+0.1.3.0+0.1.3 34-35|0.1.2 33-34|0.1.2.0 30-31|0.1.1 29-30|0.1.1.1 28-29|0.1.1.0 26-27|0.1.0.0 25-26|0.1.5.1.0 24-25|0.1.0.0.0 23-24|0.1.0.0.1 21-22|0.1.0 20-21|0.1.0.1 17-18|0.1.0.1.0.0.0.0 16-17|0.1.0.1.0.0.0.0.0.0.0+0.1.0.1.0.0.0.0.0.0+0.1.0.1.0.0.0.0.0 13-14|0.1.0.1.0.0.0 12-13|0.1.0.1.0.0.0.1 10-11|0.1.0.1.0.0 9-10|0.1.0.1.0.0.1 8-9|0.1.0.1.0.0.1.0 7-8|0.1.0.1.0.0.1.0.0 6-7|0.1.0.1.0.0.1.0.0.0 3-4|0.1.0.1.0.1+0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:19.936
(c / contrast-01 
      :ARG1 (m / many) 
      :ARG2 (a2 / and 
            :ARG0-of (c5 / contain-01 
                  :ARG1 (m2 / motif 
                        :ARG1-of (c4 / characteristic-02) 
                        :quant 3) 
                  :op2-of (a3 / and 
                        :op1 (h / have-org-role-91 
                              :ARG1 (f6 / family 
                                    :ARG1-of (k / know-02 
                                          :ARG2 (f5 / family 
                                                :mod (o2 / organization 
                                                      :name (n3 / name 
                                                            :op1 "RBCC"))) 
                                          :mod (a4 / also)) 
                                    :mod (p3 / protein 
                                          :mod (m3 / motif 
                                                :mod (t4 / tripartite 
                                                      :mod (m4 / mouse))))) 
                              :ARG2 (m5 / member)))) 
            :op1 (f4 / family 
                  :mod (t3 / this 
                        :mod (a / all)) 
                  :mod (p2 / protein)) 
            :op2 (f3 / finger 
                  :ARG1-of (r / ring-01 
                        :ARG0 -)) 
            :op3 (o / organization 
                  :name (n2 / name 
                        :op1 "B-box")) 
            :op4 (f2 / finger 
                  :mod (z / zinc)) 
            :op5 (d2 / domain 
                  :ARG1-of (c2 / coil-01 
                        :ARG0 38 
                        :ARG1-of (t / trim-01 
                              :ARG0 (p / protein))) 
                  :ARG1-of (c3 / coil-01 
                        :ARG0 (s / structure))) 
            :op6 (d / domain 
                  :ARG1-of (f / find-01) 
                  :mod (t2 / thing 
                        :name (n / name 
                              :op1 "B30")))))

# ::snt TRIM11 interacts with Humanin , a protein that suppresses the neurotoxicity associated with Alzheimer 's disease [ 46 ] .
# ::tok TRIM11 interacts with Humanin , a protein that suppresses the neurotoxicity associated with Alzheimer 's disease [ 46 ] .
# ::alignments 17-18|0.2.2 15-16|0.1 13-15|0.2.0.1+0.2.0.0.0+0.2.0.0+0.2.0 11-12|0 10-11|0.0 8-9|0.0.0 6-7|0.0.0.0 3-4|0.2.1.0.0+0.2.1.0+0.2.1 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:20.521
(a / associate-01 
      :ARG1 (n2 / neurotoxicity 
            :ARG1-of (s / suppress-01 
                  :ARG0 (p / protein))) 
      :ARG2 (d / disease) 
      :purpose-of (i / interact-01 
            :ARG0 (d2 / disease 
                  :name (n / name 
                        :op1 "Alzheimer's") 
                  :wiki "Alzheimer's_disease") 
            :ARG1 (p2 / person 
                  :name (n3 / name 
                        :op1 "Humanin")) 
            :op1-of 46))

# ::snt TRIM11 lowers Humanin levels by a mechanism that appears to involve ubiqutin-mediated proteasomal degradation [ 46 ] .
# ::tok TRIM11 lowers Humanin levels by a mechanism that appears to involve ubiqutin-mediated proteasomal degradation [ 46 ] .
# ::alignments 15-16|0.0.0.0.1 13-14|0.0 11-12|0 10-11|0.0.0 8-9|0.0.0.0 6-7|0.0.0.0.0 3-4|0.0.0.0.0.0.0 2-3|0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:20.726
(u / ubiqutin-mediat 
      :mod-of (d / degradation 
            :ARG1-of (i / involve-01 
                  :ARG2-of (a / appear-02 
                        :ARG0 (m / mechanism 
                              :ARG0-of (l2 / lower-01 
                                    :ARG1 (l / level 
                                          :mod (p / person 
                                                :name (n / name 
                                                      :op1 "Humanin"))))) 
                        :ARG1 46))))

# ::snt At present our data must be considered preliminary because the interactions have not been confirmed by any other approach .
# ::tok At present our data must be considered preliminary because the interactions have not been confirmed by any other approach .
# ::alignments 18-19|0.1.0.0 17-18|0.1.0.0.1 16-17|0.1.0.0.0 14-15|0.1.0 12-13|0.1.0.2 10-11|0.1.0.1 8-9|0.1 7-8|0.0 6-7|0 3-4|0.0.0 2-3|0.0.0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:21.025
(c3 / consider-01 
      :ARG1 (p / preliminary 
            :domain (d / data 
                  :poss (w / we))) 
      :ARG1-of (c2 / cause-01 
            :ARG0 (c / confirm-01 
                  :ARG0 (a / approach-02 
                        :mod (a2 / any) 
                        :mod (o / other)) 
                  :ARG1 (i / interaction) 
                  :polarity -)) 
      :time (p2 / present))

# ::snt However it is interesting to speculate that the interaction of PAX6 with HOMER3 and DNCL1 may be the basis of a mechanism by which synaptic signalling causes changes in gene expression .
# ::tok However it is interesting to speculate that the interaction of PAX6 with HOMER3 and DNCL1 may be the basis of a mechanism by which synaptic signalling causes changes in gene expression .
# ::alignments 30-31|0.0.0.0 29-30|0.0.0.0.1 27-28|0.0.0 26-27|0 25-26|0.0 24-25|0.0.1 21-22|0.1 15-16|0.0.0.0.0.1 13-14|0.0.0.0.0 8-9|0.0.0.0.0.0 5-6|0.0.0.0.0.1.0 3-4|0.0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:21.550
(c2 / cause-01 
      :ARG0 (s / signal-01 
            :ARG0-of (c / change-01 
                  :ARG1 (e / express-01 
                        :ARG1 (a / and 
                              :ARG1-of (i / interact-01) 
                              :op1 (p / possible-01 
                                    :ARG1-of (s3 / speculate-01 
                                          :ARG2-of (i2 / interest-01)))) 
                        :mod (g / gene))) 
            :mod (s2 / synaptic)) 
      :ARG1 (m / mechanism))

# ::snt We propose that PAX6 is sequestered in the PSD by binding to HOMER3 .
# ::tok We propose that PAX6 is sequestered in the PSD by binding to HOMER3 .
# ::alignments 10-11|0.0.0 8-9|0.1.0.0.0+0.1.0.0+0.1.0 5-6|0.1 3-4|0.1.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:21.621
(p2 / propose-01 
      :ARG0 (w / we 
            :ARG1-of (b / binding-07)) 
      :ARG1 (s / sequester-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "PSD")) 
            :ARG1 (p / PAX6)))

# ::snt Since receptor activation causes dissociation of HOMER proteins [ 35 ] , PAX6 may be released as a result of synaptic activity , allowing it to interact with DNCL1 .
# ::tok Since receptor activation causes dissociation of HOMER proteins [ 35 ] , PAX6 may be released as a result of synaptic activity , allowing it to interact with DNCL1 .
# ::alignments 26-27|0.0.0.0 23-24|0.0.0 21-22|0.0.1.0 20-21|0.0.1.0.1 18-19|0.0.1 15-16|0.0 13-14|0 9-10|0.0.1.0.0 7-8|0.0.2.0.1.0 6-7|0.0.2.0.1.0.0 4-5|0.0.2.0.1 3-4|0.0.2.0 2-3|0.0.2.0.0 1-2|0.0.2.0.0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:21.803
(p / possible-01 
      :ARG1 (r2 / release-01 
            :ARG1 (a / allow-01 
                  :ARG1 (i / interact-01)) 
            :ARG2-of (r / result-01 
                  :ARG1 (a2 / activity-06 
                        :ARG1 35 
                        :mod (s / synaptic))) 
            :time (s2 / since 
                  :op1 (c / cause-01 
                        :ARG0 (a3 / activation 
                              :mod (r3 / receptor)) 
                        :ARG1 (d / dissociation 
                              :mod (p2 / protein 
                                    :ARG1-of (h / homer-01)))))))

# ::snt The PAX6/DNCL1 complex could then participate in myosin Va-mediated transport along the PSD-associated actin cytoskeleton followed by dynein-mediated transport along the microtubule network , eventually reaching the nucleus [ 36 ] .
# ::tok The PAX6/DNCL1 complex could then participate in myosin Va-mediated transport along the PSD-associated actin cytoskeleton followed by dynein-mediated transport along the microtubule network , eventually reaching the nucleus [ 36 ] .
# ::alignments 29-30|0.0 27-28|0.1.1.0.0.0.1 25-26|0.1.1.0.0.0 24-25|0.1.1.0.0.0.3 22-23|0.1.1.0.0.0.2 21-22|0.1.1.0.0.0.2.0 19-20|0.1.1.0.0.0.2.1 18-19|0.1.1.0.0.0.2.1.0 17-18|0.1.1.0.0.0.2.1.0.0 15-16|0.1.1.0.0 14-15|0.1.1.0 13-14|0.1.1.0.1 12-13|0.1.1.0.0.0.0.0.0+0.1.1.0.0.0.0.0+0.1.1.0.0.0.0 10-11|0.1.1.1 9-10|0.1.1 8-9|0.1.1.2 7-8|0.1.1.3 5-6|0.1 4-5|0.1.2 3-4|0 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:22.619
(p2 / possible-01 
      :ARG0 36 
      :ARG1 (p / participate-01 
            :ARG0 (c2 / complex) 
            :ARG1 (t3 / transport-01 
                  :ARG1 (c / cytoskeleton 
                        :ARG0-of (f / follow-01 
                              :ARG1 (r / reach-01 
                                    :ARG0 (t2 / thing 
                                          :name (n3 / name 
                                                :op1 "PSD-associated")) 
                                    :ARG1 (n / nucleus) 
                                    :ARG4 (n2 / network 
                                          :mod (m / microtubule) 
                                          :op1-of (a / along 
                                                :location-of (t / transport-01 
                                                      :ARG1 (d / dynein-mediat)))) 
                                    :time (e / eventual))) 
                        :mod (a2 / actin)) 
                  :location (a3 / along) 
                  :mod (v / va-mediat) 
                  :mod (m2 / myosin)) 
            :time (t4 / then)))

# ::snt Since TRIM11 is implicated in protein degradation [ 46 ] , it may play a role in PAX6 protein turnover .
# ::tok Since TRIM11 is implicated in protein degradation [ 46 ] , it may play a role in PAX6 protein turnover .
# ::alignments 19-20|0.0.1 18-19|0.0.1.0 15-16|0.0.0 13-14|0.0 12-13|0 8-9|0.0.2.0.0 6-7|0.0.2.0.1 5-6|0.0.2.0.1.0 3-4|0.0.2.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:22.713
(p3 / possible-01 
      :ARG1 (p2 / play-01 
            :ARG1 (r / role) 
            :location (t / turnover 
                  :mod (p / protein)) 
            :time (s / since 
                  :op1 (i / implicate-01 
                        :ARG1 46 
                        :ARG2 (d / degradation 
                              :mod (p4 / protein))))))

# ::snt Precedents for association of transcription factors with the post-synaptic density include STAT3 and CREB , which act as messengers between the synapse and the nucleus [ 47,48 ] .
# ::tok Precedents for association of transcription factors with the post-synaptic density include STAT3 and CREB , which act as messengers between the synapse and the nucleus [ 47,48 ] .
# ::alignments 24-25|0.2 22-23|0 21-22|0.1 18-19|0.0.2 16-17|0.0 12-13|0.0.1 10-11|0.0.1.0 9-10|0.0.1.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0.0.0 2-3|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:22.918
(a / and 
      :op1 (a2 / act-02 
            :ARG0 (p / precedent 
                  :purpose (a4 / associate-01 
                        :ARG1 (f / factor 
                              :mod (t / transcription)))) 
            :ARG1 (a3 / and 
                  :ARG1-of (i / include-01 
                        :ARG0 (d / density))) 
            :ARG2 (m / messenger)) 
      :op2 (s / synapse) 
      :op3 (n / nucleus))

# ::snt Although the full-length PAX6 protein is predominantly nuclear , there is good evidence in mouse , quail and nematode for an isoform that lacks the paired domain , is both nuclear and cytoplasmic , and binds DNA through the homeodomain alone [ 49-51 ] .
# ::tok Although the full-length PAX6 protein is predominantly nuclear , there is good evidence in mouse , quail and nematode for an isoform that lacks the paired domain , is both nuclear and cytoplasmic , and binds DNA through the homeodomain alone [ 49-51 ] .
# ::alignments 40-41|0.3.3 39-40|0.3.1 36-37|0.3.0 35-36|0.3 34-35|0 32-33|0.2 31-32|0.3.2 30-31|0.1 29-30|0.3.2.0 26-27|0.0.1 25-26|0.0.1.0 23-24|0.0 21-22|0.0.0 18-19|0.4.1.1 17-18|0.4.1 16-17|0.4.1.0 14-15|0.4.2 12-13|0.4 11-12|0.4.3 7-8|0.4.0 6-7|0.4.0.1 4-5|0.4.0.0 2-3|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:23.348
(a2 / and 
      :op1 (l / lack-01 
            :ARG0 (i / isoform) 
            :ARG1 (d2 / domain 
                  :ARG1-of (p / pair-01 
                        :ARG0 (f / full-length)))) 
      :op2 (n / nucleus) 
      :op3 (c / cytoplasmic) 
      :op4 (b / bind-01 
            :ARG1 (d / DNA) 
            :ARG3 (h / homeodomain) 
            :op1-of (a3 / and 
                  :mod (b2 / both)) 
            :time (a / alone)) 
      :time-of (e / evidence-01 
            :domain-of (n3 / nucleus 
                  :domain (p3 / protein) 
                  :mod (p2 / predominant)) 
            :location (a4 / and 
                  :op1 (q / quail) 
                  :op2 (n2 / nematode)) 
            :location (m / mouse) 
            :mod (g / good)))

# ::snt In mice the paired-less isoform is relatively abundant in brain [ 49 ] ; however its subcellular localisation in neurones , and the possibility of an association with the PSD , remains to be investigated .
# ::tok In mice the paired-less isoform is relatively abundant in brain [ 49 ] ; however its subcellular localisation in neurones , and the possibility of an association with the PSD , remains to be investigated .
# ::alignments 34-35|0 31-32|0.2 29-30|0.2.0.1.1.1.0.0+0.2.0.1.1.1.0+0.2.0.1.1.1 26-27|0.2.0.1.1 23-24|0.2.0.1 21-22|0.2.0 19-20|0.2.0.0.2 17-18|0.2.0.0 16-17|0.2.0.0.1 13-14|0.0 11-12|0.1 9-10|0.2.0.0.0 7-8|0.2.0.1.0.0 6-7|0.2.0.1.1.0 4-5|0.2.0.1.0.0.0 3-4|0.2.0.1.0.0.0.0 1-2|0.2.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:23.784
(i / investigate-01 
      :ARG0 (a3 / and) 
      :ARG1 49 
      :ARG1-of (r / remain-01 
            :ARG0 (a2 / and 
                  :op1 (l / localize-01 
                        :ARG0 (b / brain) 
                        :ARG1 (s / subcellular) 
                        :location (n2 / neuron)) 
                  :op2 (p / possible-01 
                        :ARG0 (m / mouse 
                              :location-of (a4 / abundance 
                                    :domain (i2 / isoform 
                                          :mod (p2 / paired-les)))) 
                        :ARG1 (a / associate-01 
                              :ARG0 (r2 / relative) 
                              :ARG2 (o / organization 
                                    :name (n / name 
                                          :op1 "PSD")))))))

# ::snt Regarding the subcellular localisation of the putative interacting proteins , HOMER3 is predominantly found at the interface between the PSD and the cytoplasm [ 39 ] , DNCL1 is chiefly cytoplasmic , although nuclear localisation has been reported [ 51 ] , and TRIM11 is both nuclear and cytoplasmic [ 38 ] .
# ::tok Regarding the subcellular localisation of the putative interacting proteins , HOMER3 is predominantly found at the interface between the PSD and the cytoplasm [ 39 ] , DNCL1 is chiefly cytoplasmic , although nuclear localisation has been reported [ 51 ] , and TRIM11 is both nuclear and cytoplasmic [ 38 ] .
# ::alignments 50-51|0.0.1.0.0.1 48-49|0.0.1.0.0.0 47-48|0.0.0.1.0.0.0.0 46-47|0.2 45-46|0.0.0.1.0.0.0.0.0 42-43|0 39-40|0.0.0.0 37-38|0.0.1.0 34-35|0.0.1.0.0 33-34|0.0.1.0.0.2 30-31|0.0.3 29-30|0.1 24-25|0.0.0.1.0.2 22-23|0.0.2 20-21|0.0 19-20|0.0.1.1.0+0.0.1.1+0.0.1 16-17|0.0.0.2 13-14|0.0.0 12-13|0.0.4 8-9|0.0.0.1.0.0 7-8|0.0.0.1.0.0.0 6-7|0.0.0.1.0.0.1 3-4|0.0.0.1.0 2-3|0.0.0.1 0-1|0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:25.094
(a2 / and 
      :op1 (a3 / and 
            :op1 (f / find-01 
                  :ARG0 51 
                  :ARG1 (s / subcellular 
                        :mod-of (l2 / localize-01 
                              :ARG1 (p2 / protein 
                                    :ARG1-of (i2 / interact-01 
                                          :op1-of (a / and 
                                                :mod (b / both))) 
                                    :mod (p3 / putative)) 
                              :ARG1-of (r2 / regard-01) 
                              :ARG2 39)) 
                  :location (i / interface)) 
            :op2 (o / organization 
                  :ARG0-of (r / report-01 
                        :ARG1 (l / localize-01 
                              :ARG0 (c / cytoplasmic) 
                              :ARG1 38 
                              :mod (n2 / nucleus))) 
                  :name (n3 / name 
                        :op1 "PSD")) 
            :op3 (c4 / cytoplasm) 
            :op4 (c2 / cytoplasmic) 
            :time (p / predominant)) 
      :op2 (c3 / chief) 
      :op3 (n / nucleus))

# ::snt Therefore cytoplasmic PAX6 could potentially interact with all three proteins , while nuclear PAX6 could interact with TRIM11 and DNCL1 .
# ::tok Therefore cytoplasmic PAX6 could potentially interact with all three proteins , while nuclear PAX6 could interact with TRIM11 and DNCL1 .
# ::alignments 19-20|0.2.0.1 18-19|0.2.0 17-18|0.2.0.0 15-16|0.2 14-15|0.2.1 12-13|0.0 9-10|0.1.1 8-9|0.1.1.0 7-8|0.2.1.0 5-6|0.1 4-5|0.1.2 3-4|0 1-3|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:25.394
(p4 / possible-01 
      :ARG0 (n / nucleus) 
      :ARG1 (i2 / interact-01 
            :ARG0 (t2 / thing 
                  :name (n2 / name 
                        :op1 (c / cytoplasmic) 
                        :op2 (p5 / PAX6))) 
            :ARG2 (p2 / protein 
                  :quant 3) 
            :manner (p3 / potential)) 
      :condition (i / interact-01 
            :ARG1 (a / and 
                  :op1 (t / TRIM11) 
                  :op2 (d / DNCL1)) 
            :ARG1-of (p / possible-01 
                  :ARG2 (a2 / all))))

# ::snt At the tissue level , HOMER3 expression has been detected in thymus and lung but it has mainly been studied in brain where it is found in the forebrain , hippocampus and cerebellum [ 39 ] .
# ::tok At the tissue level , HOMER3 expression has been detected in thymus and lung but it has mainly been studied in brain where it is found in the forebrain , hippocampus and cerebellum [ 39 ] .
# ::alignments 34-35|0.0.0 32-33|0.1.0 31-32|0.1.1.0.0 30-31|0.1.1.0.0.1 28-29|0.1.1.0.0.0 25-26|0.1.1.0 21-22|0.1.1 19-20|0.1 17-18|0.1.2 14-15|0 13-14|0.0.2.1 12-13|0.0.2 11-12|0.0.2.0 9-10|0.0 6-7|0.0.1 5-6|0.0.1.0 3-4|0.0.3 2-3|0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:25.622
(c2 / contrast-01 
      :ARG1 (d / detect-01 
            :ARG0 39 
            :ARG1 (e / express-01 
                  :ARG1 (h2 / HOMER3)) 
            :location (a2 / and 
                  :op1 (t / thymu) 
                  :op2 (l / lung)) 
            :prep-at (l2 / level 
                  :mod (t2 / tissue))) 
      :ARG2 (s / study-01 
            :ARG1 (c / cerebellum) 
            :location (b / brain 
                  :ARG1-of (f2 / find-01 
                        :location (a / and 
                              :op1 (f / forebrain) 
                              :op2 (h / hippocampu)))) 
            :mod (m / main)))

# ::snt DNCL1 and TRIM11 both have wide expression domains that include the brain [ 44,38 ] .
# ::tok DNCL1 and TRIM11 both have wide expression domains that include the brain [ 44,38 ] .
# ::alignments 11-12|0.0.0 9-10|0.1 7-8|0.1.0 6-7|0.0 5-6|0.1.0.0 3-4|0.2 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:25.669
(a / and 
      :ARG1-of (e / express-01 
            :ARG0 (b / brain)) 
      :ARG1-of (i / include-01 
            :ARG0 (d / domain 
                  :ARG1-of (w / wide-02))) 
      :mod (b2 / both))

# ::snt Thus the expression of all three interactors overlaps with PAX6 at the tissue level [ 2,7,8,10 ] .
# ::tok Thus the expression of all three interactors overlaps with PAX6 at the tissue level [ 2,7,8,10 ] .
# ::alignments 13-14|0.0.1 12-13|0.0.1.0 9-10|0.0.0 7-8|0.0 6-7|0.1 5-6|0.1.0 4-5|0.0.1.0.0 2-3|0 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:25.733
(e / express-01 
      :ARG0-of (o / overlap-01 
            :ARG1 (p / PAX6) 
            :prep-at (l / level 
                  :mod (t / tissue 
                        :mod (a / all)) 
                  :mod (t2 / thu))) 
      :ARG1 (i / interactor 
            :quant 3))

# ::snt We detected co-expression of PAX6 , HOMER3 , DNCL1 and TRIM11 by RT-PCR in human adult brain RNA ( IH , L Harrison and A Brown , data not shown ) .
# ::tok We detected co-expression of PAX6 , HOMER3 , DNCL1 and TRIM11 by RT-PCR in human adult brain RNA ( IH , L Harrison and A Brown , data not shown ) .
# ::alignments 29-30|0 28-29|0.2 27-28|0.1 25-26|0.0.2.2+0.0.2.0.0+0.0.2.0+0.0.2 23-24|0.0.2.1 21-23|0.0.2.1.0.0.1+0.0.2.1.0.0.0+0.0.2.1.0.0+0.0.2.1.0 17-18|0.0.0.1 16-17|0.0.1 15-16|0.0.1.0.0 14-15|0.0.1.0 9-10|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:26.006
(s / show-01 
      :ARG0 (a3 / and 
            :ARG1-of (d2 / detect-01 
                  :ARG0 (w / we) 
                  :location (r / rna)) 
            :op1 (b / brain 
                  :mod (h2 / human 
                        :mod-of (a2 / adult))) 
            :op2 (p / person 
                  :name (n / name 
                        :op1 "Brown") 
                  :op2-of (a / and 
                        :op1 (t / thing 
                              :name (n2 / name 
                                    :op1 (l / L) 
                                    :op2 (h / Harrison)))) 
                  :wiki "Gordon_Brown")) 
      :ARG1 (d / data) 
      :polarity -)

# ::snt We demonstrated that the interaction between the PST domain and HOMER3 or DNCL1 was impaired by three naturally occurring mutations that are located in the PAX6 C-terminal peptide .
# ::tok We demonstrated that the interaction between the PST domain and HOMER3 or DNCL1 was impaired by three naturally occurring mutations that are located in the PAX6 C-terminal peptide .
# ::alignments 27-28|0.1.1.0 25-26|0.1.0.0 22-23|0.1.0.2 19-20|0.1.0 18-19|0.1.0.1 17-18|0.1.0.1.0 16-17|0.0.0 14-15|0.1 11-12|0.1.1.1 9-10|0.1.1.1.0.1 8-9|0.1.1.1.0 7-8|0.1.1.1.0.0 4-5|0.1.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:26.241
(d2 / demonstrate-01 
      :ARG0 (w / we 
            :mod-of 3) 
      :ARG1 (i / impair-01 
            :ARG0 (m / mutate-01 
                  :ARG1 (p2 / PAX6) 
                  :ARG1-of (o / occur-01 
                        :ARG1-of (n / natural-03)) 
                  :ARG1-of (l / locate-01)) 
            :ARG1 (i2 / interact-01 
                  :ARG0 (p / peptide) 
                  :ARG2 (o2 / or 
                        :op1 (d / domain 
                              :mod "PST" 
                              :op1-of (a / and))))))

# ::snt The Q422R mutation , which involves a glutamine to arginine substitution at the last amino acid position of PAX6 , caused a reduction in the interaction with HOMER3 and DNCL1 .
# ::tok The Q422R mutation , which involves a glutamine to arginine substitution at the last amino acid position of PAX6 , caused a reduction in the interaction with HOMER3 and DNCL1 .
# ::alignments 28-29|0.0 25-26|0.0.0 22-23|0.0.1 20-21|0 16-17|0.0.1.0.0.0.1 15-16|0.0.1.0.0.0.1.2 14-15|0.0.1.0.0.0.1.1 13-14|0.0.1.0.0.0.1.0 10-11|0.0.1.0.0.0 9-10|0.0.1.0.0.0.2 7-8|0.0.1.0.0.0.0 5-6|0.0.1.0.0 2-3|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:26.483
(c / cause-01 
      :ARG0 (a / and 
            :ARG1-of (i / interact-01) 
            :op1 (r / reduce-01 
                  :ARG0 (m / mutation 
                        :ARG0-of (i2 / involve-01 
                              :ARG1 (s / substitute-01 
                                    :ARG0 (g / glutamine) 
                                    :ARG1 (p / position 
                                          :mod (l / last) 
                                          :mod (a3 / amino) 
                                          :poss (a2 / acid)) 
                                    :mod (a4 / arginine)))))))

# ::snt The X423L and 1615del10 mutations severely reduced or completely abolished the interaction with HOMER3 and DNCL1 .
# ::tok The X423L and 1615del10 mutations severely reduced or completely abolished the interaction with HOMER3 and DNCL1 .
# ::alignments 14-15|0.0.0.1.0 11-12|0.0.0.1.1 9-10|0.0.0.1 8-9|0.0.0.1.2 7-8|0 6-7|0.0 5-6|0.0.2 4-5|0.0.0.0 2-3|0.0.0 1-2|0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:26.554
(o / or 
      :op1 (r / reduce-01 
            :ARG0 (a3 / and 
                  :op1 (m / mutate-01) 
                  :op2 (a2 / abolish-01 
                        :ARG0 (a / and) 
                        :ARG1 (i / interact-01) 
                        :ARG1-of (c / complete-02))) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "X423L")) 
            :manner (s / severe)))

# ::snt The predicted effect of the X423L and 1615del10 mutations is to cause translation into the 3 ' untranslated region , thus generating proteins with abnormal extensions that might be expected to disrupt the conformation of the C-terminal end of the protein .
# ::tok The predicted effect of the X423L and 1615del10 mutations is to cause translation into the 3 ' untranslated region , thus generating proteins with abnormal extensions that might be expected to disrupt the conformation of the C-terminal end of the protein .
# ::alignments 40-41|0 37-38|0.0 33-34|0.0.0.1 31-32|0.0.0 29-30|0.0.0.2 27-28|0.0.0.2.0 25-26|0.0.0.0 24-25|0.0.0.0.1 22-23|0.0.0.0.0.0 21-22|0.0.0.0.0 20-21|0.0.0.0.0.3 18-19|0.0.0.0.0.1 17-18|0.0.0.0.0.1.0 15-16|0.0.0.0.0.2.0.1.0 12-13|0.0.0.0.0.2.1.0+0.0.0.0.0.2.1 11-12|0.0.0.0.0.2 8-9|0.0.0.0.0.2.0.1 6-7|0.0.0.0.0.2.0 5-6|0.0.0.0.0.2.0.0.0.0.0+0.0.0.0.0.2.0.0.0.0+0.0.0.0.0.2.0.0.0 2-3|0.0.0.0.0.2.0.0 1-2|0.0.0.0.0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:27.888
(p / protein 
      :ARG1-of (e / end-01 
            :time-of (d / disrupt-01 
                  :ARG0 (e3 / extension 
                        :ARG2-of (g / generate-01 
                              :ARG1 (p3 / protein) 
                              :ARG4 (r / region 
                                    :mod (u / untranslat)) 
                              :purpose-of (c2 / cause-01 
                                    :ARG0 (a2 / and 
                                          :ARG1-of (e4 / effect-03 
                                                :ARG0 (t4 / thing 
                                                      :name (n / name 
                                                            :op1 "X423L")) 
                                                :ARG1-of (p4 / predict-01)) 
                                          :op1 (m / mutate-01 
                                                :ARG1 3)) 
                                    :ARG1 (t2 / thing 
                                          :ARG2-of (t3 / translate-01))) 
                              :time (t / thus-far)) 
                        :mod (a / abnormal)) 
                  :ARG1 (c / conformation) 
                  :ARG1-of (e2 / expect-01 
                        :ARG1-of (p2 / possible-01)))))

# ::snt The 1615del10 mutation also removes the last 5 amino acids of the C-terminal peptide [ 28 ] .
# ::tok The 1615del10 mutation also removes the last 5 amino acids of the C-terminal peptide [ 28 ] .
# ::alignments 15-16|0.2 13-14|0.1.2 9-10|0.1 8-9|0.1.1 7-8|0.1.3 6-7|0.1.0 4-5|0 3-4|0.3 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:27.993
(r / remove-01 
      :ARG0 (m / mutation) 
      :ARG1 (a / acid 
            :mod (l / last) 
            :mod (a2 / amino) 
            :poss (p / peptide) 
            :quant 5) 
      :ARG2 28 
      :mod (a3 / also))

# ::snt None of the mutations affected the interaction with TRIM11 , suggesting that they do not alter the conformation of the more N-terminal part of the PST domain .
# ::tok None of the mutations affected the interaction with TRIM11 , suggesting that they do not alter the conformation of the more N-terminal part of the PST domain .
# ::alignments 26-27|0.0.1.0.0 25-26|0.0.1.0 20-21|0.1.0 17-18|0.0.0.0.1 15-16|0.0.0.0 14-15|0.0.0.0.2 12-13|0.0.0.0.0 10-11|0.0.0 8-9|0.2 6-7|0.1 4-5|0 3-4|0.0.1 0-1|0.0.2+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:28.469
(a2 / affect-01 
      :ARG0 (p / person 
            :ARG0-of (s / suggest-01 
                  :ARG1 (a / alter-01 
                        :ARG0 (t / they) 
                        :ARG1 (c / conformation) 
                        :polarity -)) 
            :ARG1-of (m2 / mutate-01 
                  :ARG0 (P / "PST" 
                        :mod-of (d / domain))) 
            :quant (n / none)) 
      :ARG1 (i / interact-01 
            :ARG1 (m / more)) 
      :manner (t2 / TRIM11))

# ::snt All our data are consistent with the hypothesis that TRIM11 does not interact with the C-terminal peptide , but interacts with the PST domain between the homeodomain and the C-terminal peptide .
# ::tok All our data are consistent with the hypothesis that TRIM11 does not interact with the C-terminal peptide , but interacts with the PST domain between the homeodomain and the C-terminal peptide .
# ::alignments 30-31|0.2.1.1 27-28|0.2.1 26-27|0.2.1.0 23-24|0.2.0 22-23|0.3 19-20|0.2 18-19|0 16-17|0.1.0 12-13|0.1 11-12|0.1.1 7-8|0.0.1 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:29.236
(c / contrast-01 
      :ARG0 (c2 / consistent-01 
            :ARG1 (d2 / data 
                  :poss (w / we) 
                  :quant (a2 / all)) 
            :ARG2 (h2 / hypothesi)) 
      :ARG1 (i2 / interact-01 
            :ARG1 (p2 / peptide) 
            :polarity -) 
      :ARG2 (i / interact-01 
            :ARG1 (d / domain) 
            :op1-of (a / and 
                  :op2 (h / homeodomain) 
                  :op3 (p / peptide))) 
      :manner "PST")

# ::snt Most aniridia patients are heterozygous for mutations that introduce a premature termination codon into the PAX6 open reading frame [ 2,52 ] .
# ::tok Most aniridia patients are heterozygous for mutations that introduce a premature termination codon into the PAX6 open reading frame [ 2,52 ] .
# ::alignments 18-19|0.0.0.0.1 17-18|0.0.0.0.1.1 16-17|0.0.0.0.1.0 12-13|0.0.0 11-12|0.0 10-11|0 8-9|0.0.0.0 6-7|0.0.0.0.0 4-5|0.0.0.0.0.0.1 2-3|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:29.435
(p / premature 
      :ARG0-of (t / terminate-01 
            :ARG1 (c / codon 
                  :ARG1-of (i / introduce-02 
                        :ARG0 (m / mutate-01 
                              :ARG1 (p2 / person 
                                    :ARG0-of (h2 / have-rel-role-91 
                                          :ARG2 (p3 / patient 
                                                :mod (a / aniridia))) 
                                    :domain-of (h / heterozygou) 
                                    :quant (m2 / most))) 
                        :ARG2 (f / frame 
                              :ARG1-of (o / open-04) 
                              :mod (r / read-01))))))

# ::snt These alleles would be expected to encode truncated proteins or no protein at all if the mutant RNA is degraded by nonsense-mediated decay [ 52 ] .
# ::tok These alleles would be expected to encode truncated proteins or no protein at all if the mutant RNA is degraded by nonsense-mediated decay [ 52 ] .
# ::alignments 24-25|0.0.1.0.0.0 22-23|0.0.1.0.1 21-22|0.0.1.0.1.0 19-20|0.0.0.0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.0 13-14|0.0.1.0.2 11-12|0.0.1.1 10-11|0.0.1.0.1.1 9-10|0.0.1 8-9|0.0.1.0 7-8|0.0.1.0.0 6-7|0.0 4-5|0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:29.630
(e2 / expect-01 
      :ARG1 (e / encode-01 
            :ARG0 (a2 / allel 
                  :ARG1-of (d2 / degrade-01 
                        :ARG0 (r / rna 
                              :mod (m / mutant))) 
                  :mod (t2 / this)) 
            :ARG1 (o / or 
                  :op1 (p2 / protein 
                        :mod (t / truncate-01 
                              :ARG1 52) 
                        :poss (d / decay-01 
                              :ARG0 (n / nonsense-mediat) 
                              :ARG1 -) 
                        :prep-at (a / all)) 
                  :op2 (p / protein))))

# ::snt We propose that the brain anomalies that have been observed in aniridia patients may be partly explained by impaired interaction between PAX6 and HOMER3 , DNCL1 and TRIM11 .
# ::tok We propose that the brain anomalies that have been observed in aniridia patients may be partly explained by impaired interaction between PAX6 and HOMER3 , DNCL1 and TRIM11 .
# ::alignments 26-27|0 22-23|0.0 19-20|0.0.0.0 18-19|0.0.0 16-17|0.0.0.0.0 15-16|0.0.1 13-14|0.0.0.0.0.1 12-13|0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 11-12|0.0.0.0.0.0.0.0.0.0.0 9-10|0.0.0.0.0.0.0 5-6|0.0.0.0.0.0 4-5|0.0.0.1 1-2|0.0.0.0.0.1.0 0-1|0.0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:29.943
(a / and 
      :op1-of (a2 / and 
            :ARG0-of (i2 / impair-01 
                  :ARG1 (i / interact-01 
                        :ARG0-of (e / explain-01 
                              :ARG1 (a4 / anomali 
                                    :ARG1-of (o / observe-01 
                                          :ARG0 (p3 / person 
                                                :ARG0-of (h / have-rel-role-91 
                                                      :ARG2 (p4 / patient 
                                                            :mod (a3 / aniridia)))))) 
                              :ARG1-of (p2 / possible-01 
                                    :ARG1-of (p5 / propose-01 
                                          :ARG0 (w / we))))) 
                  :op1-of (b / brain)) 
            :mod (p / part)))

# ::snt The neurobehavioural phenotype associated with 1615del10 and the polymicrogyria associated with X423L may result from a specific effect of these unusual C-terminal extension mutations .
# ::tok The neurobehavioural phenotype associated with 1615del10 and the polymicrogyria associated with X423L may result from a specific effect of these unusual C-terminal extension mutations .
# ::alignments 23-24|0.1.0 22-23|0.1.0.1 20-21|0.1.0.3.0+0.1.0.3 19-20|0.1.0.2 17-18|0.1 16-17|0.1.1 13-14|0 12-13|0.0 11-12|0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 9-10|0.1.0.0.0 8-9|0.1.0.0.0.0 6-7|0.1.0.0.0.0.0 5-6|0.1.0.0.0.0.0.1 3-4|0.1.0.0.0.0.0.0 2-3|0.1.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:30.218
(r / result-01 
      :ARG1-of (p / possible-01) 
      :ARG2 (e2 / effect-03 
            :ARG0 (m / mutate-01 
                  :ARG0 (t2 / thing 
                        :ARG2-of (a / associate-01 
                              :ARG1 (p2 / polymicrogyria 
                                    :op2-of (a2 / and 
                                          :ARG2-of (a3 / associate-01 
                                                :ARG1 (p3 / phenotype)) 
                                          :op1 1615del10))) 
                        :name (n / name 
                              :op1 "X423L")) 
                  :ARG0-of (e / extend-01) 
                  :mod (t / this) 
                  :mod (u / usual 
                        :polarity -)) 
            :ARG1-of (s / specific-02)))

# ::snt There is evidence that signalling and transport mechanisms that were initially characterized in the brain may also be conserved in the retina , suggesting that impaired PAX6 protein-protein interactions may also have implications for the retinal defects observed in individuals with PAX6 mutations [ 53,54 ] .
# ::tok There is evidence that signalling and transport mechanisms that were initially characterized in the brain may also be conserved in the retina , suggesting that impaired PAX6 protein-protein interactions may also have implications for the retinal defects observed in individuals with PAX6 mutations [ 53,54 ] .
# ::alignments 42-43|0.0.3.0.0.0.0.0.0 39-40|0.0.3.0.0.0.1.0.0 37-38|0.0.3.0.0.0.1.0 36-37|0.0.3.0.0.0.1 35-36|0.0.3.0.0.0.1.1 32-33|0.0.3.0.0.0+0.0.3.0.0.0.0 30-31|0.0.3.0.0.0.0.0.2 29-30|0.0.3.0.0.0.0.0 28-29|0.0.3.0.0 25-26|0.0.3.0 23-24|0.0.3.0.0.0.0.0.1 21-22|0.0.3 18-19|0.0 16-17|0.0.4 15-16|0.0.2 14-15|0.0.0.0.0 11-12|0.0.0.0 10-11|0.0.0.0.1 7-8|0.0.0 6-7|0.2 5-6|0 4-5|0.1 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:31.287
(a3 / and 
      :ARG2-of (c / conserve-01 
            :ARG1 (m2 / mechanism 
                  :ARG0-of (c2 / characterize-01 
                        :ARG1 (b / brain) 
                        :time (i5 / initial))) 
            :ARG1-of (e / evidence-01) 
            :ARG1-of (p2 / possible-01) 
            :location (r2 / retina 
                  :location-of (i4 / impair-01 
                        :ARG1 (i3 / interaction 
                              :ARG0-of (i2 / imply-01 
                                    :ARG1 (t / thing 
                                          :ARG1-of (p / possible-01 
                                                :ARG1-of (m / mutate-01) 
                                                :ARG1-of (s / suggest-01) 
                                                :mod (a / also))) 
                                    :ARG2 (d / defect-01 
                                          :ARG1-of (o / observe-01 
                                                :ARG0 (i / individual)) 
                                          :mod (r / retinal)))))) 
            :mod (a2 / also)) 
      :op1 (s2 / signal-01) 
      :op2 (t2 / transport-01))

# ::snt We have presented preliminary evidence that the neurodevelopmental transcriptional regulator PAX6 interacts with HOMER3 , DNCL1 and TRIM11 .
# ::tok We have presented preliminary evidence that the neurodevelopmental transcriptional regulator PAX6 interacts with HOMER3 , DNCL1 and TRIM11 .
# ::alignments 16-17|0 11-12|0.0 9-10|0.0.0 7-8|0.0.1.0.1 4-5|0.0.1 3-4|0.0.1.1 2-3|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:31.339
(a / and 
      :ARG1-of (i / interact-01 
            :ARG0 (r / regulator) 
            :ARG1-of (e / evidence-01 
                  :ARG1-of (p2 / present-01 
                        :ARG0 (w / we) 
                        :ARG2 (n / neurodevelopmental)) 
                  :mod (p / preliminary))))

# ::snt We suggest that the interaction of PAX6 with HOMER3 and DNCL1 is a mechanism by which synaptic signalling could lead to regulated changes in gene expression in neurons .
# ::tok We suggest that the interaction of PAX6 with HOMER3 and DNCL1 is a mechanism by which synaptic signalling could lead to regulated changes in gene expression in neurons .
# ::alignments 27-28|0.0.2 25-26|0 24-25|0.1 22-23|0.0 21-22|0.0.0 19-20|0.0.1 18-19|0.0.1.2 17-18|0.0.1.0 16-17|0.0.1.0.0 13-14|0.0.1.1 9-10|0.0.1.1.0.0 4-5|0.0.1.1.0 1-2|0.0.1.1.0.1 0-1|0.0.1.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:31.588
(e / express-01 
      :ARG1-of (c / change-01 
            :ARG1-of (r / regulate-01) 
            :ARG2-of (l / lead-03 
                  :ARG0 (s / signal-01 
                        :mod (s2 / synaptic)) 
                  :ARG1 (m / mechanism 
                        :ARG2-of (i / interact-01 
                              :ARG1 (a / and) 
                              :ARG1-of (s3 / suggest-01 
                                    :ARG0 (w / we)))) 
                  :ARG1-of (p / possible-01)) 
            :location (n / neuron)) 
      :mod (g / gene))

# ::snt We also propose that some of the neural anomalies in patients with PAX6 mutations may be explained by impaired protein-protein interactions .
# ::tok We also propose that some of the neural anomalies in patients with PAX6 mutations may be explained by impaired protein-protein interactions .
# ::alignments 20-21|0.0.1 18-19|0.0.1.1 16-17|0.0.1.0 14-15|0.0.1.0.1 13-14|0.0 12-13|0 10-11|0.0.0.1+0.0.0+0.0.0.0 8-9|0.0.1.0.0 7-8|0.0.1.0.0.0 4-5|0.0.1.1.0 2-3|0.0.1.0.1.0 1-2|0.0.1.0.1.0.1 0-1|0.0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:31.810
(p2 / PAX6 
      :ARG1-of (m / mutate-01 
            :ARG1-of (h / have-rel-role-91 
                  :ARG0 (p3 / person) 
                  :ARG2 (p4 / patient)) 
            :ARG2 (i / interaction 
                  :ARG0-of (e / explain-01 
                        :ARG1 (a / anomali 
                              :mod (n / neural)) 
                        :ARG1-of (p / possible-01 
                              :ARG1-of (p5 / propose-01 
                                    :ARG0 (w / we) 
                                    :mod (a2 / also)))) 
                  :ARG1-of (i2 / impair-01 
                        :ARG0 (s / some)))))

# ::snt Sequence database searches were carried out using the BLAST program available through the Bioinformatics Applications at the Rosalind Franklin Centre for Genomics Research [ 24 ] .
# ::tok Sequence database searches were carried out using the BLAST program available through the Bioinformatics Applications at the Rosalind Franklin Centre for Genomics Research [ 24 ] .
# ::alignments 24-25|0.1.0.1.0 21-23|0.1.0.0.1.0.1.1+0.1.0.0.1.0.1.0+0.1.0.0.1.0.1+0.1.0.0.1.0 18-20|0.1.0.0.1.0.0.0.1+0.1.0.0.1.0.0.0.0+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0 13-15|0.1.0.0.1.1.1+0.1.0.0.1.1.0+0.1.0.0.1.1+0.1.0.0.1 10-11|0.1.0.0 9-10|0.1.0 8-9|0.1.0.1 6-7|0.1 4-5|0 2-3|0.0 1-2|0.0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:32.204
(c2 / carry-out-03 
      :ARG1 (s / search-01 
            :ARG1 (d / database)) 
      :ARG2 (u / use-01 
            :ARG1 (p / program 
                  :ARG2-of (a / available-02 
                        :ARG1 (s2 / sequence) 
                        :location (o2 / organization 
                              :mod-of (o / organization 
                                    :location-of (t / thing 
                                          :name (n2 / name 
                                                :op1 (f / Franklin) 
                                                :op2 (c / Centre))) 
                                    :name (n / name 
                                          :op1 "Genomics" 
                                          :op2 "Research")) 
                              :name (n3 / name 
                                    :op1 "Bioinformatics" 
                                    :op2 "Applications"))) 
                  :topic (b / blast-01 
                        :ARG1 24))))

# ::snt Protein sequences that were highly homologous to the C-terminus of human PAX6 were aligned using CLUSTAL [ 24 ] .
# ::tok Protein sequences that were highly homologous to the C-terminus of human PAX6 were aligned using CLUSTAL [ 24 ] .
# ::alignments 17-18|0.0.0.0.0.0.0 15-16|0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 14-15|0.0.0.0 13-14|0.0.0 10-11|0.0.0.0.1 8-9|0 5-6|0.0 4-5|0.0.1 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:32.313
(c / c-terminu 
      :op1-of (h2 / homologou 
            :concession-of (a / align-01 
                  :ARG1 (u / use-01 
                        :ARG0 (s / sequence 
                              :mod (p / protein 
                                    :poss 24)) 
                        :ARG1 (h / human) 
                        :ARG2 (o / organization 
                              :name (n / name 
                                    :op1 "CLUSTAL")))) 
            :degree (h3 / high)))

# ::snt Secondary structure prediction was performed using the JPRED consensus method [ 25,26 ] .
# ::tok Secondary structure prediction was performed using the JPRED consensus method [ 25,26 ] .
# ::alignments 9-10|0.0.0 8-9|0.0.0.0 7-8|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 5-6|0.0 4-5|0.0.1 2-3|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:32.506
(p2 / predict-01 
      :ARG0-of (u / use-01 
            :ARG1 (m / method 
                  :mod (c / consensus) 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "JPRED"))) 
            :ARG1-of (p / perform-02)) 
      :ARG1 (s / structure 
            :mod (s2 / secondary)))

# ::snt All cDNA and amino acid numbering is based on the human PAX6 cDNA and protein reference sequences available from the Human PAX6 Allelic Variant Database web site [ 27 ] .
# ::tok All cDNA and amino acid numbering is based on the human PAX6 cDNA and protein reference sequences available from the Human PAX6 Allelic Variant Database web site [ 27 ] .
# ::alignments 28-29|0.0.1.1.0 26-27|0.0.1.1.3 25-26|0.0.1.1.3.1 23-25|0.0.1.1.3.2.0.1+0.0.1.1.3.2.0.0+0.0.1.1.3.2.0+0.0.1.1.3.2 21-23|0.0.1.1.3.0.0.1+0.0.1.1.3.0.0.0+0.0.1.1.3.0.0+0.0.1.1.3.0 20-21|0.0.0 17-18|0.0.1.1.2 16-17|0.0.1.1.2.0 15-16|0.0.1.1.2.0.0 14-15|0.0.1.1.2.0.0.0 13-14|0 12-13|0.0.2 11-12|0.0.2.0 10-11|0.0.2.0.0 7-8|0.0 5-6|0.0.1.1 4-5|0.0.1.1.1 3-4|0.0.1.1.4 2-3|0.0.1 1-2|0.0.1.0 0-1|0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:33.016
(a3 / and 
      :op1 (b / base-02 
            :ARG0 (h / human) 
            :ARG1 (a6 / and 
                  :op1 (c2 / cdna) 
                  :op2 (n3 / number-01 
                        :ARG0 27 
                        :ARG1 (a4 / acid) 
                        :ARG1-of (a2 / available-02 
                              :ARG2 (s2 / sequence 
                                    :ARG0-of (r / reference-04 
                                          :ARG1 (p2 / protein)))) 
                        :ARG2 (s / site 
                              :location (t2 / thing 
                                    :name (n2 / name 
                                          :op1 (p / PAX6) 
                                          :op2 (a / Allelic))) 
                              :mod (w / web) 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 (v / Variant) 
                                          :op2 (d / Database)))) 
                        :mod (a5 / amino)) 
                  :quant (a7 / all)) 
            :ARG2 (c / cdna 
                  :mod (p3 / PAX6 
                        :mod (h2 / human)))))

# ::snt Standard PCR and subcloning techniques were used to make three PAX6 cDNA constructs in the pDBLeu expression vector ( ProQuest Two-Hybrid System , Invitrogen ) , which generates a protein fused to the yeast GAL4 DNA binding domain .
# ::tok Standard PCR and subcloning techniques were used to make three PAX6 cDNA constructs in the pDBLeu expression vector ( ProQuest Two-Hybrid System , Invitrogen ) , which generates a protein fused to the yeast GAL4 DNA binding domain .
# ::alignments 37-38|0.0.1.1.1 36-37|0.0.1.1 35-36|0.0.1.1.0 34-35|0.0.2.0.0+0.0.2.0+0.0.2 33-34|0.0.1.0.0.0 30-31|0.0 29-30|0 27-28|0.0.1 23-24|0.0.3.0.0.0.0+0.0.3.0.0.0+0.0.3.0.0 19-22|0.0.3.2.0.2+0.0.3.2.0.1+0.0.3.2.0.0+0.0.3.2.0+0.0.3.2 17-18|0.0.1.0 16-17|0.0.1.0.0 12-13|0.0.1.0.1 10-12|0.0.1.0.1.0.0.1+0.0.1.0.1.0.0.0+0.0.1.0.1.0.0+0.0.1.0.1.0 9-10|0.0.0 6-7|0.0.3.0 4-5|0.0.3.1 2-3|0.0.3 0-2|0.0.3.0.1.0.1+0.0.3.0.1.0.0+0.0.3.0.1.0+0.0.3.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:33.775
(p / protein 
      :ARG1-of (f / fuse-01 
            :ARG0 3 
            :ARG1-of (g / generate-01 
                  :ARG0 (v / vector 
                        :ARG1-of (e / express-01 
                              :ARG0 (y / yeast)) 
                        :location-of (c / construct 
                              :mod (t2 / thing 
                                    :name (n4 / name 
                                          :op1 (p2 / PAX6) 
                                          :op2 (c2 / cDNA))))) 
                  :condition-of (b / binding-07 
                        :ARG0 (d2 / DNA) 
                        :ARG1 (d / domain))) 
            :ARG2 (t / thing 
                  :name (n / name 
                        :op1 "GAL4")) 
            :op3-of (a / and 
                  :ARG2-of (u / use-01 
                        :ARG0 (o / organization 
                              :name (n2 / name 
                                    :op1 "Invitrogen")) 
                        :ARG1 (t4 / thing 
                              :name (n5 / name 
                                    :op1 (s / Standard) 
                                    :op2 (p3 / PCR)))) 
                  :op1 (t3 / technique) 
                  :op2 (o2 / organization 
                        :name (n3 / name 
                              :op1 "ProQuest" 
                              :op2 "Two-Hybrid" 
                              :op3 "System")))))

# ::snt PAX6PST contains the whole PST domain ( amino acids 278 -- 422 of the full-length PAX6 protein ) .
# ::tok PAX6PST contains the whole PST domain ( amino acids 278 -- 422 of the full-length PAX6 protein ) .
# ::alignments 16-17|0 15-16|0.0 14-15|0.1 9-10|0.0.0.0.0 8-9|0.0.0.0 7-8|0.0.0.0.0.0 5-6|0.0.0.1 4-5|0.0.0.1.0 3-4|0.0.0.1.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:34.021
(p / protein 
      :mod (p2 / PAX6 
            :op1 (c / contain-01 
                  :ARG0 (a / acid 
                        :mod-of (2 / 278 
                              :mod (a2 / amino))) 
                  :ARG1 (d / domain 
                        :mod "PST" 
                        :mod (w / whole)))) 
      :mod (f / full-length))

# ::snt Primers were ST001 ( forward ) 5 ' - AAA AGT TCG ACT GCC AGC AAC ACA CCT AGT C-3 ' and ST005 ( R ) 5 ' - TTT TGC GGC TTT TTA CTG TAA TCT TGG CCA GTA TTG-3 ' .
# ::tok Primers were ST001 ( forward ) 5 ' - AAA AGT TCG ACT GCC AGC AAC ACA CCT AGT C-3 ' and ST005 ( R ) 5 ' - TTT TGC GGC TTT TTA CTG TAA TCT TGG CCA GTA TTG-3 ' .
# ::alignments 39-41|0.1.0.0.0.0.0.0.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0.0 37-39|0.1.0.0.0.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0.0.0.0.0.0.0 35-37|0.1.0.0.0.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0.0.0.0 33-35|0.1.0.0.0.0.0+0.1.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0 31-33|0.1.0.0+0.1.0.0.0.1+0.1.0.0.0+0.1.0.0.0.0 29-31|0.1.0.1.1+0.1.0.1.0+0.1.0.1+0.1.0 26-27|0.5.0 24-25|0.5 21-22|0 18-20|0.4.0.1+0.4.0.0+0.4.0+0.4 16-18|0.4.0.0.0.0.1+0.4.0.0.0.0.0+0.4.0.0.0.0+0.4.0.0.0 14-16|0.3.0.1+0.3.0.0+0.3.0+0.3 13-14|0.2.1+0.2.0.0+0.2.0+0.2 12-13|0.0 10-12|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 6-7|0.5.0.1 4-5|0.5.0.0 2-3|0.1.1.0.0+0.1.1.0+0.1.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:36.186
(a / and 
      :ARG0-of (a6 / act-01 
            :ARG2 (t18 / thing 
                  :name (n11 / name 
                        :op1 (a7 / AGT) 
                        :op2 (t19 / TCG)))) 
      :mod (p / primer 
            :mod-of (t12 / thing 
                  :mod-of (t11 / TTT 
                        :op2-of (n5 / name 
                              :name-of (t10 / thing 
                                    :mod-of (c2 / CTG 
                                          :op2-of (n4 / name 
                                                :name-of (t8 / thing 
                                                      :mod-of (t6 / TAA 
                                                            :op1-of (n3 / name 
                                                                  :name-of (t5 / thing 
                                                                        :mod-of (c / CCA 
                                                                              :op2-of (n2 / name 
                                                                                    :name-of (t3 / thing 
                                                                                          :mod-of (t2 / TTG-3 
                                                                                                :op2-of (n / name 
                                                                                                      :name-of (t / thing) 
                                                                                                      :op1 (g / GTA)))) 
                                                                                    :op1 (t4 / TGG)))) 
                                                                  :op2 (t7 / TCT)))) 
                                                :op1 (t9 / TTA)))) 
                              :op1 (g2 / GGC))) 
                  :name (n6 / name 
                        :op1 (t13 / TTT) 
                        :op2 (t14 / TGC))) 
            :poss (t20 / thing 
                  :name (n12 / name 
                        :op1 "ST001"))) 
      :op1 (o / organization 
            :name (n10 / name 
                  :op1 "GCC") 
            :wiki "Gulf_Cooperation_Council") 
      :op2 (t17 / thing 
            :name (n9 / name 
                  :op1 (a4 / AGC) 
                  :op2 (a5 / AAC))) 
      :op3 (t15 / thing 
            :name (n7 / name 
                  :op1 (a2 / AGT 
                        :mod (t16 / thing 
                              :name (n8 / name 
                                    :op1 (a3 / ACA) 
                                    :op2 (c4 / CCT)))) 
                  :op2 (c3 / C-3))) 
      :op4 (r / r 
            :quant (5 / 5 
                  :mod (f / forward) 
                  :poss-of 5)))

# ::snt PAX6CTP contains the newly defined C-terminal peptide alone ( 391 -- 422 ) .
# ::tok PAX6CTP contains the newly defined C-terminal peptide alone ( 391 -- 422 ) .
# ::alignments 11-12|0.0 9-10|0.1.0.0 7-8|0.1.1 6-7|0.1 4-5|0.1.0 3-4|0.1.0.1 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:36.291
(c / contain-01 
      :ARG0 422 
      :ARG1 (p / peptide 
            :ARG1-of (d / define-01 
                  :ARG0 391 
                  :degree (n / newly)) 
            :mod (a / alone)))

# ::snt Primers were ST004 ( F ) 5 ' - AAA AGT CGA CTA CCA CTT CAA CAG GAC TCA TT-3 ' and ST005 ( R ) .
# ::tok Primers were ST004 ( F ) 5 ' - AAA AGT CGA CTA CCA CTT CAA CAG GAC TCA TT-3 ' and ST005 ( R ) .
# ::alignments 24-25|0.0.0.0.3 21-22|0.0.0.0 18-20|0.0.0.0.2.0.1+0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 16-18|0.0.0.0.2.0.1.0.0.1+0.0.0.0.2.0.1.0.0.0+0.0.0.0.2.0.1.0.0+0.0.0.0.2.0.1.0 14-16|0.0.1+0+0.0+0.0.0 11-14|0.0.1.0.0.2+0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 9-11|0.0.0.0.1.0.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 6-7|0.0.1.0.1 4-5|0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 0-1|0.0.0.0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:36.533
(c2 / CTT 
      :op1-of (n3 / name 
            :name-of (t5 / thing 
                  :op3-of (a / and 
                        :op1 (a2 / aircraft-type 
                              :name (n6 / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor") 
                        :op2 (o / organization 
                              :name (n5 / name 
                                    :op1 "AAA" 
                                    :op2 "AGT")) 
                        :op4 (t / thing 
                              :name (n / name 
                                    :op1 (t2 / TCA) 
                                    :op2 (t3 / TT-3 
                                          :mod (t4 / thing 
                                                :name (n2 / name 
                                                      :op1 (c / CAG) 
                                                      :op2 (g / GAC)))))) 
                        :op5 (r / r) 
                        :poss-of (p / primer))) 
            :op2 (c3 / CAA 
                  :mod (t6 / thing 
                        :name (n4 / name 
                              :op1 (c4 / CGA) 
                              :op2 (c5 / CTA) 
                              :op3 (c6 / CCA)) 
                        :op1 5))))

# ::snt PAX6PST-CT contains the PST domain minus the C-terminal peptide ( 278 -- 390 ) .
# ::tok PAX6PST-CT contains the PST domain minus the C-terminal peptide ( 278 -- 390 ) .
# ::alignments 10-11|0.1 8-9|0.0.1.0 5-6|0.0.1 4-5|0.0 3-4|0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:36.578
(c / contain-01 
      :ARG1 (d / domain 
            :mod "PST" 
            :op1-of (m / minus 
                  :op2 (p / peptide))) 
      :domain-of 278)

# ::snt This was made by cutting PAX6PST with NdeI and NotI to drop out the C-terminal peptide , and inserting a synthetic linker between the two restriction sites .
# ::tok This was made by cutting PAX6PST with NdeI and NotI to drop out the C-terminal peptide , and inserting a synthetic linker between the two restriction sites .
# ::alignments 26-27|0.0.0.0 25-26|0.0.0 24-25|0.0.0.0.0 21-22|0.0 20-21|0 18-19|0.0.1.2 17-18|0.0.1 15-16|0.0.1.0.1.0.0 11-12|0.0.1.0.1.0 9-10|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 8-9|0.0.1.0.1 7-8|0.0.1.0.1.1.0.0+0.0.1.0.1.1.0+0.0.1.0.1.1 4-5|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:36.977
(s2 / synthetic 
      :ARG1-of (l / link-01 
            :ARG2 (r / restrict-01 
                  :ARG0 (s / site 
                        :quant 2)) 
            :op4-of (a / and 
                  :op1 (c / cut-02 
                        :ARG0 (t / this) 
                        :ARG1 (a2 / and 
                              :ARG2-of (d / drop-01 
                                    :ARG1 (p / peptide)) 
                              :op1 (p3 / person 
                                    :name (n2 / name 
                                          :op1 "NdeI")))) 
                  :op2 (p2 / person 
                        :name (n / name 
                              :op1 "NotI")) 
                  :op3 (i / insert-01))))

# ::snt All fragments generated by PCR or with linkers were sequenced to check that no errors had been introduced .
# ::tok All fragments generated by PCR or with linkers were sequenced to check that no errors had been introduced .
# ::alignments 17-18|0.0.0.0.0 14-15|0.0.0.0.0.1 13-14|0.0.0.0.0.2 11-12|0.0.0.0 7-8|0.0.0.0.0.0 5-6|0 2-3|0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:37.071
(o / or 
      :ARG0-of (g / generate-01 
            :ARG1 (f / fragment-01 
                  :ARG0-of (c / check-01 
                        :ARG1 (i / introduce-02 
                              :ARG0 (l / linker) 
                              :ARG1 (e / error) 
                              :polarity -)) 
                  :mod (a / all))))

# ::snt A PAX6 PST domain construct containing the mutation 1627A > G ( Q422R ) was generated in the same way as the PAX6PST construct , but using the reverse PCR primer ST006 5 ' - TTT TGC GGC CGC TTT TTA CCG TAA TCT TGG CCA GTA TTG AG-3 ' , which contains the mutant nucleotide substitution ( underlined ) .
# ::tok A PAX6 PST domain construct containing the mutation 1627A > G ( Q422R ) was generated in the same way as the PAX6PST construct , but using the reverse PCR primer ST006 5 ' - TTT TGC GGC CGC TTT TTA CCG TAA TCT TGG CCA GTA TTG AG-3 ' , which contains the mutant nucleotide substitution ( underlined ) .
# ::alignments 58-59|0 56-57|0.1.1.1.0.0.0.1 55-56|0.1.1.1.0.0.0.1.1 54-55|0.1.1.1.0.0.0.1.1.1 52-53|0.1.1.1.0.0.0.1.1.0 47-49|0.1.1.1.0.0.0.1.1.0.1.0.1+0.1.1.1.0.0.0.1.1.0.1.0.0+0.1.1.1.0.0.0.1.1.0.1.0+0.1.1.1.0.0.0.1.1.0.1 44-46|0.1.1.1.0.0.0.1.1.0.0.0.1+0.1.1.1.0.0.0.1.1.0.0.0.0+0.1.1.1.0.0.0.1.1.0.0.0+0.1.1.1.0.0.0.1.1.0.0 42-44|0.1.1.1.0.0.0.1.1.0.0.0.0.0.0.1+0.1.1.1.0.0.0.1.1.0.0.0.0.0.0.0+0.1.1.1.0.0.0.1.1.0.0.0.0.0.0+0.1.1.1.0.0.0.1.1.0.0.0.0.0 40-42|0.1.1.0.0.0.1+0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 38-40|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 36-38|0.0.0.1+0.0.0.0+0.0.0+0.0 32-33|0.1.1.0.1 31-32|0.1.1.1.0.0.0.1.0.0.0+0.1.1.1.0.0.0.1.0.0+0.1.1.1.0.0.0.1.0 30-31|0.1.1.1.0.0.0.0.0 28-29|0.1.1.1.2 26-27|0.1.1.1.0.0.0.0 25-26|0.1.1.1.0.0.0.0.1 23-24|0.1 19-20|0.1.1 18-19|0.1.1.0 15-16|0.1.1.1 10-11|0.1.1.1.1.1+0.1.1.1.1.0.0+0.1.1.1.1.0+0.1.1.1.1 7-8|0.1.1.1.0 5-6|0.1.1.1.0.0 4-5|0.1.1.1.0.0.1 3-4|0.1.1.1.0.0.0 2-3|0.1.1.1.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:43.521
(u / underline-01 
      :ARG0 (t12 / thing 
            :name (n7 / name 
                  :op1 (t13 / TGC) 
                  :op2 (g / GGC))) 
      :ARG1 (c6 / construct-01 
            :ARG1 (t10 / thing 
                  :name (n6 / name 
                        :op1 (c4 / CGC) 
                        :op2 (t11 / TTT))) 
            :compared-to-of (w / way 
                  :ARG1-of (s2 / same-01 
                        :ARG2 (t8 / thing 
                              :name (n5 / name 
                                    :op1 (t9 / TTA) 
                                    :op2 (c3 / CCG))) 
                        :op1-of 5) 
                  :manner-of (g2 / generate-01 
                        :ARG0 (m2 / mutation 
                              :ARG1-of (c7 / contain-01 
                                    :ARG0 (d / domain 
                                          :ARG0-of (u2 / use-01 
                                                :ARG1 (p / primer) 
                                                :ARG2-of (c5 / contrast-01)) 
                                          :ARG1-of (s / substitute-01 
                                                :ARG0 (o / organization 
                                                      :name (n8 / name 
                                                            :op1 "ST006")) 
                                                :ARG2 (n / nucleotide 
                                                      :ARG1-of (c / contain-01 
                                                            :ARG0 (t3 / thing 
                                                                  :name (n3 / name 
                                                                        :op1 (t4 / TGG 
                                                                              :mod (t5 / thing 
                                                                                    :name (n4 / name 
                                                                                          :op1 (t6 / TAA) 
                                                                                          :op2 (t7 / TCT)))) 
                                                                        :op2 (c2 / CCA))) 
                                                            :ARG3 (t / thing 
                                                                  :name (n2 / name 
                                                                        :op1 (t2 / TTG) 
                                                                        :op2 (a / AG-3)))) 
                                                      :mod (m / mutant))) 
                                          :mod "PST") 
                                    :ARG1-of (c8 / construct-01))) 
                        :ARG1 (o2 / organization 
                              :name (n9 / name 
                                    :op1 "G-8") 
                              :wiki "G8") 
                        :ARG1-of (r / reverse-01)))))

# ::snt cDNA sequences containing the mutations 1615del10 [ 28 ] and 1629insT ( X423L ) [ 12 ] were generated by PCR from reverse transcribed RNA ( a gift from Dr K Williamson and Prof V van Heyningen ) .
# ::tok cDNA sequences containing the mutations 1615del10 [ 28 ] and 1629insT ( X423L ) [ 12 ] were generated by PCR from reverse transcribed RNA ( a gift from Dr K Williamson and Prof V van Heyningen ) .
# ::alignments 34-37|0.2.1.2+0.2.1.1+0.2.1.0+0.2.1+0.2 33-34|0.2.0 32-33|0 30-32|0.1.0.1+0.1.0.0+0.1.0+0.1 27-28|0.0+0.0.0 24-25|0.3.0.1.1 23-24|0.3.0.1 22-23|0.3.0.1.1.0 18-19|0.3.0.1.1.1 15-16|0.3.0.1.0 12-13|0.3.1.0.0+0.3.1.0+0.3.1 9-10|0.3 7-8|0.3.2 4-5|0.3.0.1.1.0.0 2-3|0.3.0 1-2|0.3.0.0 0-1|0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:44.128
(a / and 
      :ARG0-of (g / gift-01 
            :ARG1 (t3 / thing)) 
      :op1 (t2 / thing 
            :name (n2 / name 
                  :op1 (k / K) 
                  :op2 (w / Williamson))) 
      :op2 (t / thing 
            :mod (p / prof) 
            :name (n / name 
                  :op1 (v / V) 
                  :op2 (v2 / van) 
                  :op3 (h / Heyningen))) 
      :op2-of (a2 / and 
            :ARG1-of (c / contain-01 
                  :ARG0 (s / sequence 
                        :mod (c2 / cdna)) 
                  :ARG2-of (t4 / transcribe-01 
                        :ARG0 12 
                        :ARG1 (r / rna 
                              :ARG1-of (r2 / reverse-01 
                                    :ARG1-of (m / mutate-01)) 
                              :ARG2-of (g2 / generate-01)))) 
            :op1 (t5 / thing 
                  :name (n3 / name 
                        :op1 "X423L")) 
            :quant 28))

# ::snt Primers were ST015 ( F ) 5 ' - CCC ACA TAT GCA GAC ACA C-3 ' and ST031 ( R ) 5 ' - TTG CGG CCG CAT CCA TCC AGT CTA CAT TGT TC-3 ' .
# ::tok Primers were ST015 ( F ) 5 ' - CCC ACA TAT GCA GAC ACA C-3 ' and ST031 ( R ) 5 ' - TTG CGG CCG CAT CCA TCC AGT CTA CAT TGT TC-3 ' .
# ::alignments 34-36|0.2.1+0.2.1.0.1+0.2.1.0+0.2.1.0.0 33-34|0.2.1.0.0.0.1+0.2.1.0.0.0.0.0+0.2.1.0.0.0.0+0.2.1.0.0.0 31-33|0.2.2.1+0.2.2.0+0.2.2+0.2 29-31|0.2.0.1.1+0.2.0.1.0+0.2.0.1+0.2.0 28-29|0.2.0.0.1+0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 26-28|0.2.0.1.1.0.0.1+0.2.0.1.1.0.0.0+0.2.0.1.1.0.0+0.2.0.1.1.0 22-23|0.1.0 20-21|0.1 17-18|0 14-16|0.0.0.1+0.0.0.0+0.0.0+0.0 12-14|0.0.0.1.0.0.1+0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 10-12|0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 9-10|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 6-7|0.1.0.1 4-5|0.1.0.2.1+0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:44.769
(a2 / and 
      :op1 (t8 / thing 
            :name (n7 / name 
                  :op1 (a3 / ACA) 
                  :op2 (c5 / C-3 
                        :mod (t9 / thing 
                              :name (n8 / name 
                                    :op1 (g / GCA) 
                                    :op2 (g2 / GAC))))) 
            :poss-of (t10 / thing 
                  :mod (o / organization 
                        :name (n10 / name 
                              :op1 "CCC")) 
                  :name (n9 / name 
                        :op1 (a4 / ACA) 
                        :op2 (t11 / TAT)))) 
      :op2 (r / r 
            :quant (5 / 5 
                  :mod-of (p3 / primer) 
                  :mod-of 5 
                  :poss-of (a5 / aircraft-type 
                        :name (n11 / name 
                              :op1 "F22") 
                        :wiki "Lockheed_Martin_F-22_Raptor"))) 
      :op3 (t4 / thing 
            :mod (t5 / thing 
                  :mod (p2 / product 
                        :name (n5 / name 
                              :op1 "CAT-5") 
                        :wiki "Category_5_cable") 
                  :name (n4 / name 
                        :op1 (c2 / CCA) 
                        :op2 (t6 / TCC 
                              :mod (t7 / thing 
                                    :name (n6 / name 
                                          :op1 (c3 / CGG) 
                                          :op2 (c4 / CCG)))))) 
            :mod-of (t3 / TC-3 
                  :op2-of (n / name 
                        :name-of (t / thing 
                              :mod (p / product 
                                    :name (n2 / name 
                                          :op1 "CAT-5") 
                                    :wiki "Category_5_cable")) 
                        :op1 (t2 / TGT))) 
            :name (n3 / name 
                  :op1 (a / AGT) 
                  :op2 (c / CTA))))

# ::snt The PAX6PST construct was cut with NdeI and NotI to release the normal C-terminal peptide , and the mutant sequence was inserted .
# ::tok The PAX6PST construct was cut with NdeI and NotI to release the normal C-terminal peptide , and the mutant sequence was inserted .
# ::alignments 21-22|0.2 19-20|0.2.0 18-19|0.2.0.0 16-17|0 14-15|0.0.0.1.1.0 12-13|0.0.0.1.1.0.0 10-11|0.0.0.1.1 8-9|0.1.0.0+0.1.0+0.1 7-8|0.0.0.1 6-7|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0 2-3|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:44.866
(a / and 
      :op1 (c / cut-01 
            :ARG1 (p3 / person 
                  :name (n3 / name 
                        :op1 "NdeI") 
                  :op1-of (a2 / and 
                        :ARG1-of (c2 / construct-01) 
                        :ARG2-of (r / release-01 
                              :ARG1 (p / peptide 
                                    :ARG1-of (n / normal-02)))))) 
      :op2 (p2 / person 
            :name (n2 / name 
                  :op1 "NotI")) 
      :op3 (i / insert-01 
            :ARG1 (s / sequence 
                  :mod (m / mutant))))

# ::snt Yeast two-hybrid library screens .
# ::tok Yeast two-hybrid library screens .
# ::alignments 3-4|0 2-3|0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:44.875
(s / screen-01 
      :ARG1 (l / library) 
      :quant (y / yeast))

# ::snt A mouse brain cDNA library ( ProQuest , Invitrogen ) was screened with the PAX6PST and PAX6CTP pDBLeu constructs .
# ::tok A mouse brain cDNA library ( ProQuest , Invitrogen ) was screened with the PAX6PST and PAX6CTP pDBLeu constructs .
# ::alignments 18-19|0.0.1.0 16-18|0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 15-16|0.0 11-12|0 8-9|0.0.0.0.0+0.0.0.0+0.0.0 6-7|0.1.0.0+0.1.0+0.1 4-5|0.2 3-4|0.2.0 2-3|0.2.0.0 1-2|0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:45.467
(s / screen-01 
      :ARG0 (a / and 
            :op1 (o / organization 
                  :name (n2 / name 
                        :op1 "Invitrogen")) 
            :op2 (t / thing 
                  :mod-of (c / construct) 
                  :name (n / name 
                        :op1 (p / PAX6CTP) 
                        :op2 (p2 / pDBLeu)))) 
      :ARG1 (o2 / organization 
            :name (n3 / name 
                  :op1 "ProQuest")) 
      :ARG2 (l / library 
            :mod (c2 / cdna 
                  :mod (b / brain 
                        :mod (m / mouse)))))

# ::snt The library was constructed in the pPC86 vector , which produces proteins fused to the yeast GAL4 activation domain .
# ::tok The library was constructed in the pPC86 vector , which produces proteins fused to the yeast GAL4 activation domain .
# ::alignments 18-19|0.0 17-18|0 16-17|0.0.1.0.0+0.0.1.0+0.0.1 15-16|0.0.0.1 12-13|0.0.0 11-12|0.0.0.0 10-11|0.0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.0.1 3-4|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:45.723
(a / activation 
      :mod-of (d / domain 
            :ARG2-of (f / fuse-01 
                  :ARG0 (p / protein 
                        :ARG1-of (p2 / produce-01 
                              :ARG0 (v / vector 
                                    :location-of (c / construct-01 
                                          :ARG1 (l / library)) 
                                    :mod (p3 / pPC86)))) 
                  :ARG1 (y / yeast)) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "GAL4"))))

# ::snt The system uses three GAL4-activated reporter genes , HIS3 , URA3 and lacZ , to identify positive interactions .
# ::tok The system uses three GAL4-activated reporter genes , HIS3 , URA3 and lacZ , to identify positive interactions .
# ::alignments 17-18|0.2.1 16-17|0.2.1.0 15-16|0.2 12-13|0.0.3 11-12|0.0 10-11|0.0.2 8-9|0.0.1 6-7|0.1 5-6|0.0.0 4-5|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 3-4|0.1.0 2-3|0 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:46.202
(u2 / use-01 
      :ARG0 (a / and 
            :ARG0-of (r / report-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "GAL4-activated"))) 
            :op1 (h / HIS3) 
            :op2 (u / URA3) 
            :op3 (l / lacZ)) 
      :ARG1 (g / gene 
            :quant 3) 
      :ARG2 (i2 / identify-01 
            :ARG0 (s / system) 
            :ARG1 (i / interaction 
                  :mod (p / positive))))

# ::snt Reporters are activated when the bait protein fused to the GAL4 DNA binding domain ( pDBLeu ) interacts with the prey protein fused to the GAL4 activation domain ( pPC86 ) , thus reconstituting GAL4 function .
# ::tok Reporters are activated when the bait protein fused to the GAL4 DNA binding domain ( pDBLeu ) interacts with the prey protein fused to the GAL4 activation domain ( pPC86 ) , thus reconstituting GAL4 function .
# ::alignments 35-36|0.0.0 33-34|0.0 32-33|0 27-28|0.0.1.1 26-27|0.0.1.1.0 22-23|0.0.1 21-22|0.0.1.0 20-21|0.0.1.0.0 17-18|0.0.1.2 13-14|0.0.1.2.0.1.0.0 12-13|0.0.1.2.0.1.0 11-12|0.0.1.2.0.1.0.1 10-11|0.0.1.2.0.1.0.0.0.0.0+0.0.1.2.0.1.0.0.0.0+0.0.1.2.0.1.0.0.0 7-8|0.0.1.2.0.1 6-7|0.0.1.2.0 5-6|0.0.1.2.0.0 2-3|0.0.1.2.1.0 0-1|0.0.1.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:46.592
(t / thus-far 
      :time-of (r / reconstitute-01 
            :ARG1 (f / function-01) 
            :purpose-of (f2 / fuse-01 
                  :ARG1 (p / protein 
                        :mod (p2 / prey)) 
                  :ARG2 (d / domain 
                        :mod (a / activation)) 
                  :manner-of (i / interact-01 
                        :ARG0 (p3 / protein 
                              :ARG1-of (b2 / bait-01) 
                              :ARG1-of (f3 / fuse-01 
                                    :ARG2 (b / binding-07 
                                          :ARG0 (d2 / domain 
                                                :mod (t2 / thing 
                                                      :name (n / name 
                                                            :op1 "GAL4"))) 
                                          :ARG1 (d3 / DNA)))) 
                        :ARG1 (r2 / reporter 
                              :ARG1-of (a2 / activate-01))))))

# ::snt HIS3 activation allows growth on plates lacking histidine .
# ::tok HIS3 activation allows growth on plates lacking histidine .
# ::alignments 7-8|0.1.0.0 6-7|0.1.0 5-6|0.1.1 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:46.826
(a / allow-01 
      :ARG0 (a2 / activation 
            :mod (h2 / HIS3)) 
      :ARG1 (g / grow-01 
            :ARG0-of (l / lack-01 
                  :ARG1 (h / histidine)) 
            :location (p / plate)))

# ::snt Weak URA3 activation suppresses growth on plates containing 5-fluro-orotic acid while strong URA3 activation permits growth on plates lacking uracil .
# ::tok Weak URA3 activation suppresses growth on plates containing 5-fluro-orotic acid while strong URA3 activation permits growth on plates lacking uracil .
# ::alignments 19-20|0 18-19|0.0 17-18|0.0.0 15-16|0.0.0.0 14-15|0.0.0.0.1 13-14|0.0.0.0.1.0 11-12|0.0.0.0.1.0.0 9-10|0.0.0.0.0.0.0.0.0.0 7-8|0.0.0.0.0.0.0.0.0 6-7|0.0.0.0.0.0.0.0 4-5|0.0.0.0.0.0.0 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0 0-2|0.0.0.0.0.1.0.1+0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:47.266
(u / uracil 
      :ARG1-of (l / lack-01 
            :ARG0 (p / plate 
                  :location-of (g / grow-01 
                        :ARG0 (a3 / activation 
                              :ARG0-of (s2 / suppress-01 
                                    :ARG1 (g2 / grow-01 
                                          :location (p3 / plate 
                                                :ARG0-of (c / contain-01 
                                                      :ARG1 (a2 / acid))))) 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 (w / Weak) 
                                          :op2 (u2 / URA3)))) 
                        :ARG1-of (p2 / permit-01 
                              :ARG0 (a / activation 
                                    :ARG1-of (s / strong-02)))))))

# ::snt LacZ activation causes X-gal to turn blue in a beta-galactosidase assay .
# ::tok LacZ activation causes X-gal to turn blue in a beta-galactosidase assay .
# ::alignments 10-11|0.1.1 6-7|0.1.0 5-6|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:47.290
(c / cause-01 
      :ARG0 (a2 / activation) 
      :ARG1 (t / turn-02 
            :ARG1 (b / blue) 
            :ARG2 (a / assay)))

# ::snt All assays were carried out in parallel with the five ProQuest control yeast strains A-E , which range from non-interactor ( A ) to strong interactor ( E ) .
# ::tok All assays were carried out in parallel with the five ProQuest control yeast strains A-E , which range from non-interactor ( A ) to strong interactor ( E ) .
# ::alignments 27-28|0.0 25-26|0.1.1.1 24-25|0.1.1 17-18|0.2.0.0.0.0 13-14|0.2.0.0.0 12-13|0.2.0.0 11-12|0.2.0 10-11|0.2.1.0+0.2.1+0.2 9-10|0.1.1.0 6-7|0 3-4|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:47.495
(p / parallel-01 
      :ARG0 (e / E) 
      :ARG0-of (c2 / carry-out-03 
            :ARG1 (a / assay 
                  :quant (a2 / all)) 
            :ARG2-of (s / strong-02 
                  :ARG0 5 
                  :ARG1 (i / interactor))) 
      :ARG2 (o / organization 
            :ARG1-of (c / control-01 
                  :mod-of (y / yeast 
                        :mod-of (s2 / strain 
                              :ARG1-of (r / range-01)))) 
            :name (n / name 
                  :op1 "ProQuest")))

# ::snt All procedures were carried out according to the supplier 's protocols .
# ::tok All procedures were carried out according to the supplier 's protocols .
# ::alignments 10-11|0.1.0.0 8-9|0.1.0 5-6|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:47.609
(c / carry-out-03 
      :ARG1 (p2 / procedure 
            :quant (a / all)) 
      :ARG2 (s2 / say-01 
            :ARG1 (s / supply-01 
                  :ARG0 (p / protocol))))

# ::snt Briefly , chemically competent MaV203 yeast cells were co-transformed with the cDNA library and the bait plasmid pDBLeu PAX6CTP or pDBLeu PAX6PST .
# ::tok Briefly , chemically competent MaV203 yeast cells were co-transformed with the cDNA library and the bait plasmid pDBLeu PAX6CTP or pDBLeu PAX6PST .
# ::alignments 20-22|0.2.1.0.0.1+0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 19-20|0.2.1 17-19|0.2.0.1+0.2.0.0+0.2.0+0.2 15-16|0.1 13-14|0 12-13|0.1.0.0 11-12|0.1.0 6-7|0.0 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0.0 2-3|0.1.1 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:47.994
(a / and 
      :domain-of (c2 / cell 
            :ARG1-of (c3 / competent-01) 
            :mod (y / yeast 
                  :mod (m / MaV203))) 
      :op1 (b / bait-01 
            :ARG1 (c / cdna 
                  :mod-of (l / library)) 
            :manner (c4 / chemically)) 
      :op2 (t2 / thing 
            :name (n2 / name 
                  :op1 (p3 / pDBLeu) 
                  :op2 (p4 / PAX6CTP)) 
            :op1-of (o / or 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 (p / pDBLeu) 
                              :op2 (p2 / PAX6PST))))) 
      :time (b2 / briefly))

# ::snt Transformants ( 5  107 ) were plated on medium lacking histidine to check for HIS3 activation .
# ::tok Transformants ( 5  107 ) were plated on medium lacking histidine to check for HIS3 activation .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:47.996
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt HIS3 positives were then assayed for all 3 reporters .
# ::tok HIS3 positives were then assayed for all 3 reporters .
# ::alignments 8-9|0+0.0 7-8|0.0.0 6-7|0.0.1 3-4|0.1.1 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:48.046
(r / report-01 
      :ARG0 (p / person 
            :quant 3 
            :quant (a / all)) 
      :ARG1 (p2 / positive 
            :mod (h / HIS3) 
            :quant (t / then)))

# ::snt The pPC86 prey plasmid was isolated from all HIS3/URA3/LacZ positives and the cDNA insert sequenced .
# ::tok The pPC86 prey plasmid was isolated from all HIS3/URA3/LacZ positives and the cDNA insert sequenced .
# ::alignments 14-15|0.1 13-14|0.1.0 12-13|0.1.0.0 10-11|0 9-10|0.0.1 7-8|0.2 5-6|0.0 3-4|0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:48.129
(a / and 
      :op1 (i2 / isolate-01 
            :ARG1 (p2 / plasmid 
                  :mod (p3 / prey)) 
            :ARG2 (p / positive)) 
      :op2 (s / sequence 
            :ARG0-of (i / insert-01 
                  :ARG1 (c / cdna))) 
      :quant (a2 / all))

# ::snt BLAST searches were performed to identify the cDNA insert [ 24 ] .
# ::tok BLAST searches were performed to identify the cDNA insert [ 24 ] .
# ::alignments 10-11|0.0.0.0.0 8-9|0.0.1 7-8|0.0.1.0 5-6|0.0 3-4|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:48.187
(p / perform-02 
      :ARG1 (i2 / identify-01 
            :ARG0 (s / search-01 
                  :ARG1 (b / blast-01 
                        :ARG1 24)) 
            :ARG1 (i / insert-01 
                  :ARG1 (c / cdna))))

# ::snt Specific interactions were tested by transforming competent MaV203 yeast cells with one bait construct ( in pDBLeu ) and one prey construct ( in pPC86 ) and testing the resulting colonies for activation of the HIS3 , URA3 and LacZ reporters as before .
# ::tok Specific interactions were tested by transforming competent MaV203 yeast cells with one bait construct ( in pDBLeu ) and one prey construct ( in pPC86 ) and testing the resulting colonies for activation of the HIS3 , URA3 and LacZ reporters as before .
# ::alignments 42-43|0.0.0.0.0.1.0.1.1.0.0 40-41|0.0.0.0.0.1.3.0+0.0.0.0.0.1.3 38-39|0.0.0.0.0.1.1 32-33|0.0.0.0.0.0 30-31|0.0 29-30|0 27-28|0.0.0 26-27|0.0.0.0 21-22|0.0.0.0.0 20-21|0.0.0.0.0.1.2 18-19|0.0.0.0.0.1 13-14|0.0.0.0.0.1.0.1.1 12-13|0.0.0.0.0.1.0.1.1.0 9-10|0.0.0.0.0.1.0.1.0 8-9|0.0.0.0.0.1.0.1.0.1 6-7|0.0.0.0.0.1.0.1.0.0 5-6|0.0.0.0.0.1.0.1 3-4|0.0.0.0.0.1.0 1-2|0.0.0.0.0.1.0.0 0-1|0.0.0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:48.641
(r2 / result-01 
      :ARG1 (c / colony 
            :ARG1-of (t / test-01 
                  :op2-of (a3 / and 
                        :op1 (c2 / construct-01 
                              :ARG1 (a2 / activation) 
                              :op3-of (a4 / and 
                                    :op1 (t3 / test-01 
                                          :ARG1 (i / interaction 
                                                :mod (s / specific)) 
                                          :ARG2 (t2 / transform-01 
                                                :ARG1 (c4 / cell 
                                                      :ARG1-of (c5 / competent-01) 
                                                      :mod (y / yeast)) 
                                                :purpose (c3 / construct-01 
                                                      :ARG1 (b2 / bait-01 
                                                            :ARG1 (b / before))))) 
                                    :op1-of (a / and) 
                                    :op2 (p2 / prey) 
                                    :op4 (p / person 
                                          :ARG0-of (r / report-01))))))))

# ::snt To create a full-length Homer3 clone for pairwise tests , a cDNA clone ( IMAGE clone 3602414 , accession number BE569374 ) containing the missing N-terminal 70 amino acids was identified by a BLAST search of the EST nucleotide sequence database and obtained from the Rosalind Franklin Centre for Genomics Research .
# ::tok To create a full-length Homer3 clone for pairwise tests , a cDNA clone ( IMAGE clone 3602414 , accession number BE569374 ) containing the missing N-terminal 70 amino acids was identified by a BLAST search of the EST nucleotide sequence database and obtained from the Rosalind Franklin Centre for Genomics Research .
# ::alignments 49-51|0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 46-48|0.2.2.1.1+0.2.2.1.0+0.2.2.1+0.2.2 42-43|0.2 41-42|0 40-41|0.1.2.1 39-40|0.1.2.1.0 38-39|0.1.2.1.0.0 37-38|0.1.0 34-35|0.1.2 33-34|0.1.2.2 30-31|0.1 28-29|0.2.0.0.0 27-28|0.2.0.0.0.0 26-27|0.2.0.0.0.1 24-25|0.2.2.0 22-23|0.2.0.0 20-21|0.1.2.2.0 19-20|0.3.0.0 18-19|0.3.0 16-17|0.1.2.0.2+0.1.2.0.1+0.1.2.0.0+0.1.2.0 15-16|0.1.1 14-15|0.1.1.0 12-13|0.2.0 11-12|0.2.0.1 8-9|0.0 7-8|0.0.0 5-6|0.3.1 3-4|0.3.1.0 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:51.416
(a / and 
      :op1 (t2 / test-01 
            :ARG1 (p / pairwise)) 
      :op2 (i / identify-01 
            :ARG0 (e / e) 
            :ARG1 (c3 / clone 
                  :mod (i2 / image)) 
            :manner (s2 / search-01 
                  :ARG0 (d2 / date-entity 
                        :day 14 
                        :month 24 
                        :year 360) 
                  :ARG1 (d / database 
                        :mod (s / sequence 
                              :mod (n3 / nucleotide))) 
                  :medium (b / blast-01 
                        :ARG1 (b2 / BE569374)))) 
      :op3 (o2 / obtain-01 
            :ARG0 (c4 / clone 
                  :ARG0-of (c2 / contain-01 
                        :ARG1 (a2 / acid 
                              :mod (a3 / amino) 
                              :quant 70)) 
                  :mod (c5 / cdna)) 
            :ARG2 (o / organization 
                  :name (n / name 
                        :op1 "Genomics" 
                        :op2 "Research")) 
            :ARG3 (t / thing 
                  :ARG1-of (m / miss-01) 
                  :name (n2 / name 
                        :op1 (f / Franklin) 
                        :op2 (c / Centre)))) 
      :time (c7 / create-01 
            :ARG0 (a4 / accession 
                  :mod-of (n4 / number)) 
            :ARG1 (c6 / clone 
                  :mod (f2 / full-length))))

# ::snt The missing fragment was amplified from the IMAGE clone by PCR and inserted into the pPC86-Homer3 plasmid to create a full-length expression construct .
# ::tok The missing fragment was amplified from the IMAGE clone by PCR and inserted into the pPC86-Homer3 plasmid to create a full-length expression construct .
# ::alignments 22-23|0.0 21-22|0 20-21|0.0.1 18-19|0.0.0 16-17|0.0.0.0 12-13|0.0.0.1 11-12|0.0.0.1.1 8-9|0.0.0.1.0.0 7-8|0.0.0.1.0 4-5|0.0.0.1.1.0 2-3|0.0.0.1.1.0.0 1-2|0.0.0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:51.553
(e / express-01 
      :ARG1-of (c / construct-01 
            :ARG1-of (c2 / create-01 
                  :mod-of (p / plasmid) 
                  :purpose-of (i / insert-01 
                        :ARG0 (i2 / image 
                              :mod-of (c3 / clone)) 
                        :op2-of (a / and 
                              :op1 (a2 / amplify-01 
                                    :ARG1 (f2 / fragment-01 
                                          :ARG1 (m / miss-01)))))) 
            :mod (f / full-length)))

# ::snt To check the relative representation of clones in the cDNA library , semi-quantitative PCR was performed on Pax6 , Homer3 , Dncl1 , Trim11 and the constitutively expressed genes Gapdh and Atp5a1 [ 29,30 ] .
# ::tok To check the relative representation of clones in the cDNA library , semi-quantitative PCR was performed on Pax6 , Homer3 , Dncl1 , Trim11 and the constitutively expressed genes Gapdh and Atp5a1 [ 29,30 ] .
# ::alignments 31-32|0.2.0.0+0.2.0+0.2 30-31|0 29-30|0.1.1.0+0.1.1+0.1 28-29|0.1.0 27-28|0.0 26-27|0.0.0 24-25|0.0.1 23-24|0.0.1.4 21-22|0.0.1.3 19-20|0.0.1.2 17-18|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 15-16|0.0.1.0 13-14|0.0.1.0.0 10-11|0.0.1.0.1.0.0 9-10|0.0.1.0.1.0.0.0 6-7|0.0.1.0.1.0.1 4-5|0.0.1.0.1.0 3-4|0.0.1.0.1.0.2 1-2|0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:52.062
(a / and 
      :op1 (e / express-01 
            :ARG1 (c / constitutively) 
            :op6-of (a2 / and 
                  :op1 (p / perform-02 
                        :ARG1 (p2 / PCR) 
                        :purpose (c4 / check-01 
                              :ARG1 (r / representation-02 
                                    :ARG0 (l / library 
                                          :mod (c2 / cdna)) 
                                    :ARG1 (c3 / clone-01) 
                                    :mod (r2 / relative)))) 
                  :op2 (t2 / thing 
                        :name (n3 / name 
                              :op1 "Pax6")) 
                  :op3 (h / Homer3) 
                  :op4 (d / Dncl1) 
                  :op5 (t / Trim11))) 
      :op2 (o2 / organization 
            :mod (g / gene) 
            :name (n2 / name 
                  :op1 "Gapdh")) 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "Atp5a1")))

# ::snt Primers were designed to cross at least one intron , so that only correctly spliced clones were amplified .
# ::tok Primers were designed to cross at least one intron , so that only correctly spliced clones were amplified .
# ::alignments 17-18|0.0.1 15-16|0.0 14-15|0.0.2 13-14|0 12-13|0.0.0 10-11|0.0.1.0 8-9|0.0.1.0.0.1.0 4-5|0.0.1.0.0.1 2-3|0.0.1.0.0 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:10:52.123
(c2 / correct-02 
      :ARG1 (c / clone-01 
            :ARG1 (o / only) 
            :ARG1-of (a / amplify-01 
                  :ARG1-of (c3 / cause-01 
                        :ARG0 (d / design-01 
                              :ARG1 (p / primer) 
                              :ARG3 (c4 / cross-02 
                                    :ARG1 (i / intron))))) 
            :ARG1-of (s / splice-01)))

# ::snt Primer sequences were : Pax6-F CAG CCA AAA TAG ATC TAC CTG ; Pax6-R CGA TCA CAT GCT CTC TCC TT ; Homer3-F CCC AGG TGG CTG TAG AGC ; Homer3-R CTC TAC ACA GTG CAA AGC TCA G ; Trim11-F GTG CAG GAT GTG AAG CTG ; Trim11-R GCC TGC AGA TAG TCA TAG GG ; Dncl1-F CAA AAA TGC AGA CAT GTC G ; Dncl1-R CTA AGG GAG AAA AAA ATG GGG ; Gapdh-F : CAT CAC CAT CTT CCA GGA GC ; Gapdh-R : ATG ACC TTG CCC ACA GCC TT ; Atp5a1-F : CAC ACG TGA GAT GTC CTC CA ; Atp5a1-R : CAC AGA GAT TCG GGG ATA A. 10 ng library cDNA were amplified in a reaction containing 1xAmpliTaq polymerase buffer ( Perkin Elmer ) , 1.5 mM MgCl2 , 200M each primer and 2.5 units of AmpliTaq polymerase ( Perkin Elmer ) .
# ::tok Primer sequences were : Pax6-F CAG CCA AAA TAG ATC TAC CTG ; Pax6-R CGA TCA CAT GCT CTC TCC TT ; Homer3-F CCC AGG TGG CTG TAG AGC ; Homer3-R CTC TAC ACA GTG CAA AGC TCA G ; Trim11-F GTG CAG GAT GTG AAG CTG ; Trim11-R GCC TGC AGA TAG TCA TAG GG ; Dncl1-F CAA AAA TGC AGA CAT GTC G ; Dncl1-R CTA AGG GAG AAA AAA ATG GGG ; Gapdh-F : CAT CAC CAT CTT CCA GGA GC ; Gapdh-R : ATG ACC TTG CCC ACA GCC TT ; Atp5a1-F : CAC ACG TGA GAT GTC CTC CA ; Atp5a1-R : CAC AGA GAT TCG GGG ATA A. 10 ng library cDNA were amplified in a reaction containing 1xAmpliTaq polymerase buffer ( Perkin Elmer ) , 1.5 mM MgCl2 , 200M each primer and 2.5 units of AmpliTaq polymerase ( Perkin Elmer ) .
# ::alignments 146-148|0.18.0.2.1.1.2.0.1+0.18.0.2.1.1.2.0.0+0.18.0.2.1.1.2.0+0.18.0.2.1.1.2 144-145|0.18.0.2.1.1.1.0 143-144|0.18.0.1.0.0+0.18.0.1.0+0.18.0.1 141-142|0.18.0.2.1.1.1 140-141|0.18.0.2.0 139-140|0.18.0.2.1.1 138-139|0.18.0.2.1.1.1.0.0 137-138|0.18.0.2.1.1.1.0.0.0 134-135|0.18.0.2.1.1.0 133-134|0.18.0.2.1.1.0.0 132-133|0.18.0.0 128-130|0.18.0.2.1.0.0.0.1+0.18.0.2.1.0.0.0.0+0.18.0.2.1.0.0.0+0.18.0.2.1.0.0 126-127|0.18.0.2.1.0 125-126|0.18.0.2.1.0.1 123-124|0.18.0.2.1 122-123|0.18.0 119-120|0.18.0.2 117-118|0.18.0.2.2 116-117|0.18.0.2.2.0 115-116|0.18.0.2.2.0.0 114-115|0.18.0.2.1.0.2 112-114|0.18.0.2.2.1.0.1+0.18.0.2.2.1.0.0+0.18.0.2.2.1.0+0.18.0.2.2.1 110-112|0.8.0.1.0.1+0.8.0.1.0.0+0.8.0.1.0+0.8.0.1 108-110|0.18.1.1+0.18.1.0+0.18.1+0.18 103-104|0.17.0.1+0.17.0.0.0+0.17.0.0+0.17.0 101-103|0.17.1.1+0.17.1.0+0.17.1+0.17 99-101|0.16.0.1+0.16.0.0+0.16.0+0.16 97-99|0.15.0.1+0.15.0.0+0.15.0+0.15 91-94|0.14.0.2+0.14.0.1+0.14.0.0+0.14.0+0.14 89-91|0.14.0.0.0.0.1+0.14.0.0.0.0.0+0.14.0.0.0.0+0.14.0.0.0 87-89|0.13.0.1+0.13.0.0+0.13.0+0.13 82-84|0.12.0.1+0.12.0.0+0.12.0+0.12 80-82|0.12.0.0.0.0.1+0.12.0.0.0.0.0+0.12.0.0.0.0+0.12.0.0.0 79-80|0.8.0.0.1+0.8.0.0.0.0+0.8.0.0.0+0.8.0.0 77-79|0.10.0.1+0.10.0.0+0.10.0+0.10 72-74|0.9.0.1+0.9.0.0+0.9.0+0.9 70-72|0.9.0.1.0.0.1+0.9.0.1.0.0.0+0.9.0.1.0.0+0.9.0.1.0 69-70|0.8.0 66-69|0.8.0.2.0.2+0.8.0.2.0.1+0.8.0.2.0.0+0.8.0.2.0+0.8.0.2 64-65|0.8.1.1+0.8.1.0.0+0.8.1.0+0.8.1 62-64|0.8.2.1+0.8.2.0+0.8.2+0.8 59-62|0.7.0.2+0.7.0.1+0.7.0.0+0.7.0+0.7 57-59|0.6.0.1+0.6.0.0+0.6.0+0.6 54-56|0.5.0.1+0.5.0.0+0.5.0+0.5 52-54|0.5.0.1.0.0.1+0.5.0.1.0.0.0+0.5.0.1.0.0+0.5.0.1.0 50-52|0.4.0.1+0.4.0.0+0.4.0+0.4 49-50|0.3.1+0.3.0.0+0.3.0+0.3 45-47|0.2.0.1+0.2.0.0+0.2.0+0.2 43-45|0.2.0.0.0.0.1+0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 41-43|0.1.0.1+0.1.0.0+0.1.0+0.1 38-39|0.25.0.1+0.25.0.0.0+0.25.0.0+0.25.0 36-38|0.25.1.1+0.25.1.0+0.25.1+0.25 34-36|0.24.0.1+0.24.0.0+0.24.0+0.24 32-34|0.23.0.1+0.23.0.0+0.23.0+0.23 30-32|0.22.0.1+0.22.0.0+0.22.0+0.22 27-29|0.21.0.1+0.21.0.0+0.21.0+0.21 25-27|0.21.0.0.0.0.1+0.21.0.0.0.0.0+0.21.0.0.0.0+0.21.0.0.0 22-25|0.20.0.2+0.20.0.1+0.20.0.0+0.20.0+0.20 19-21|0.19.0.1+0.19.0.0+0.19.0+0.19 17-19|0.19.0.1.0.0.1+0.19.0.1.0.0.0+0.19.0.1.0.0+0.19.0.1.0 16-17|0.19.0.1.0.0.1.0.1+0.19.0.1.0.0.1.0.0.0+0.19.0.1.0.0.1.0.0+0.19.0.1.0.0.1.0 14-16|0.11.0.1+0.11.0.0+0.11.0+0.11 12-13|0 10-12|0.0.0.1+0.0.0.0+0.0.0+0.0 8-10|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 7-8|0.0.0.0.0.0.0.0 5-7|0.0.0.0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0 1-2|0.8.0.3 0-1|0.8.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:12:22.825
(a21 / and 
      :op1 (t51 / thing 
            :name (n45 / name 
                  :op1 (t52 / TAC 
                        :mod (t53 / thing 
                              :name (n46 / name 
                                    :op1 (t54 / TAG 
                                          :mod (a23 / aaa 
                                                :mod (t55 / thing 
                                                      :name (n47 / name 
                                                            :op1 (c21 / CAG) 
                                                            :op2 (c22 / CCA))))) 
                                    :op2 (a22 / ATC)))) 
                  :op2 (c20 / CTG))) 
      :op10 (t33 / thing 
            :name (n32 / name 
                  :op1 (g14 / GTG) 
                  :op2 (c13 / CAG))) 
      :op11 (t31 / thing 
            :name (n30 / name 
                  :op1 (a16 / AAG 
                        :mod (t32 / thing 
                              :name (n31 / name 
                                    :op1 (g12 / GAT) 
                                    :op2 (g13 / GTG)))) 
                  :op2 (c12 / CTG))) 
      :op12 (o3 / organization 
            :name (n29 / name 
                  :op1 "GCC") 
            :wiki "Gulf_Cooperation_Council") 
      :op13 (t29 / thing 
            :name (n28 / name 
                  :op1 (t30 / TGC) 
                  :op2 (a15 / AGA))) 
      :op14 (t24 / thing 
            :name (n26 / name 
                  :op1 (t25 / TAG) 
                  :op2 (g11 / GG 
                        :mod (t26 / thing 
                              :name (n27 / name 
                                    :op1 (t27 / TAG) 
                                    :op2 (t28 / TCA)))))) 
      :op15 (t23 / thing 
            :name (n25 / name 
                  :op1 (d2 / Dncl1-F) 
                  :op2 (c11 / CAA))) 
      :op16 (t21 / thing 
            :name (n24 / name 
                  :op1 (a13 / AAA) 
                  :op2 (t22 / TGC) 
                  :op3 (a14 / AGA))) 
      :op17 (t20 / thing 
            :ARG0-of (g9 / gag-01 
                  :ARG1 (p6 / product 
                        :name (n17 / name 
                              :op1 "CAT-5") 
                        :wiki "Category_5_cable") 
                  :ARG2 (t3 / thing 
                        :name (n6 / name 
                              :op1 (t4 / TCG) 
                              :op2 (g / GGG))) 
                  :mod (t19 / thing 
                        :name (n21 / name 
                              :op1 (d / Dncl1-R) 
                              :op2 (c9 / CTA) 
                              :op3 (a12 / AGG))) 
                  :op1-of (s2 / sequence 
                        :mod (p8 / primer))) 
            :mod-of (o2 / organization 
                  :name (n22 / name 
                        :op1 "G-8") 
                  :wiki "G8") 
            :name (n23 / name 
                  :op1 (c10 / CAT) 
                  :op2 (g10 / GTC))) 
      :op18 (t17 / thing 
            :name (n19 / name 
                  :op1 (a9 / ATG) 
                  :op2 (g8 / GGG 
                        :mod (t18 / thing 
                              :name (n20 / name 
                                    :op1 (a10 / AAA) 
                                    :op2 (a11 / AAA)))))) 
      :op19 (t16 / thing 
            :name (n18 / name 
                  :op1 (c7 / CAT) 
                  :op2 (c8 / CAC))) 
      :op2 (t49 / thing 
            :name (n44 / name 
                  :op1 (c19 / CGA) 
                  :op2 (t50 / TCA))) 
      :op20 (t14 / thing 
            :name (n15 / name 
                  :op1 (g6 / GGA 
                        :mod (t15 / thing 
                              :name (n16 / name 
                                    :op1 (c5 / CTT) 
                                    :op2 (c6 / CCA)))) 
                  :op2 (g7 / GC))) 
      :op21 (t13 / thing 
            :name (n14 / name 
                  :op1 (a7 / ATG) 
                  :op2 (a8 / ACC))) 
      :op22 (t9 / thing 
            :name (n12 / name 
                  :op1 (a6 / ACA 
                        :mod (t11 / thing 
                              :name (n13 / name 
                                    :op1 (t12 / TTG) 
                                    :op2 (c4 / CCC)))) 
                  :op2 (g5 / GCC) 
                  :op3 (t10 / TT))) 
      :op23 (o / organization 
            :name (n11 / name 
                  :op1 "CAC" 
                  :op2 "ACG")) 
      :op24 (t7 / thing 
            :name (n10 / name 
                  :op1 (t8 / TGA) 
                  :op2 (g4 / GAT))) 
      :op25 (t6 / thing 
            :mod-of (s / state 
                  :name (n8 / name 
                        :op1 "CA") 
                  :wiki "California") 
            :name (n9 / name 
                  :op1 (g3 / GTC) 
                  :op2 (c3 / CTC))) 
      :op26 (t5 / thing 
            :ARG1-of (r / react-01 
                  :ARG0 1.5 
                  :ARG2 (t / thing 
                        :name (n2 / name 
                              :op1 "AmpliTaq")) 
                  :manner-of (a2 / amplify-01 
                        :ARG0 2.5 
                        :ARG0-of (c / contain-01 
                              :ARG1 (b / buffer-01 
                                    :ARG0 (p4 / person 
                                          :name (n3 / name 
                                                :op1 "Perkin" 
                                                :op2 "Elmer")) 
                                    :ARG1 (p5 / polymerase) 
                                    :ARG2 10) 
                              :op1-of (a / and 
                                    :op2 (m / MgCl2 
                                          :mod (m2 / mm)) 
                                    :op3 (u / unit 
                                          :quant-of (p2 / polymerase 
                                                :mod-of (p3 / primer 
                                                      :mod (e / each)))) 
                                    :op4 (p / person 
                                          :name (n / name 
                                                :op1 "Perkin" 
                                                :op2 "Elmer")))) 
                        :ARG1 (c2 / cdna 
                              :mod (l / library 
                                    :mod (n4 / ng)) 
                              :mod (t2 / thing 
                                    :name (n5 / name 
                                          :op1 (a3 / ATA) 
                                          :op2 (a4 / A.)))))) 
            :name (n7 / name 
                  :op1 (a5 / AGA) 
                  :op2 (g2 / GAT))) 
      :op3 (t45 / thing 
            :name (n41 / name 
                  :op1 (t46 / TCC) 
                  :op2 (t47 / TT 
                        :mod (t48 / thing 
                              :name (n42 / name 
                                    :op1 (g16 / GCT) 
                                    :op2 (c18 / CTC 
                                          :mod (p7 / product 
                                                :name (n43 / name 
                                                      :op1 "CAT-5") 
                                                :wiki "Category_5_cable"))))))) 
      :op4 (t44 / thing 
            :name (n40 / name 
                  :op1 (h2 / Homer3-F) 
                  :op2 (c17 / CCC) 
                  :op3 (a20 / AGG))) 
      :op5 (t40 / thing 
            :name (n38 / name 
                  :op1 (t41 / TAG 
                        :mod (t42 / thing 
                              :name (n39 / name 
                                    :op1 (t43 / TGG) 
                                    :op2 (c16 / CTG)))) 
                  :op2 (a19 / AGC))) 
      :op6 (t39 / thing 
            :name (n37 / name 
                  :op1 (h / Homer3-R) 
                  :op2 (c15 / CTC))) 
      :op7 (t37 / thing 
            :name (n36 / name 
                  :op1 (t38 / TAC) 
                  :op2 (a18 / ACA))) 
      :op8 (t36 / thing 
            :name (n35 / name 
                  :op1 (g15 / GTG) 
                  :op2 (c14 / CAA))) 
      :op9 (t34 / thing 
            :mod-of (o4 / organization 
                  :name (n33 / name 
                        :op1 "G-8") 
                  :wiki "G8") 
            :name (n34 / name 
                  :op1 (a17 / AGC) 
                  :op2 (t35 / TCA))))

# ::snt PCR conditions were ( 95 C for 30 sec )  1 , ( 94 C for 30 sec , 55 C for 30 sec , 72 C for 30 sec )  32 and ( 72 C for 2 min )  1 .
# ::tok PCR conditions were ( 95 C for 30 sec )  1 , ( 94 C for 30 sec , 55 C for 30 sec , 72 C for 30 sec )  32 and ( 72 C for 2 min )  1 .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:12:22.828
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Products were resolved on a 2.5 % agarose gel with X174/HaeIII size markers ( Promega ) .
# ::tok Products were resolved on a 2.5 % agarose gel with X174/HaeIII size markers ( Promega ) .
# ::alignments 14-15|0.0.1.0+0.0.1+0.0 12-13|0.2.0 11-12|0.2.0.0 10-11|0.2.0.1.0.0+0.2.0.1.0+0.2.0.1 8-9|0.2 6-7|0.2.1 5-6|0.0.0 2-3|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:12:22.914
(r / resolve-01 
      :ARG0 (o / organization 
            :mod 2.5 
            :name (n / name 
                  :op1 "Promega")) 
      :ARG1 (p2 / product) 
      :ARG4 (g / gel 
            :beneficiary (m / marker 
                  :mod (s / size) 
                  :mod (t / thing 
                        :name (n2 / name 
                              :op1 "X174/HaeIII"))) 
            :mod (p / percentage-entity)))

# ::snt PST domain , proline - , serine - and threonine-rich domain ; PSD , post-synaptic density ; PCR , polymerase chain reaction .
# ::tok PST domain , proline - , serine - and threonine-rich domain ; PSD , post-synaptic density ; PCR , polymerase chain reaction .
# ::alignments 21-22|0.0.0.0 20-21|0.0.0.0.1 19-20|0.0.0.0.2 15-16|0.0.0.1 12-13|0.3.0.0.0+0.3.0.0+0.3.0 11-12|0.3 10-11|0.2 8-9|0 6-7|0.1 3-4|0.0.0.0.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:12:23.098
(a2 / and 
      :op1 (d3 / domain 
            :mod (P / "PST" 
                  :ARG2-of (r / react-01 
                        :ARG1 (p2 / proline) 
                        :mod (c / chain) 
                        :mod (p / polymerase)) 
                  :mod-of (d / density))) 
      :op2 (s / serine) 
      :op3 (d2 / domain) 
      :op4 (a / and 
            :op1 (o / organization 
                  :name (n / name 
                        :op1 "PSD"))))

# ::snt STC carried out the bioinformatic analyses and all experimental work .
# ::tok STC carried out the bioinformatic analyses and all experimental work .
# ::alignments 9-10|0.2.0 8-9|0.2.0.1 7-8|0.2.0.2 6-7|0.2 5-6|0.1 4-5|0.2.0.0 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:12:23.471
(c / carry-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "STC")) 
      :ARG1 (a3 / analysis) 
      :ARG2 (a2 / and 
            :op1 (w / work-01 
                  :ARG1 (b / bioinformatic) 
                  :mod (e / experiment-01) 
                  :quant (a / all))))

# ::snt IMH conceived , designed and supervised the study , and obtained funding .
# ::tok IMH conceived , designed and supervised the study , and obtained funding .
# ::alignments 11-12|0.2.1.0 10-11|0.2.1 9-10|0.2 7-8|0.2.0.0 5-6|0.2.0 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:12:23.519
(a2 / and 
      :op1 (c / conceive-01 
            :ARG0 (o2 / organization 
                  :name (n / name 
                        :op1 "IMH"))) 
      :op2 (d / design-01) 
      :op3 (a / and 
            :op1 (s2 / supervise-01 
                  :ARG1 (s / study-01)) 
            :op2 (o / obtain-01 
                  :ARG1 (f / fund-01))))

# ::snt The manuscript was prepared jointly by STC and IMH , who have both read and approved the final version .
# ::tok The manuscript was prepared jointly by STC and IMH , who have both read and approved the final version .
# ::alignments 18-19|0.0.2.2.0.0 17-18|0.0.2.2.0.0.0 15-16|0.0.2.2.0 14-15|0.0.2.2 13-14|0.0.2 12-13|0.0.2.1 8-9|0.0.1.0.0+0.0.1.0+0.0.1 7-8|0.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0.2.0 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:12:24.107
(p / prepare-02 
      :ARG0 (a3 / and 
            :op1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "STC")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "IMH")) 
            :op3 (r / read-01 
                  :ARG1 (j / joint) 
                  :mod (b / both) 
                  :op1-of (a2 / and 
                        :ARG0-of (a / approve-01 
                              :ARG1 (v / version 
                                    :mod (f / final)))))) 
      :ARG1 (m / manuscript))

# ::snt We gratefully acknowledge Dr A Brown for technical advice on the yeast two-hybrid system and the Rosalind Franklin Centre for Genomics Research for supplying the Homer3 IMAGE clone .
# ::tok We gratefully acknowledge Dr A Brown for technical advice on the yeast two-hybrid system and the Rosalind Franklin Centre for Genomics Research for supplying the Homer3 IMAGE clone .
# ::alignments 27-28|0.1.2.0.1.1.1 26-27|0.1.2.0.1.1.1.0 23-24|0.1.2.0.1.1 20-22|0.1.2.0.1.1.0.0.1+0.1.2.0.1.1.0.0.0+0.1.2.0.1.1.0.0+0.1.2.0.1.1.0 17-19|0.1.2.0.1.0.0.1+0.1.2.0.1.0.0.0+0.1.2.0.1.0.0+0.1.2.0.1.0 14-15|0.1.2.0.1 13-14|0.1.2.0 11-12|0.1.2.0.0 8-9|0.1.2 7-8|0.1.2.1 5-6|0.1.3+0.1.1.0+0.1.1+0.1 3-5|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:12:25.160
(a4 / acknowledge-01 
      :ARG0 (w / we) 
      :ARG1 (p / person 
            :mod (t3 / thing 
                  :name (n4 / name 
                        :op1 (d / Dr) 
                        :op2 (a3 / A))) 
            :name (n3 / name 
                  :op1 "Brown") 
            :purpose (a2 / advise-01 
                  :ARG1 (s2 / system 
                        :mod (y / yeast) 
                        :op1-of (a / and 
                              :op2 (t / thing 
                                    :name (n2 / name 
                                          :op1 (f / Franklin) 
                                          :op2 (c2 / Centre))) 
                              :op3 (s / supply-01 
                                    :ARG0 (o / organization 
                                          :name (n / name 
                                                :op1 "Genomics" 
                                                :op2 "Research")) 
                                    :ARG1 (c / clone 
                                          :mod (i / image))))) 
                  :mod (t2 / technical)) 
            :wiki "Gordon_Brown") 
      :manner (g / grateful))

# ::snt STC was supported by Fight for Sight and IMH was supported by a Career Development Award from the UK Medical Research Council .
# ::tok STC was supported by Fight for Sight and IMH was supported by a Career Development Award from the UK Medical Research Council .
# ::alignments 18-22|0.0.2.0.3+0.0.2.0.2+0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 15-16|0.0.0 13-15|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 10-11|0.0 8-9|0.2.0.0+0.2.0+0.2 7-8|0 6-7|0.1 4-5|0.0.1 2-3|0.0.1.0 0-1|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T02:12:25.466
(a2 / and 
      :ARG1-of (s / support-01 
            :ARG0 (a / award-01 
                  :ARG1 (t / thing 
                        :name (n2 / name 
                              :op1 (c / Career) 
                              :op2 (d / Development)))) 
            :ARG1-of (f / fight-01 
                  :manner-of (s3 / support-01 
                        :ARG1 (o3 / organization 
                              :name (n4 / name 
                                    :op1 "STC")))) 
            :ARG2 (o / organization 
                  :name (n / name 
                        :op1 "UK" 
                        :op2 "Medical" 
                        :op3 "Research" 
                        :op4 "Council"))) 
      :op1 (s2 / sight-01) 
      :op2 (o2 / organization 
            :name (n3 / name 
                  :op1 "IMH")))

